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Abstract
Electrospray ionization mass spectrometry (ESI-MS) is a powerful technique for
investigating protein structures, conformations, and interactions. Despite its widespread
use, many fundamental aspects of ESI remain poorly understood. In this thesis, we use a
combination of molecular dynamics (MD) simulations and experiments to gain insights
into the hidden complexities of ESI-MS.

Chapter 2 discusses the topic of salt-induced protein signal degradation. Salts
such as NaCl, CsCl, and tetrabutylammonium chloride (NBu4Cl) interfere with MS data
acquisition, leading to adduct formation and signal suppression. MD simulations provide
an explanation for these salt interferences. Signal suppression can be broken down into
two effects, i.e., i) peak splitting due to adduction, ii) “genuine” signal suppression. The
results obtained may be helpful to anticipate solution conditions for improved protein
analyses by ESI-MS.
The two subsequent Chapters examine the mechanism of native protein
supercharging, which represents a highly contentious topic. Chapter 3 uses MD
simulations along with ion mobility mass spectrometry (IMS/MS). Holo-myoglobin
(hMb) serves as a model protein, along with the two most common supercharging agents
(SCAs), sulfolane and m-nitrobenzyl alcohol (m-NBA). Our data show that supercharging
is caused by ‘charge trapping’ that arises from solvent segregation in the droplets,
resulting in the formation of SCA-enriched surface layer and an aqueous core. The key
factor to charge trapping is the differential solubility of charge carriers (such as Na+ or
NH4+) in water compared to the exterior SCA layer. After complete water evaporation,
residual SCA molecules impede charge carrier release from the droplet, and any
remaining charge carriers will bind to the protein. Slow SCA evaporation eventually
releases a highly charged protein into the gas phase that may undergo Coloumbic
unfolding. These findings represent the first atomistic view of protein supercharging.
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In Chapter 4, we explore the mechanism of native protein supercharging from a
different perspective using a crown ether (18C6). 18C6 selectively binds Na+/NH4+ and
enhances their solubility in the SCA layer. This facilitates the release of 18C6-bound
charge carriers from the droplet. As a result, 18C6 suppressed supercharging effect, as
confirmed both in MD simulations and experimentally. These data support the proposed
charge trapping mechanism for both proteins and dendrimers.
A chain ejection model (CEM) has been proposed to account for the protein ESI
behavior under such non-native conditions. The CEM envisions that unfolded proteins are
driven to the droplet surface by hydrophobic and electrostatic factors, followed by
gradual ejection via intermediates where droplets carry extended protein tails. Thus far it
has not been possible to support the CEM through MD simulations. In Chapter 5 we
overcome these difficulties and use MD simulations along with ion mobility experiments
to confirm CEM as an ejection mechanism for unfolded proteins. Overall, the modeling
and experimental work in this thesis provide unprecedented insights into the mechanism
of protein charging and supercharging during ESI.

Keywords: electrospray ionization mass spectrometry | molecular dynamics (MD)
simulations | supercharging | charging | protein ion.
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Chapter 1. Introduction
1.1. Protein Structure-Function Relationship
Proteins are biological polymers that are involved in all physiological processes. There are
structural proteins (viral coat proteins, epidermal keratin); catalytic proteins (enzymes); transport
and storage proteins (hemoglobin, myoglobin, ferritin); regulatory proteins (hormones,
transcription regulators), and proteins of the immune system. Their size ranges from a few
thousand Daltons (Da) all the way to the megadalton (MDa) range.1
Proteins adopt their higher order structure through folding (Figure 1.1). Twenty
naturally occurring amino acids represent the basic building blocks during protein biosynthesis.
These amino acids form polypeptide chains via peptide bonds; this is known as the primary
structure (Figure 1.1a). Secondary structure forms via intramolecular hydrogen bonds that
organize the backbone into α-helices and β-sheets. The arrangement of secondary motifs results
in the formation of tertiary structure that is stabilized by non-covalent interactions (hydrogen
bonds, van der Waals forces, ionic interactions and hydrophobic packing) (Figure 1.1b, c).
Quaternary structure refers to an assembly of two or more protein chains.2
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N-terminal

C-terminal

(a)

(b)

(c)

Figure 1.1. a) A polypeptide showing a peptide bond in red. b) NMR structure of S100B (PDB:
1UWO), showing α-helices c) Tertiary structure of outer membrane protein A (PDB: 1QJP), illustrating
β-sheets.

1.2. Factors that Contribute to the Stability of Native Protein
Structures in Solution
In their biologically active (“native”) state, most proteins are folded into highly ordered compact
structures. There is a delicate balance between the folded native conformation (N) and the
unfolded state (U). Folding transitions are often discussed in terms of a simple two-state
equilibrium N⇌U, and the corresponding equilibrium constant K = [U]/[N] can be affected by
changes in temperature or solvent properties.
The Gibb’s free energy change ∆𝐺° = −𝑅𝑇𝑙𝑛𝐾 provides a framework for discussing protein
stability; it includes enthalpic ( ∆𝐻) and entropic ( ∆𝑆) contributions arising from the protein and
the surrounding solvent according to
∆𝐺°𝑁→𝑈 = ∆𝐻°𝑁→𝑈 − 𝑇∆𝑆°𝑁→𝑈

(1.1)
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For N to be stable, G° has to be positive. To decipher the basics of protein stability, it is
essential to identify the types of interactions that affect ∆𝐻 and ∆𝑆.3
Hydrogen bonds (H-bonds) are one of the primary stabilizing factors for secondary
structure (α-helices and β-sheets). H-bonds are non-covalent interactions that occur between a
hydrogen donor and acceptor e.g., in α-helices the amide hydrogen donor (N-H) is hydrogen
bonded to the oxygen of the carbonyl group. In addition to these backbone contacts, H-bonds can
form among side chains, or between side chains and the backbone.4-5
Van der Waals interactions take place between atoms that are in close contact with one
another. The protein has favorable internal van der Waals interactions, but there are also
favorable van der Waals contacts with the solvent.6
Salt bridges form due to electrostatic interactions between the positively charged side
chain of lysine (Lys) and arginine (Arg) and the carboxylate group of glutamic acid (Glu) and
aspartic acid (Asp). Salt bridges are rarely located within the protein as it is energetically
unfavorable to desolvate two charged groups. Mostly, salt bridges are located on the surface
where they are solvated by water. Therefore, the contribution of salt bridges to protein stability is
limited.7
Disulfide (S-S) bridges are covalent contacts formed between pairs of cysteine (Cys)
side chains. These bonds are found in many proteins such as lysozyme and insulin. They
contribute to the stabilization of native state by decreasing the conformational entropy of the
unfolded state.8
The hydrophobic effect is the most dominant factor in protein stability. Nonpolar amino
acids tend to sequester themselves in the protein interior to avoid solvation by water. This
phenomenon can be explained thermodynamically. The surface of the protein is decorated with
hydrophilic residues that are solvated by water which is enthalpically favorable. The hydrophobic
residues that cannot form H-bonds are buried inside which will decrease the entropic penalty as
described by the “iceberg model”. In liquid water, the hydrogen bond network is very dynamic
due to Brownian motions. Placing a non-polar molecule in bulk water will cause the formation of
immobilized “water cages” around them. This iceberg water has lower entropy than bulk water.
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To avoid this undesirable effect, water molecules decrease their contact with non-polar
molecules. This is achieved by the burial of hydrophobic molecules within the protein core.9-10
The entropy of the polypeptide chain decreases dramatically upon folding. This will
reduce the entropy of the protein (∆𝑆 < 0) which is thermodynamically unfavorable. At the same
time, hydrophobic interactions will compensate for this effect by increasing the entropy of the
surrounding water. When the hydrophobic chains are clustered together, the water molecules
surrounding these non-polar patches will be released in bulk water and participate into the Hbond network of the solvent. Overall, the magnitude and the sign of ∆𝐺° in equation 1.1
represents a delicate balance between numerous competing factors and interactions.

1.3. Methods for Studying of Protein Structure and Dynamics
1.3.1. X-ray Crystallography
X-ray crystallography represents the most important tool for determining highresolution 3D protein structures. Thousands of protein structures in the Protein Data Bank (PDB)
have been obtained via X-ray crystallography. Under optimal conditions, this technique can yield
structural data with a resolution of about 1 Å which is on the order of atomic bond lengths.11
The birth of X-ray crystallography started with the work of Nobel prize winner Max von
Laue, who discovered the interaction of X-ray photons with crystals. In 1915, Nobel Prize
winners Lawrence Bragg and his father William Bragg developed Bragg’s law that is used to
analyze the diffraction patterns produced by the crystal lattice upon exposure to X-ray. In X-ray
crystallography, protein crystals are exposed to an X-ray beam. The X-ray photons are diffracted
by the electrons in the crystal lattice which constructively or destructively interfere with each
other. From the resulting diffraction pattern, it is possible to produce a three-dimensional electron
density map, from which atomic positions and bonds in the crystal can be obtained.12
Proteins undergo incessant thermal motions and fluctuate between different
conformations.13 The crystallographic B-factors report on the thermal displacement of atoms
from their average positions, but they also have contributions from crystal imperfections.14-15
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Overall, dynamic information obtained from B-factors is limited, calling for the use of
complementary techniques such as nuclear magnetic resonance spectroscopy.16-17

1.3.2. Nuclear Magnetic Resonance (NMR) Spectroscopy
The development of NMR spectroscopy started in the 1940s by the Rabi, Purcell, and Bloch
groups.18-19 All of them received the Nobel Prize for their achievements. Since then, NMR has
evolved into a valuable tool that is used for a wide range of applications, from the
characterization of small molecules to the conformational determination of biomolecules. NMR
probes nuclei that have a spin such as 1H, 13C, 15N, 17O, 33S. Unlike X-ray crystallography, NMR
is conducted in aqueous solution and it provides a near physiological environment for protein
analyses.
Various NMR techniques are available for probing of protein structures20 and dynamics
at atomic resolution.21 NMR spectra often suffer from spectral congestion and decreased
intensity, especially for larger proteins. Replacement of hydrogen with deuterium in conjunction
with transverse relaxation- optimized spectroscopy (TROSY) experiments is one way to address
this difficulty, thereby extending the size range accessible by NMR methods.22

1.3.3. Cryogenic Electron Microscopy (Cryo-EM)
In recent years, cryo-EM has become a powerful tool in structural biology. In 2017 the Nobel
Prize in chemistry was granted to Dubochet, Frank, and Henderson for the development of cryoEM which helps in obtaining structural information for non-crystallized proteins.23 This
technique has proved to be an excellent tool in case of multimeric proteins and membrane
proteins. Cryo-EM uses frozen protein samples.24 The continuous developments of cryo-EM
made it possible to resolve challenging structures that have been unamenable to X-ray
crystallography, e.g., the yeast exocyst that is responsible for vesicle transport25 and the structure
of actin bound to myosin which is important for muscle contraction.26
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1.3.4. Optical Methods
Optical methods are easy to use, quick and sensitive, but they do not provide high-resolution
structural information. Examples include UV-Visible (UV-Vis) absorption, circular dichroism
(CD) and fluorescence spectroscopy.
UV-Vis absorption spectroscopy can be used to probe protein conformations as a
peptide bond absorbs light in the far UV range around 195 nm. A second absorption maximum
around 280 nm arises from aromatic amino acids such as tyrosine, tryptophan, and
phenylalanine. Sometimes prosthetic groups have a strong absorption band, e.g., the
spectroscopic properties of heme groups depend on the oxidation state, the presence of ligands,
and the surrounding environment.27 In addition, protein concentrations can be calculated using
the Beer-Lambert law
𝐴 = 𝜀𝐶𝑑

(1.2)

where A is the absorbance, 𝜀 is the molar absorption coefficient as a function of
wavelength, 𝐶 is the concentration, and 𝑑 is the path length of the cuvette.28
Circular Dichroism spectroscopy is useful for interrogating chromophores that contain
chiral centers (such as the alpha carbons along the protein backbone). A CD spectrum represents
the absorption difference between left and right circularly polarized light. This technique is
commonly used to probe changes in protein secondary structure. For example, a dominant CD
band at 222 nm is a hallmark of α-helical structure, while a band around 215 nm corresponds to
β-sheets. The random coil signal appears at ~ 200 nm.29-30
Fluorescence spectroscopy is routinely used for protein structural analyses. An excited
fluorophore emits photons due to relaxation to the ground state. Tryptophan (Trp) is the most
intense fluorophore in proteins.31 The chromophore environment has a significant effect on
fluorescence. Förster Resonance Energy Transfer (FRET) is a valuable method for characterizing
protein conformations. FRET depends on the distance between the excited donor and acceptor.
One of the consequences of FRET is quenching. Quenching takes place if a fluorophore is close
to a non-fluorescent acceptor, such as the heme group in cytochrome c, where the energy
transfers from Trp59 to heme takes place in native conformation, so Trp59 becomes non-
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fluorescent. In contrast, for unfolded cytochrome c Trp59 is highly fluorescent, thereby providing
a tool to monitor conformational changes.32

1.4. Mass Spectrometry
Mass spectrometry (MS) has become an indispensable tool in the field of structural biology and
proteomics. Its applications include measuring mass to charge ratio (m/z), as well as providing
information on structures, protein-ligand interactions and post-translational modifications. MS
can be used either as an isolated technique or coupled to liquid chromatography (LC), gas
chromatography (GC), capillary electrophoresis (CE) or ion mobility spectrometry (IMS).

1.4.1. Ion Source
Ionization of analytes takes place in the ion source. There are different methods of ionization in
MS, such as electron ionization (EI), fast atom bombardment (FAB) and chemical ionization (CI)
These “traditional” techniques tend to cause fragmentation, particularly for larger analytes.33 The
analysis of biomolecules such as proteins requires gentle ionization techniques such as
electrospray ionization (ESI) and matrix-assisted laser absorption/desorption ionization
(MALDI). In 2002, Fenn

34

and Tanaka won the Chemistry Nobel Prize for developing ESI and

MALDI, respectively. In the positive ion mode, both ESI and MALDI predominantly form
protonated analyte ions with m/z that is given by
𝑚 [𝑀 + 𝑧 × 1.008]
=
𝑧
𝑧

(1.3)

where M is the mass of the neutral analyte and 1.008 represents the proton mass. The mechanism
of ESI will be discussed in more detail below (section 1.6).
MALDI is a gentle surface desorption ionization technique that was introduced by
Hillenkamp and Karas in 1985.35-36 The protein sample is mixed with a matrix, for example, 2,4
dihydroxybenzoic acid. The matrix absorbs UV laser energy and then desorbs from the surface
together with the protein. The charge is transferred from the matrix to the gaseous analyte within
the MALDI plume.37-38 One of the drawbacks of MALDI is that the extent of charging is limited,
such that analyte ions tend to appear at very high m/z, beyond the range accessible to some mass
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analyzers. For this reason, MALDI is often coupled with time of flight mass analyzers (TOF)
which have a very wide m/z range. Also, MALDI imaging-MS has become a widely used
technique for direct, label-free detection of proteins, lipids, and metabolites in tissue sections.39-40

1.4.2. Mass Analyzers
A mass analyzer is the part of the mass spectrometer that separates gas phase ions according to
their m/z. There are several mass analyzers such as quadrupoles, ion traps, TOFs and Fouriertransform ion cyclotron resonance (FT-ICR) instruments. Only the quadrupole and TOF
operation will be briefly discussed due to their use in the experiments of the current thesis.
TOF analyzers have an excellent ion transmission, resolution and an extended mass
range. The TOF operation is straightforward; ions with different m/z are accelerated by the same
voltage supplied by an ion pusher. The voltage pulse DELTA 𝑈 supplies all ions with potential
energy which is then converted into kinetic energy.
𝑧𝑒∆𝑈 =

1
𝑚𝑣 2
2

(1.4)

𝑚, 𝑣, 𝑧𝑒 represent the mass, velocity and ion charge. rearrangement of equation 1.4 yields
2𝑧𝑒∆𝑈
𝑣=√
𝑚

(1.5)

The time for an ion to reach the detector 𝑡 is given by

𝑡=

𝑙
𝑙 √𝑚
𝑙
𝑚
√
=
=
𝑣 √2𝑧𝑒∆𝑈 √2𝑒∆𝑈 𝑧

(1.6)

Equation 1.6 shows that the flight time 𝑡 for an ion depends on m/z. Therefore, a mass
spectrum can be recorded as a function of flight time. Ions with different m/z will have variable
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velocities and different fight times. However, under realistic conditions some ions with the same
m/z may have slightly different kinetic energy because they do not all experience exactly the
same acceleration potential ∆𝑈.

These conditions cause peak broadening and decreased

resolution.41 Reflectrons are used to correct this issue. The reflectron provides an electrostatic
field to reverse the direction of the ion trajectory. If two ions have the same m/z but different
velocities, the faster one penetrates deeper into the reflectron before being directed back toward
the detector. A reflectron increase the TOF resolution up to 40,000, but at the same time
sensitivity (ion transmission) is decreased.42-43 TOF mass spectrometers can easily be combined
with a pulsed ionization technique such as MALDI. However, it is also possible to use
continuous ionization techniques such as ESI (see below).

1.4.3. Quadrupole
One of the most commonly used mass analyzers is the quadrupole. It is composed of four parallel
cylindrical rods. Both radiofrequency (RF) and direct current (DC) electric potentials are applied
to the rods if the quadrupole is used as a ‘mass filter’. At a constant DC/RF ratio, ions of a
certain m/z travel through the quadrupole and reach the detector. Any ions with other m/z values
will have unstable trajectories and hit one of the rods, i.e. they will not be transmitted (Figure
1.2a). In the absence of DC, all ions will pass through the quadrupole regardless of their m/z. In
this ‘RF-only’ mode, the quadrupole acts as an ion guide (Figure 1.2b). RF-only quadrupole can
also be used as collision cell in the presence of a suitable background gas and an accelerating
bias.44
Quadrupole mass analyzers have a relatively low resolution (~4000) but offer excellent
sensitivity. Usually, they are combined with a TOF (Q-TOF) or in a series of three quadrupoles
known as “triple quads” for tandem MS applications, where the second quadrupole acts as a
collision cell.43
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Figure 1.2. Cartoon representation showing quadrupole operation. a) Application of DC voltage
locks the quadrupole so only specific m/z can pass (blue line). b) RF only where all ions can pass.

1.5. MS Techniques for Studying of Protein Structure and
Dynamics
1.5.1. Collision-Induced Dissociation and Tandem MS
Fragmentation experiments are essential for deciphering the chemical composition of gaseous
analytes such as peptides and proteins. The bottom-up methodologies are very common, they
involve enzymatic digestion of the protein prior to gas phase fragmentation and MS analysis.45
On the other hand, in the top-down approach, intact proteins undergo fragmentation inside the
mass spectrometer without prior enzymatic digestion.46
In collision-induced dissociation (CID), protein or peptide ions are accelerated by an
electric voltage in a region filled with inert gas. Collisions with this background gas will
gradually increase the internal energy, ultimately resulting in the rupture of noncovalent contacts
and covalent bonds. CID can be conducted directly in the ion sampling interface (in-source CID),
or in an RF-only ion guide after quadrupole-based precursor selection. The latter technique is
known as tandem MS (MS/MS) which is essential for analyte mixtures.47

1.5.2. HDX-MS, Covalent Labelling, and Cross-Linking
Hydrogen/deuterium exchange (HDX) MS is commonly employed to detect proteinligand interactions and to explore protein conformational dynamics. HDX uses deuterium (D2O)
as a labeling reagent.48 HDX exploits the exchange of labile protein hydrogen atoms with
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deuterium from the solvent. Backbone NH sites and those of side chains tend to exchange
rapidly. However, hydrogens that are H-bonded (in α-helices and β-sheets) and/or those that are
buried will exchange much more slowly. Deuteration at these protected sites is mediated by
thermal opening/closing transitions, i.e. by the conformational dynamics of the protein.49 HDX
experiments were initially conducted with NMR spectroscopic detection,50 later the use of MS
for this purpose has become the more widely used approach.48, 51
The HDX workflow starts with the mixing of the protein solution with D2O based buffer
for various time intervals (continuous labeling), or just for a fixed labeling period (pulsed HDX).
This labeling step is followed by quenching at pH ~2.5 and at low temperature, to avoid
deuterium back exchange. Information about the exchange can be obtained either from intact
protein mass analyses (global HDX) or after proteolytic digestion and LC-MS of the resulting
peptides.49, 52-53
Covalent labeling is a powerful technique that can probe the surface accessibility of
amino acids in solution via irreversible chemical modifications.54-55 The principle of covalent
labeling is related to HDX, the main difference is that HDX reports on backbone H-bonds while
covalent labeling targets protein side chains. Hydroxyl radical (•OH) is a commonly employed
highly reactive covalent label that modifies side chains via oxidation. •OH radical can be
generated by X-ray radiolysis of water or by photolysis of hydrogen peroxide (H2O2) and Fenton
chemistry. In the last method, a metal is used such as Fe (Ⅱ) to reduce H2O2.56 UV photolysis of
H2O2 is a method developed by Hambly and Gross, known as fast photochemical oxidation of
proteins (FPOP).57-58 To determine the location and extent of oxidation, protein digestion is used
along with MS/MS. Caution must be taken to avoid extensive oxidation, low concentrations of
H2O2 must be employed and control experiments should be done with no laser treatment to
evaluate the extent of oxidation. Radical scavengers such as glutamine are used to quench the
reaction to decrease the •OH lifetime. A recent study by our group has shown that FPOP can be
complicated by the presence of secondary radicals that can form during FPOP which extend the
time of the reaction and give rise to artifacts.59 Despite that, FPOP holds great promise as a
technique to probe protein-protein or protein-ligand interactions. In studies done by Stocks and
Konermann, FPOP was used to probe short-lived intermediates in protein folding and
unfolding.60-62
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Chemical cross-linking is another widely used approach. The choice of a cross-linking
reagent relies on the distance between two peptide residues. The crosslinker is a molecule with
two reactive groups separated by a spacer of a certain length. They can be of different types such
as homobifuncational molecules that target the same groups on the protein, or heterobifunctional
molecules that bind different amino acids.63 The main target residues for crosslinking are the
primary amines and NS carboxyls.64 Cross-linked proteins are analyzed by enzymatic digestion
followed by LC-MS/MS. The resulting data are used to identify the modified peptide and the
sites of linkage. Cross-linking provides a distance constraint that limits the number of possible
structures and helps to draw the topology of subunits in complexes which promotes its use in
computer modeling. Interpretation of data is quite challenging as the there may be too many
cross-links.65-67 This can be resolved by comparing the possible cross-linked peptides against
database searches.68

1.5.3. Ion Mobility Spectrometry (IMS)
IMS is a technique for separating analytes that have different gas-phase structures.15 The history
of IMS can be traced back to the early 20th century.69 In recent years, the coupling of IMS with
soft ionization techniques such as ESI and MALDI has opened up new avenues for the analysis
of biomolecules.70-73 In IMS, protein ion separation depends on size, charge and conformation.
Drift tubes represent the conceptually most straightforward type of IMS device. Ions
move into a background gas (typically helium) under the influence of a weak constant electric
field 𝐸 in a radial direction towards the mass analyzer. The ions are separated based on their
mobility K
𝐾=

𝑣
𝐿
=
𝐸 𝑡𝐷 𝐸

(1.7)

In this equation L refers to the length of the drift tube, 𝑡𝐷 is the drift time and 𝑣 is the
velocity. The reduced ion mobility 𝐾0 can be calculated according to standard conditions of
temperature and pressure of the buffer gas to compensate for differences between laboratories
and instruments.
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𝐾0 = 𝐾

𝑇0 𝑃
𝑇 𝑃0

(1.8)

where 𝑇0 =273.2 K, and 𝑃0 = 760 Torr. Drift tubes have high-resolving power. Early versions
suffered from poor ion transmission, but continuous improvements and the use of ion guides
before the drift cell helps in ion storage and focusing.15
The collision cross section (CCS) represents a type of projection area that arises from
the average of all possible orientations involved in the gas phase collisions. The CCS depends on
the shape of ion and its interaction with the background gas. The dependence between the CCS
(𝛺) and the measured drift time tD is given by equation 1.9 74

𝑒𝐸
18𝜋 𝑃0 𝑇
√
𝛺 = 𝑡𝐷 𝑧
16𝑁𝐿 𝜇𝑘𝐵 𝑇 𝑃 𝑇0

(1.9)

where N is the number density of the gas, µ is the reduced mass of ion and gas. 𝑘𝐵 is the
Boltzmann constant.74-75 Large ions have a longer drift time due to their more frequent collisions
with the background gas, while smaller ions will experience a less frictional force. Ions with
more charges will reach the detector faster, i.e., they will have higher mobilities.
The introduction of the Synapt platform by Waters in the early 2000s for the first time
allowed the use of a different type of IM separation. This approach involves the use of traveling
wave ion guides (TWIGs), and the technique is known as traveling wave ion mobility
spectrometry (TWIMS). The main difference between drift tube IMS and TWIMS is that drift
tubes have a static electric field, while TWIMS technology uses “peristaltic” traveling waves.
More specifically, ions travel through a stack of ring electrodes at which opposite phases of
radiofrequency (RF) are applied to adjacent electrodes. This creates a radial confining potential
well. Ions are trapped inside the well. When a transient direct current (DC) voltage that jumps
from ring to ring is superimposed on the RF voltage ions will travel through the ion guide by
“surfing” on these waves. Ions with high mobility will tend to be swept along with the wave,
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while ions of low mobility will occasionally roll over and slip behind the crest of the wave.76-77
TWIMS generally has a lower resolution than drift tube IMS, but its performance can be
enhanced by using a He cell prior to the TWIMS device (triwave cell), or by manipulating the
wave amplitude and velocity .77
The nature of the TWIMS separation process is not fully understood, so calibration
methods have been developed to extract numerically accurate CCSs from TWIMS experiments.78
CCS values can also be predicted on the basis of 3D protein conformations. Different
algorithms have developed for this purpose. These include the projection approximation (PA)
which represents the simplest and least accurate of all available methods.79 The exact hard
sphere (EHSS) is computationally fast and considers the scattering effects of colliding ions, but
does not include the long-range interactions.80 The later effects are being included in the
trajectory method (TM ) which by far is the most accurate and expensive method.81

Capillary

TOF
TWIG Quadrupole

IMS TWIG

Pusher

Detector

Reflectron

Figure 1.3. Schematic layout of a typical “Synapt” Q-TOF mass spectrometer with a quadrupole,
TOF and ion mobility (TWIMS) separator. The blue line represents the ion trajectory.
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1.6. Electrospray Ionization (ESI)
ESI is the most common atmospheric pressure ionization technique. The idea behind ESI started
with Malcolm Dole who was the first to exploit the idea of electrostatic spray painting for
electrospraying kDa polymers. Dole’s results were the starting point for the subsequent “ESI
revolution”.82 In the 1980s, ESI was further developed by John Fenn. Since then, this ionization
technique has been proven to be effective for a wide range of analytes including proteins, amino
acids, DNA, lipids, and sugars.34
ESI has many advantages such as the possibility for coupling with LC, and the
production of multiply charged ions which allows the detection of high molecular weight
biomolecules on analyzers with limited m/z range. ESI cannot tolerate high salt concentrations
except when the samples are desalted (e.g., by LC, see Chapter 2).83
ESI starts with analyte solution that is infused through a metal capillary (typically ~ 0.1
mm I.D.) held at an electric potential of several kV. The following discussion will be limited to
positive ion mode as this is most commonly used for a wide range of applications. Charge
separation takes place by removal of electrons from solution through oxidation (e.g. 2H2 O →
O2 + 4H + + 4e− ). This will induce charge accumulation at the tip of the capillary, forming a
Taylor cone that emits a mist of µm-sized droplets. The droplets will be charged with excess
positive ions (such as Na+, K+, H+, NH4+). Acceleration potentials between the capillary exit and
orifice will drive the droplets toward the ion sampling interface. During their journey, the
droplets undergo evaporation assisted by the heating elements in most commercial ion sources.
Evaporation enhances the charge density on the shrinking droplets until Coulombic repulsive
forces exceed surface tension; this is known as the Rayleigh limit.84-85 At this point, the
number 𝑧𝑅 of elementary charges e on the droplet is givent by

𝑧𝑅 =

8𝜋√𝜀0 𝛾𝑅 3
𝑒

where R is the droplet radius, 𝜀0 is the vacuum permittivity, and 𝛾 is the surface tension.

(1.10)

16

At the Rayleigh limit, the droplet becomes unstable and undergoes jet fission, resulting
in the formation of smaller droplets. Repeated evaporation/fission cycles generate nanodroplets
from which gas phase analyte ions are released. These ions will travel to the vacuum interface
where any remaining solvent clusters will be removed by collisional activation.83, 86-88
Initial droplets Final droplets
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Figure 1.4. Schematic representation of ESI source operated in positive ion mode.

1.6.1. Mechanism of Gas Phase Ion Release During ESI
The ESI mechanism remains controversial; three main models have been suggested to describe
how protein ion is ejected from the droplet, known as charged residue model (CRM), ion
evaporation model (IEM) and chain ejection model (CEM).
In the IEM, successive evaporation and fission events will increase the repulsion of
charges on the surface of the droplet; this will allow the ejection of small analytes (Figure 1.5a)
when the electrostatic repulsion allows the ions to overcome the free energy barrier for
ejection.34, 89-91 The IEM was initially suggested for small inorganic ions such as Na+ and NH4+.
However, some authors suggest that the IEM also applies to macromolecules.92
𝑁𝑎+ (𝑎𝑞) → 𝑁𝑎+ (𝐻2 𝑂)𝑛 (𝑔)

(1.11)
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Ion release in IEM depends mainly on the ability of a solvated ion to cross the free
energy barrier, so if the ion resides close to the liquid-vacuum surface, then this will enhance its
ejection probability. De la Mora’s work provided experimental support for the IEM

93-94

while

MD simulations have shed light on how small solvated ions get released from the surface of the
droplet.83, 95
Large globular analytes such as natively folded proteins are believed to follow the CRM,
where evaporation and Coulombic fission occur until a single analyte molecule remains inside
the droplet. This molecule gets released into the gas phase upon droplet evaporation to dryness.
Any remaining charges inside the vanishing droplet transfer to the analyte (Figure 1.5b).96 MD
simulations and experimental work support the CRM. The CRM/Rayleigh charge model shows
good agreement between the expected final charge state of protein ions using equation 1.10 and
the charge produced under experimental conditions.97-98 This charge is exactly what would be
expected for droplets that dry out until they have reached the same size as the protein. Very
likely, salt clusters like [ NanCln-1] are also formed by the CRM.99
A related framework is known as the combined charged residue-field emission model
(CCRFEM). It envisions that the number of charges the protein holds is related to the release of
low molecular weight (MW) charge carriers from the droplet, i.e., any ion that fails to leave the
droplet will end up on the macromolecule. It can be argued that CCRFEM is very similar to the
CRM but one difference between both models is that the final analyte charge state does not
depend on the Rayleigh limit but on the rate of low MW ion departure from the droplet.100-101
One key factor that determines the mechanism whereby macromolecules are released
from ESI nanodroplets is their conformation. In native proteins, hydrophobic amino acids are
buried inside the core while hydrophilic groups are on the surface. These conditions favor the
CRM. However, under denaturing conditions (i.e. high organic, low pH) the hydrophobic core is
exposed to solvent. This is energetically unfavorable as described in section 1.2. To understand
how disordered protein chains are released from the droplet, it is essential to examine the
behavior of macromolecules such as polyethylene glycol (PEG) and polypropylene glycol (PPG).
They are conceptually similar to unfolded proteins in being randomly coiled. Simulations using
PEG as a model by Consta suggest that PEG travels to the surface of the droplet. One chain
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terminus then erupts from the droplet and can remain attached until complete dryness of the
droplet or it can separate from it.102-103 Our laboratory proposed that a similar ESI mechanism
applies to unfolded proteins named chain ejection model (CEM).83 In the CEM, the protein
travels to the droplet surface and then undergoes stepwise ejection via hydrated ‘tadpole-like’
conformers where the droplet carries an extended protein tail. This chain ejection is enhanced by
electrostatic repulsion of the charge on the protruding tail and the remaining charges on the
droplet along with hydrophobicity. CEM is mechanistically similar to CID processes of multisubunit systems.104-105 So far it was not feasible to simulate the CEM for unfolded proteins due to
difficulties associated with the droplet size and charge migration. Details about how we were
able to deal with those difficulties are discussed in Chapter 5.

Figure 1.5. Cartoon representation of proposed ESI models. a) The ion evaporation model is
proposed for small ions, b) The charged residue model is suggested for globular folded proteins,
c) The chain ejection model is envisioned for polymers and unfolded proteins.
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1.6.2. Nanoelectrospray Ionization (NanoESI)
NanoESI is a variation of ESI that was developed in the mid-1990s by Wilm and Mann.106 Both
nanoESI and conventional ESI follow the same fundamental steps. NanoESI uses a lower flow
rate, typically less than 100 nL min-1, while conventional ESI operates in the µL min-1 range. The
emitter tip diameter in nanoESI is typically on the order of 1 µm. The analyte can be in contact
with high voltage at the tip of the emitter, or with a metal (Pt) wire that is placed inside the
needle. The need to initiate and maintain a constant flow rate can be achieved by using gentle N2
back-pressure. The low flow rate is responsible for the high ionization efficiency. One of the
advantages of nanoESI is its higher salt tolerance. Because the initial droplets formed in nano
ESI are smaller, the salt concentration after evaporative droplet shrinkage tends to be lower.
NanoESI is also beneficial because of its much lower sample consumption.107-108 It has been
proposed that nanoESI is even more gentle than regular ESI for the preservation of non-covalent
complexes109 but these claims are not universally accepted.110-112 In recent years, nanoESI with
very small emitter diameters have been used to increase charge states,113 to observe membrane
proteins, 114 and to study proteins in physiological buffers by direct infusion nanoESI-MS.115

1.7. Protein ESI under Native and Denaturing Conditions
Electrosprayed proteins are always multiply charged. The number of charges can be described by
charge state (z), and the protein charge state distribution (CSD) depends critically on the protein
conformation in solution.
Globular proteins are characterized by a hydrophobic core and a hydrophilic surface.
Their tightly folded structure gives rise to CSDs centered at low charged states. Direct analysis of
these globular folded proteins by MS was developed in the 1990s by Katta

116

and Ganem,117

this was later known as ‘native ESI-MS’. The name originates from the ability of the technique to
preserve protein-ligand and protein-protein interactions in the gas phase.118-120 Both Robinson121
and Heck122 have contributed to the development of native ESI-MS in investigating mega Dalton
proteins, viruses or their capsid shells.123-128 This field has benefited greatly from the
development of nanoESI, the inception of novel mass analyzers, and the development of
commercially available IMS devices.129-131
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Controlling the instrumental parameters along with using suitable buffers helps in the
analysis of protein and protein complexes under native ESI-MS. Typically, ammonium acetate is
used as a buffer in native ESI-MS to mimic the cellular environment and decrease the probability
of structural changes. However, ammonium acetate is not an actual ‘buffer’ at pH 7 because it is
not composed of a weak acid and its conjugate base. Ammonium acetate is nonetheless used due
to its volatile character which facilitates the formation of adduct-free protein ions. Conventional
pH 7 buffers (e.g. phosphate buffer) cannot be used for direct infusion experiments because they
would trigger extensive adduct formation.132 Ammonium carbonate is a volatile pH 7 buffer, but
it can destabilize proteins under ESI conditions.133-134 Substantial evidence has been accumulated
that globular proteins generated by native ESI are formed via the CRM. As outlined above, the
low charge states of these ions are close to the Rayleigh charge of a protein-sized water droplet.
The ESI behavior of unfolded proteins is completely different, these species show wide
CSDs that are shifted to much higher z values than in native ESI. Any non-covalent interactions
are disrupted. This effect can be triggered by solution unfolding after exposure to acid,135-136
base,137 heat,138 or reduction of disulfide bonds.139 Instrumental parameters such as increasing the
temperature inside the ion source can also induce unfolding.140 As noted above, unfolded proteins
are likely transferred into the gas phase via the CEM, but this concept remains controversial (see
Chapter 5).
High protein charge states can also be achieved by supercharging agents (SCA) in both
native and denatured protein solutions.141-143 SCAs are added to the sample at low concentration
that do not affect protein structure.144 Nonetheless, SCAs increase protein charging during ESI.
SCAs have a high dipole moment and low volatility.145 They concentrate inside the ESI droplet,
therefore the final nanodroplets contain significantly enhanced SCA concentrations compared to
the initial bulk solution. The mechanism of supercharging is highly controversial.146 (see
Chapters 3 and 4). High protein charge states formed after unfolding and/or in the presence of
SCAs enhance fragmentation in top-down experiments.147 Also, increased charges are beneficial
for mass analyzers that have limited m/z, or that have m/z-dependent performance characteristics
(resolution and sensitivity) such as FT-ICR or orbitrap mass analyzers.
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1.8. Proteins in the Gas Phase vs. in Solution
It is common to think of proteins as biomolecules that are surrounded by a buffered aqueous
environment. Water is essential for proteins to function and to maintain the native conformation.
The presence of salts along with water dipoles screens electrostatic interactions and decreases the
magnitude of Coulombic interactions. In addition, water plays a role in protein folding by
enhancing hydrophobic collapse. Ideally, experiments should be done under native conditions to
avoid any structural changes. However, MS experiments involve desolvated proteins ions in a
vacuum, usually in charge states that are very different from those in solution. The absence of
water will decrease hydrophobic interactions and electrostatic interactions (both attractive and
repulsive) will be enhanced.148-149
Electrostatic interactions between two charges 𝑞𝑖 and 𝑞𝑗 that are separated by distance 𝑟
having a potential 𝑉𝑖𝑗 are described by Coulomb’s law:
𝑉𝑖𝑗 =

𝑞𝑖 𝑞𝑗
4𝜋𝜀0 𝑘𝑒 𝑟

(1.12)

ε0 is the vacuum permittivity and 𝑘𝑒 is the dielectric constant of the medium. Water has 𝑘𝑒 ≈ 80
. Water dipoles arrange themselves around charges inside the medium. Therefore, interactions
between q1 and q 2 tend to be quite weak. In contrast, vacuum has 𝑘𝑒 = 1 so interactions
between charges are much more pronounced.
In solution, pKa values of the main amino acids such as Lys (K), Arg (R), His (H), Glu
(E), Asp (D), added to N-terminus and C-terminus govern the titration behavior and the net
charge of the protein.150 Generally, pKa characterizes the protonation status in solution which is
affected by pH changes and the surrounding environment. At pH 7 Asp (pKa~ 4), Glu (pKa~4.4)
and C-terminal carboxylic acids (pKa ~3.9) are expected to be negatively charged while Lys,
Arg, and N-terminus are protonated.151 In the gas phase, proton affinity or gas phase basicity
controls the protonation of amino acids. Gas phase basicity indicates the transfer of H+ from
gaseous biomolecular ions to another gas phase species and vice versa. For electrosprayed ions of
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the same charge states, unfolded proteins tend to have a higher gas phase basicity than folded
ones due to electrostatic interactions in globular proteins.152
Some studies have attempted to explain the factors that affect the charging of protein in
solution150 or the gas phase. Suggestions include increase in the accessibility of possible charge
sites,116,

153

decreased of Coulombic repulsion between charges, disruption of interactions

between COO- and positive sites

154

and formation of salt bridges.155 Besides, ESI process plays

a role in determining the charge state of native protein according to CRM, where the droplet
transfers its remaining charges to contained macromolecules just at complete evaporation.
Despite the vastly different environment experienced by proteins in solution and in the
gas phase, it is well documented that protein ions produced by “native ESI” generally retain
solution-like properties. In other words, gas phase conformers appear to be kinetically trapped in
conformations that resemble those in bulk solution. Evidence to support this view includes the
observation of CCSs that are consistent with crystal structures

15, 110, 127, 156-157

, as well as the

survival of intricate multi-component protein complexes in the gas phase.126, 158-160
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1.9. Computer Simulations
Computational simulations enable us to study system properties and model phenomena that are
difficult to observe experimentally. Simulations can act as a link between theory and experiment.
To perform simulations, we need to use algorithms that provide numerical solutions for some of
the fundamentals of physical laws. Recent advances related to software development and the
ever-increasing speed of computers continue to push this entire field forward.
Exact solutions of the Schrödinger equation exist only for a small number of systems
such as the particle in a box, harmonic oscillator, and hydrogen atom. Because of that,
approximative ab initio methods have been developed to give the closest solution to the
Schrödinger equation. These methods do not rely on experimental parameters, but they are
extremely computationally expensive and can only be applied to small systems.
Molecular mechanics (MM) is a modeling tool that is used for simulating large
molecules. MM is not based on quantum mechanics calculations. Instead, it uses classical
methods to calculate the potential energy of the system. These methods are known as force field
methods which contain a set of parameters that are derived from experimental data or ab initio
methods.161
Monte Carlo methods generate different configurations for the system randomly, with
relative occupancies that are governed by free energies. Monte Carlo methods can provide a good
conformational sampling of proteins and other large systems, but they cannot study the system in
a time-dependent fashion.161

1.10. Molecular Dynamics (MD) Simulations
The development of MD simulations started in the 50s with work by Alder, Wainwright, and
Rahmann.162-163 Ever since the field has advanced rapidly. Today, MD simulations are being
applied in many fields such as modeling of biomolecules, drug discovery and materials science.
164

MD simulations model the motion of atoms by solving the classical (Newtonian) laws of

motion. Many MD methods employ the fact that the statistical ensemble average is equal to the
time average of a single system according to the ergodic principle. The ensemble average
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corresponds to a series of microstates of the system under study. The macroscopic properties of
the system under equilibrium can be predicted from these microstates. There are different
ensembles that can be modeled based on the experimental conditions. They are named according
to what is kept constant for example, the microcanonical ensemble (NVE) can be used for
isolated system simulations in which the number of particles, volume, and energy is kept
constant; in isobaric-isothermal ensemble (NPT), the temperature and pressure are constant; the
canonical ensemble (NVT) with constant number of particles, volume and temperature.165
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A typical MD simulation has the following scheme:

At zero time( 𝑡0 ), ,
choose the positions( 𝑟𝑖 ),
velocities (𝑣𝑖 ) and the
time step (∆𝑡)

Calculate forces on all
particles using potential
energy (𝑉) due to
interaction between
atoms (force fields)

Repeat

Integration of Newton’s law
of motion using the suitable
integration scheme, update
positions and velocities at
(𝑡 + ∆𝑡)

Temperature and pressure
control using thermostat and
barostat

System is sampled to
calculate physical
properties
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1.10.1. Initial Coordinates and Velocities
As outlined in the above scheme, the first step in MD simulations is to find the starting
positions and velocities. Three-dimensional X-ray structures are used to obtain the primary
coordinates. Initial velocities can be assigned randomly from Maxwell-Boltzmann distribution at
a specific temperature.166
𝑚𝑖
𝑚𝑖 𝑣 2
𝑝(𝑣) = √
exp [−
]
2𝜋𝑘𝐵 𝑇
2𝑘𝐵 𝑇

(1.13)

Where 𝑝(𝑣) is the probability distribution of atoms having velocities between 𝑣 and 𝑣 + ∆𝑣, 𝑣
represents velocity in three directions, 𝑘𝐵 is the Boltzmann constant, 𝑇 is the temperature and 𝑚
is the mass. The temperature of the system during simulation will not be constant due to
randomization of velocity but this can be adjusted using thermostats (section 1.10.6)

1.10.2. Force Fields
The idea behind the use of forcefields for macromolecules is based on the work of Warshel,
Levitt, and Karplus who shared the 2013 Chemistry Nobel Prize.167 Force fields consist of
parameters that are obtained from ab-initio methods or DFT. These calculations are quite
expensive for large molecules such as proteins. Therefore, the interactions between atoms are
modeled semi-empirically using MM force field. Force fields include terms that are derived from
interactions between atoms in the microscopic system to form molecules. These interactions
contribute to the total potential of the system. The total potential energy is derived from N
interacting atoms as a function of their position 𝑉 (𝑟⃗𝑖 … ⃗⃗⃗⃗
𝑟𝑁 ). From this 𝑉 term the force acting on
each atom i can be calculated as the gradient with respect to the atom’s position

𝐹𝑖 = − ∇ 𝑉(𝑟⃗𝑖 … ⃗⃗⃗⃗
𝑟𝑁 )

(1.14)
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𝑉 (𝑟⃗𝑖 … ⃗⃗⃗⃗
𝑟𝑁 )is the sum of bonded and non-bonded interactions at any point in time.
𝑉𝑡𝑜𝑡𝑎𝑙 = 𝑉𝑏𝑜𝑛𝑑𝑒𝑑 + 𝑉𝑛𝑜𝑛−𝑏𝑜𝑛𝑑𝑒𝑑

(1.15)

Bonded interactions (𝑉𝑏𝑜𝑛𝑑𝑒𝑑 ) arise from covalent bonds. They consist of a sum of terms related
to bond stretching, change in angles, and torsion terms.
𝑉𝑏𝑜𝑛𝑑𝑒𝑑 = ∑
𝑏𝑜𝑛𝑑𝑠

1
1
𝑘𝑏 (𝑏 − 𝑏0 )2 + ∑
𝑘 (𝜃 − 𝜃0 )2
2
2 𝜃

+

(1.16)

𝑎𝑛𝑔𝑙𝑒𝑠

∑
𝑑𝑖ℎ𝑒𝑑𝑟𝑎𝑙𝑠

1
𝑘 [1 + cos(𝑛∅ − 𝛿)] +
2 𝑛

∑

𝑘𝜓 (𝜓 − 𝜓0 )2

𝑖𝑚𝑝𝑟𝑜𝑝𝑒𝑟𝑠

In equation 1.16 the first term involves changes in the bond energy that is taken to have
harmonic form, 𝑘𝑏 is the force constant of the bond, 𝑏 is current bond length, 𝑏0 is the
equilibrium bond length. The second term represents energies associated with changes in bond
angles. It is also using harmonic potentials, where 𝑘𝜃 is the force constant of angle, 𝜃 is the
distorted angle, 𝜃0 is the equilibrium value.
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Figure 1.6. Interactions in a typical forcefield between atoms a) Bond stretch, b) Angle rotation,
c) Dihedral angle rotation, or torsion angle applies where two pairs of covalently bonded atoms
are joined by another covalent bond. It is the angle between the planes formed by two atom pairs.
d) Improper dihedral angle is the angle between the planes formed by atoms i, j, l and j, k, l.
Non-bonded interactions (𝑉𝑛𝑜𝑛−𝑏𝑜𝑛𝑑𝑒𝑑 ) refer to contacts between atoms or molecules
that are not directly bonded. These interactions are very essential for the stability of biological
macromolecules. From a computational point of view, the most important ones are the shortrange interactions which are described by Lennard Jones (LJ) potentials (𝑉𝐿𝐽 ) and electrostatic
interactions represented by Coulomb potential.
Lennard Jones (LJ) potentials are weak and proportional to a distance of

1
6

𝑑

, where A is

the repulsion component which falls off with 𝑑 −12 and B is the attractive component due to
dipole-interactions that also degenerates after 𝑑 −6 .
𝐴
𝐵
𝑉𝐿𝐽 = 4𝜀 ( 12 − 6 )
𝑑
𝑑

(1.17)
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In Coulomb potentials, the electrostatic energy is a function of charges on non-bonded
atoms along with the distance separating them. Dielectric constant accounts for increasing or
decreasing the strength of interactions (section 1.8).
Some of the most commonly used force fields are Optimized Potential for Liquid SimulationsAll Atoms (OPLS/AA)

168

, Assisted Model Building with Energy Refinement (AMBER), and

The Chemistry at Harvard Molecular Mechanics (CHARMM). 169

1.10.3. Integration Algorithms
MD simulations study the time-dependent behavior of a microscopic system using classical laws
of motion. This is achieved by integration of Newton’s second law of motion.

𝐹𝑖 = 𝑚𝑖 𝑎𝑖 = 𝑚𝑖

𝑑 2 ⃗𝑟𝑖
𝜕 𝑉(𝑟⃗𝑖 … ⃗⃗⃗⃗
𝑟𝑁 )
=−
2
𝑑𝑡
𝜕𝑟𝑖

(1.18)

Where, 𝐹𝑖 is the net force acting on atom i, ai is the corresponding acceleration, mi is the mass, ⃗𝑟𝑖
is the position, and V is the potential energy.
V is a function of the 3N atomic positions (x, y, z) of all N atoms in the simulation.
Because of that there is no explicit solution to the equation of motion, and numerical algorithms
must be used. These algorithms should allow for a long integration time step (∆𝑡), and to achieve
that bond constraints such as SHAKE, LINCS and SETTLE are commonly used to eliminate fast
vibrational bond motions.161 The positions, velocities and accelerations of atoms at points in (t +
∆t) or (t − ∆t) can be approximated by a Taylor series expansion. After calculating the
acceleration for each atom, coordinates are updated, and the process is repeated.
⃗𝑟𝑖 (𝑡 + ∆𝑡) = ⃗𝑟𝑖 (𝑡) + ∆𝑣𝑖 (𝑡). ∆𝑡 +

∆𝑡 2
𝑎 (𝑡) + 𝑂 (∆𝑡 3 )
2 𝑖

(1.19)

⃗𝑟𝑖 (𝑡 − ∆𝑡) = ⃗𝑟𝑖 (𝑡) − ∆𝑣𝑖 (𝑡). ∆𝑡 +

∆𝑡 2
𝑎 (𝑡) + 𝑂 (∆𝑡 3 )
2 𝑖

(1.20)

The 𝑂 indicates higher order terms that decays to zero and can be neglected
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Adding and rearranging equations 1.19 and 1.20 gives the Verlet algorithm,

⃗𝑟𝑖 (𝑡 + ∆𝑡) ≃ 2𝑟⃗𝑖 (𝑡) − ⃗𝑟𝑖 (𝑡 − ∆𝑡) + ∆𝑡 2 𝑎𝑖 (𝑡)

(1.21)

The Verlet algorithm is easy to apply and efficient, but an explicit velocity term is
missing. A modification of the Verlet algorithm can solve the velocity problem; this is known as
velocity Verlet algorithm.
⃗𝑟𝑖 (𝑡 + ∆𝑡) = ⃗𝑟𝑖 (𝑡) + ∆𝑡𝑣𝑖 (𝑡) +

𝑣𝑖 (𝑡 + ∆𝑡) = 𝑣𝑖 (𝑡) +

∆𝑡 2
𝑎𝑖 (𝑡)
2

(1.22)

∆𝑡
(𝑎𝑖 (𝑡) + 𝑎𝑖 (𝑡 + ∆𝑡))
2

(1.23)

The velocity Verlet algorithm calculates the position and velocity at the same time.
Another important tool is the leapfrog algorithm that is commonly used in MD simulations due to
simplicity. Velocity calculations are done at halftime step interval while the positions are
calculated at full-time step. Within the leapfrog scheme, both positions and velocities leap over
each other.
𝑣𝑖 (𝑡 +
Velocities at time 𝑡 +

∆𝑡
2

∆𝑡
∆𝑡
) = 𝑣𝑖 (𝑡 − ) + ∆𝑡 𝑎𝑖 (𝑡)
2
2

are calculated from velocities at time(𝑡 −

(1.24)

∆𝑡
2

) and accelerations at the

time(𝑡).
The position is calculated in full-time step
⃗𝑟𝑖 (𝑡 + ∆𝑡) = ⃗𝑟𝑖 (𝑡) + ∆𝑡𝑣𝑖 (𝑡 +

∆𝑡
)
2

(1.25)
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1.10.4. Energy Minimization
At the beginning of each simulation, the internal configuration (usually obtained from X-ray or
NMR structures) may involve unfavorable local contacts between atoms of the system. The
purpose of energy minimization is to perform a simple MM relaxation procedure that will
eliminate direct clashes and moves the system into a local energy minimum. The most common
method for this purpose is the steepest descent algorithm, which is an iterative method to obtain
an approximate solution.
𝑟𝑛+1 = 𝑟𝑛 − 𝐾𝑛 𝛻𝑉(𝑟(𝑛))

(1.26)

𝑟𝑛 is a vector representing the position of all particles in the system, 𝐾𝑛 is the step size towards
the lowest energy minima and ∇𝑉 is the gradient of potential energy.161, 165

1.10.5. Water Models
Water is very important as most chemical reactions take place in aqueous media. The quality of
macromolecular simulations depends on the choice of water model. Although water molecules
are very small there are different models to describe it.
Water models can be classified into rigid models where only non-bonded interactions
considered and the bonded interactions are restrained. Polarizable models include explicit
parameters for polarization. Rigid models are usually preferred for MD simulations of large
systems because of their low computational cost. Rigid models differ in their interaction sites,
e.g. the SPC (simple point charge model) and TIP3P (transferable intermolecular 3-point
potential) where point charges are placed on each of the three H2O atoms. Both are
computationally cheap and perform well in bulk solution. However, their surface tension
properties are poor compared to experimentally measured values.170 The TIP4P and TIP4P/2005
models have four interaction sites; the negative charge of the oxygen is moved slightly and is
placed on a virtual point on the bisector of the HOH angle which improves electrostatic
properties.170 TIP4P/2005 is mostly used in the work described in the thesis as it gives the best
representation of surface tension compared to all other commonly used models. 171-172
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1.10.6. Thermostats
Thermostat algorithms are indispensable in MD simulations to keep the temperature of the
system close to the desired one for sampling in NVT or NPT ensemble
Temperature is related to the average kinetic energy or velocity (equation 1.27).161, 173
𝑁

𝐾𝑎𝑣𝑔 = ∑
𝑖=1

𝑚𝑖 𝑣 2 1
= 𝑘𝐵 𝑇𝑁𝑓
2
2

(1.27)

Where 𝐾𝑎𝑣𝑔 is the average kinetic energy, 𝑁𝑓 is the number of degrees of freedom in 3dimensional space, 𝑘𝐵 is the Boltzmann constant, 𝑇 is the temperature.
One of the ways to adjust temperature is to rescale velocity known as the velocityrescaling temperature coupling. In this algorithm, the velocity is rescaled by multiplying the
velocity of each particle with rescaling factor 𝜆.
𝑇𝑡𝑎𝑟𝑔𝑒𝑡
𝜆=√
𝑇𝑐𝑢𝑟𝑟𝑒𝑛𝑡

(1.28)

This is an easy and straightforward method but temperature fluctuations are expected.
Another way to control the temperature is to couple the system to heat bath at a fixed temperature
where the velocity is rescaled at each step by supplying or removing heat from the system like in
the Berendsen thermostat.174 The rate of temperature change is kept proportional to the
temperature difference between the bath and system. However, the Berendsen thermostat
represents a weak coupling of the system with a heat bath so the system will spend a long time to
reach the desired temperature.
The Nosé-Hoover thermostat is an extended method algorithm which provides a
rigorous way of a system and heat bath coupling. Both the system and the heat bath exchange
kinetic energy. The average kinetic energy of the particles in the system does not change at each
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time step while the temperature is kept constant by scaling of velocity. This can be represented
by introducing an additional parameter (𝜉) to the equation of motion. This introduced parameter
(𝜉) reflects the frictional or drag force which can slow down or accelerates the particles in the
system until the desired temperature is reached. The Nosé-Hoover equations of motion showing
an additional frictional term (𝜉) :

𝜉=

∑𝑖 𝑃𝑖⁄𝑚𝑖 − 3𝑁𝑘𝐵 𝑇

(1.29)

𝑄

Equation 1.29 shows 𝑄 which determines the strength of coupling between the heat bath and the
system, 𝑇 is the desired temperature and 𝑃𝑖 is the momentum. This thermostat reproduces the
NVT ensemble, time-reversible but computationally expensive.161

1.10.7. Periodic Boundary Conditions (PBC)
Modeling the bulk properties and the behavior of massive systems such as proteins or DNA is
done in an explicit solvent which increases their modeling complexity. Periodic boundary
conditions can be used to avoid the finite-size problem and to eliminate surface artifacts.175
PBC use a simulation box that contains the system under study, and this box is repeated
on all sides such that the simulated system is surrounded by identical copies of itself. Any
particle that leaves the box from one side, will re-enter the box from the opposite side. In this
way, the number of particles in the simulation box remains the same, and there are no physical
boundaries or surface molecules. In protein simulations, ions such as Na+ or Cl- are used to
compensate the intrinsic charge of protein and neutralize the box. Different box shapes can be
used, such as cubic, hexagonal, etc.176 It is necessary to choose a suitable box shape that is
compatible with the geometry of the system and also minimize the number of solvent molecules
to save the computer time.
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.
Figure 1.7. Periodic boundary conditions in two dimensions. The shaded middle cell represents
the simulation cell, where the filled blue atom moves out of the box and all images move in the
same manner.

1.10.8. Treatment of Non-Bonded Interactions
Non-bonded interactions are the most time-consuming part of MD simulations. To reduce
computational cost, cut-offs are used. This means that the interaction between two atoms
separated by more than the cut-off distance is ignored. For short range (LJ) interactions, the cutoff is simply introduced to potential (𝑉𝐿𝐽 ) and any interactions beyond this cut-off are set to zero
without causing noticeable perturbations. A different approach is needed for the Coulomb
potential which represents a long-range interaction. In PBC simulations this problem is solved by
using Particle Mesh Ewald (PME) summation. This method is based on fast Fourier transform
algorithms that calculate the potential for charges beyond a certain cutoff and maps them on a
mesh.177 A disadvantages of using PBCs with PME is that the approach is only suitable for
neutral systems as applying it to the charged system causes artifacts.178-180
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Using PBC/PME with cutoffs is not suitable for gas phase simulations due to the
strength of electrostatic interactions in the vacuum, plus the fact that the vacuum ions (or
droplets) considered below carry a net charge. Also, periodic images would feel each other due to
Coulomb interactions. Nowadays, the speed of the modeling is controlled by graphics processing
units (GPU). Unfortunately, widely used MD packages such as Gromacs that run with GPU
acceleration were designed for use with PBC/PME and cutoffs. This problem can be
circumvented by using a ‘pseudo-PBC’ method that allows gas phase simulations using GPUacceleration without PBC/PME artifacts. Generally, the simulation system under study is placed
in the center of the PBC box with large dimensions (999.9nm3), PME is switched off, cutoffs are
set less than the dimensions of the box. The atoms contained inside the box will then interact
among themselves, while interactions with periodic images are absent.181 Effectively, this
method provides an environment that is indistinguishable from a genuine vacuum environment
without cutoffs.

1.10.9. Neighbor Lists
The use of cutoff may not reduce the time spent to calculate non-bonded interactions because the
distance between every pair of atoms must be computed to decide whether they are close enough
to calculate their interaction energy. This pair distance calculations can be time-consuming, but
the problem can be addressed by using a Verlet neighbor list. This list sorts all atoms that are
potential partners and lie within the cutoff distance or slightly further from the cutoff distance.
Initially, the neighbor list is constructed for each pair of particles. Only the pairs in the list are
checked for force calculations for some integration steps, if the particle moves by more than the
cutoff distance then an algorithm automatically update the neighbor list in a way that it is not too
fast or too slow.161, 175
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1.11. Scope of the Thesis
In this dissertation, we use ESI-MS experiments and MD simulations to answer several
controversial questions related to protein ESI.
Sample preparation is one of the most challenging aspects of protein ESI-MS. The
presence of salts like NaCl can severely degrade the quality of the data obtained. Even after
sample cleanup using different desalting techniques, the presence of residual salt can still be
problematic. The mechanism of salt interferences in protein ESI-MS is not fully understood.
Previous work relied on equilibrium-partitioning and charge competition to explain the behavior
of mono-cations.86, 182 In Chapter 2, we investigate the concept of charge competition between
proteins and cations like tetrabutylammonium chloride and CsCl and we clarify that the concept
of salt-induced signal suppression has different facets that have been under-appreciated in the
previous literature.
Supercharging agents offer an attractive approach for increasing the protein charge
under “native” ESI conditions, where SCAs are added to the bulk solution in low concentration
where they do not affect protein structure or stability. Several proposals exist in the literature that
aim to explain how SCAs work. These include surface tension effects and protein unfolding
within droplets, but none of these explanation attempts offers a consistent picture. Chapters 3 and
4 scrutinize the native ESI supercharging mechanism from a new perspective. In Chapter 3, we
uncover the first atomistic view of the supercharging mechanism. Our findings indicate that
protein supercharging takes place due to “charge trapping” afforded by a SCA peripheral layer.
This mechanism is further tested and confirmed in Chapter 4, where we use crown ether (18C6)
to test the charge trapping hypothesis on both proteins and dendrimers.
Chapter 5 provides a detailed study about the behavior of unfolded proteins in ESI
nanodropets. For the first time, we apply a combination of MD simulations and ESI-MS/IMS to
address this topic. We show unequivocally that the CEM is the actual ESI mechanism for acidunfolded proteins in high charge states.
Finally, Chapter 6 highlights possible future research directions, outlining how the
combination of MD simulations and ESI-IM/MS will continue to advance the field.
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Chapter 2. Exploring the Mechanism of Salt-Induced Signal
Suppression in Protein Electrospray Mass Spectrometry
Using Experiments and Molecular Dynamics Simulations
2.1. Introduction
Electrospray ionization (ESI) mass spectrometry (MS)1 has become an indispensable tool for a
wide range of bioanalytical applications. The impact of ESI-MS has been particularly
pronounced for research in the areas of protein structure, dynamics, and interactions.2-5 The ESI
process commences when analyte solution is passed through a capillary that is held at a high
electric potential. Charged droplets are emitted from a Taylor cone at the capillary outlet. These
droplets undergo several rounds of solvent evaporation and jet fission,6 ultimately generating
nanodroplets that are close to the Rayleigh limit and from which analyte ions are released into
the gas phase.7
The mechanism of the final ESI steps remains a matter of debate,8-11 although recent studies
seem to converge towards a consensus view.7, 12 Accordingly, low molecular weight gaseous ions
are produced by field emission from the nanodroplet surface, as envisioned by the ion
evaporation model (IEM).13 Globular proteins are released via nanodroplet evaporation to
dryness, in line with the charged residue model (CRM).14 A third mechanism, the chain ejection
model (CEM), has been proposed for unfolded proteins12 and other disordered polymers.15 The
CEM posits that macromolecular chains get expelled from aqueous droplets by electrostatic and
hydrophobic effects.12,

16

ESI can be conducted under positive and under negative polarity

conditions. We will restrict our considerations to positive ion mode, as it is more widely used for
protein analyses.
A well-known problem in ESI-MS is the fact that non-volatile salts in the analyte
solution can cause a significant degradation of the spectral S/N ratio.17-24 The presence of Na+ is
particularly problematic, as it represents a ubiquitous contaminant. Also, NaCl is used in many
biochemical experiments for ensuring a physiological ionic strength of ~150 mM.25 Direct
infusion of such samples into an ESI source is not a viable option. Numerous desalting
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approaches have been devised to address this issue.17-24 Even with these treated samples,
however, the presence of residual salt contaminants often remains problematic.
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Figure 2.1. Schematic protein ESI mass spectra (only the 10+ region is shown), illustrating two
different types of salt effects. (a) Protonated ion signal generated from salt-free solution. (b) Peak
splitting due to adduct formation. The integrated signal intensity in panels a and b is identical. (c)
Protein ion suppression.

The mechanistic basis of salt interferences in protein ESI-MS continues to be a matter of
debate. One fairly trivial aspect is the fact that species such as NanClm(n-m)+ can obscure protein
signals due to spectral crowding.26-28 Clusters of this type are formed via the CRM as saltcontaining nanodroplets evaporate to dryness.29-31 Of greater concern are issues that are
commonly treated under the umbrella of salt-induced “signal suppression”.17,

23, 32-38

In the

literature this term may carry different connotations, a fact that can complicate discussions of the
topic. Here, we propose that signal suppression can be conceptually dissected into (i) peak
splitting due to adduct formation and (ii) ion suppression. Both effects will degrade the spectral
S/N ratio, as briefly outlined in the following sections.
(1) While salt-free solutions generate clean [M + zH]z+ species, protein ions formed in
the presence of nonvolatile salts tend to have a heterogeneous composition such as [M + zH +
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n(Na - H) + m(Cl + H)]z+ where both n and m can cover a wide range.39-40 This adduct formation
is particularly pronounced for native proteins that follow the CRM, because the salt
concentration in vanishing droplets increases dramatically during solvent evaporation to
dryness.39,

41

Under these conditions the total ion count of each charge state z is split into a

multitude of peaks, thus reducing the [M + zH]z+ intensity.39,

42

We hypothesize that peak

splitting does not represent a genuine signal suppression effect, as it may occur without reducing
the total protein signal intensity. In other words, the sum of the mixed adduct signals for all
values of z, n, and m may still add up to the same intensity as for [M + zH]z+ species produced in
the absence of salt (Figure 2.1a, b).
(2) Ion suppression occurs under conditions where the presence of salt reduces the total
analyte signal (Figure 2.1c). This effect was first examined for singly charged small analytes,
assuming that different species compete with each other for excess charge.32 This framework was
subsequently extended into an equilibrium-partitioning model17 which envisions that ESI
droplets consist of an electrically neutral core, and a charged surface layer. Analytes that become
part of the surface charge layer are thought to be more easily ejected under IEM conditions. The
development of this model was spurred by the observation that surface-active species generally
exhibit high ESI-MS signal intensities. Related charge competition models were also proposed to
account for the effects of salts on the ESI-MS signals of proteins.33, 36
Despite the substantial body of work in this area, the mechanism of salt interferences in
protein ESI-MS is still not fully understood. Recent work has put into question the tenet that
excess charge carriers always reside on the droplet surface,12 an assumption that is central to the
equilibrium-partitioning model.17 The purported link between charge competition and ion
suppression17, 32-33, 36 is readily understood for mono-cationic species, but for multiply charged
analytes the situation is less clear. For example, charge competition may reduce ESI charge
states,43 but this does not necessarily imply the occurrence of ion suppression because proteins
will remain observable as long as z > 0.44 Finally, the relationship between adduct formation and
ion suppression remains to be elucidated. It is unclear if the phenomena indicated in Figure 2.1b,
c can actually occur independently of one another, or if they are always coupled.
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This work explores the ESI-MS behavior of cytochrome c (Cyt c), ubiquitin (Ubq), and
lysozyme (Lyz) under native and denaturing solvent conditions. To investigate the effects of salts
with different physicochemical properties we tested NaCl, CsCl, and tetra-butyl ammonium
chloride (NBu4Cl). The three cations cover a wide range of hydration free energies, from highly
favorable for Na+ (hydG = -365 kJ mol-1) to unfavorable for NBu4+ (hydG  0). The properties
of Cs+ lie in between these two extremes (hydG = -250 kJ mol-1).45 It is found that the effects of
NaCl are largely consistent with the “pure” adduction scenario of Figure 2.1b, whereas NBu 4Cl
displays “pure” ion suppression (Figure 2.1c). MD simulations on salt-containing droplets
suggest that NBu4+ induces ion suppression primarily by interfering with the formation of
progeny droplets within the ESI plume.

2.2. Materials and Methods
2.2.1. Protein Solutions
Horse heart Cyt c, hen egg white Lyz, bovine Ubq, 1,4-dithiothreitol (DTT), NBu4Cl,
ammonium acetate, CsCl, and formic acid were purchased from Sigma (St. Louis, MO). For
native ESI-MS, proteins were infused in aqueous solution at pH 7. Denatured (unfolded) samples
were prepared by dissolving proteins in water/methanol (50:50 v/v) in the presence of formic acid
(pH 2.0). Lysozyme unfolding was further promoted by disulfide reduction .46 For this purpose,
100 M Lyz was incubated in 10 mM DTT at 75 ℃ for 1 h. The reduced protein is referred to as
“rLyz”. Protein samples for ESI-MS had a concentration of 5 μM and contained 10 mM
ammonium acetate. This volatile electrolyte represents a standard additive in ESI-MS.7 The
solutions were supplemented with NaCl, CsCl, or NBu4Cl at concentrations up to 10 mM.

2.2.2. Mass Spectrometry (ESI-MS)
ESI mass spectra were acquired in sensitivity mode on a Synapt G2 time-of-flight
instrument (Waters, Milford, MA) equipped with a dual ESI source. The ESI capillary was held
at +3 kV. Protein solutions were infused using a syringe pump at a flow rate of 5 L min-1. Cone
and desolvation gas flow rates were 50 and 600 L h-1, respectively. The desolvation temperature
was 200 °C, and the source was kept at 80 C. For native solutions the cone voltage was set to a
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relatively high value of 75 V which promotes the conversion of mixed cation/chloride adducts to
[M + zH + n(cation - H)]z+ species via HCl loss.39, 41 These settings considerably improve the
spectral S/N ratio (Figure 2.2a-f). High charge states formed under denaturing conditions would
suffer from rupture of covalent bonds under these conditions. For those measurements the cone
voltage was reduced to 40 V (Figure 2.2d-f). Except for the cone voltage, all data were acquired
under identical instrument settings as the sum of 500 one-second scans. Intensity units refer to
analog-to-digital converter (ADC) count.
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Figure 2.2. Cone voltage effects on ESI mass spectra of cyt c. Panels a-c refer to data acquired
at pH 7 in aqueous solution, spectra in panels d-f were recorded at pH 2 in 50:50 (v/v)
water/methanol. (a) Complete spectrum of native Cyt c electrosprayed in the absence of NaCl.
Complete spectra ( no salt)
(b) Close-up view of the 8+ charge state in the presence of 1 mM NaCl at a cone voltage of 5 V.
(c) Same as in panel b, but for a cone voltage of 75 V. Note that the m/z axes were converted to
Mass in panels b, c, e, and f. The “cleaner” appearance of the spectrum in panel c is due to the
collisional loss of chloride adducts (as HCl). (d) Complete spectrum of denatured Cyt c
electrosprayed in the absence of NaCl. (e) Close-up view of the 14+ charge state in the presence
of 1 mM NaCl at a cone voltage of 5 V. (f) Same as in panel e, but for a cone voltage of 40 V.
Numbers 0, 1, 2, … indicate how many adducted sodium ions can be resolved in the spectra.
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2.2.3. Experimental Design and Data Analysis
A potential problem with measurements on salt-contaminated samples is a drift in
sensitivity, caused by the deposition of non-volatile material on the ion optics during a series of
measurements. An internal standardization procedure was devised to compensate for such drifts,
taking advantage of the dual ESI source on the Synapt instrument. The regular (analyte) source
was used to deliver actual protein samples at salt concentrations C between zero and 10 mM. The
integrated signal intensity for each of these spectra is referred to as I(C). Integration was
performed using Microsoft Excel over the spectral range that was deemed to contain adducted
protein ions, as identified via comparisons with low salt spectra, up to m/z ~3000. Signals
corresponding to protein-free cluster ions (recognizable by their characteristic isotope
distributions and low charge states29,

31

) were eliminated manually prior to integration. After

recording each of these spectra, the second (lock spray) source was used to deliver an internal
standard comprising the same protein and solvent, but without salt. Salt-containing samples and
reference solutions were infused in an alternating fashion, using a mechanical baffle to switch
between both sprayers. The flow for the non-operating sprayer was turned off to eliminate any
cross-contamination. In each case, it was ensured that the ESI-MS signals had stabilized before
data acquisition commenced. From these pairwise measurements a normalized intensity N(C) can
be calculated as N(C) = I(C) / Iref, where Iref is the integrated signal intensity of the reference
sample. As a final step, these data were normalized according to R(C) = N(C) / N(C = 0). These
R(C) values will be referred to as “integrated ion intensity”, and they directly reflect the extent of
salt-induced signal attenuation relative to a salt-free sample. To reiterate, R(C) comprises the
contributions of all protein signals regardless of their salt adduction state. All measurements were
conducted in triplicate. Error bars represent standard deviations.
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2.2.4. Molecular Dynamics Simulations
All atom MD simulations of salt-containing droplets were carried out using Gromacs
4.6.5 with CHARMM36 force field
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and TIP3P water model.48 Production runs employed

trajectory stitching as described previously31 with Nosé-Hoover temperature coupling. The
structure of NBu4+ was obtained from the ZINC database,49 and it was parameterized using the
ParamChem server.50 All bonds were constrained, thereby allowing for a 2fs integration time
step. To take advantage of GPU acceleration the simulations were carried out in a 1 μm box
using a potential-shift non-bonded interaction cut-off of 333.3 nm without relying on particlemesh Ewald summation. Initial system configurations consisted of spherical water droplets with
radius 3 nm containing 10 Na/Cl pairs. Each droplet also contained a 12+ excess charge
consisting of either 12 Na+ or 12 NBu4+. These systems were subjected to energy minimization
followed by 10ps of equilibration at 330 K using a modified Berendsen thermostat.51 Individual
MD segments consisted of 500 ps windows at 330 K, between which any molecules that had
drifted more than 10 nm from the droplet center were removed from the system. The simulated
droplets are highly dynamic and undergo occasional distortions into non-spherical shapes. For
reporting the droplet size we report an “effective” radius r corresponding to that of a sphere with
the equivalent number of molecules. Calculations involving the surface tension of water
employed the experimental value of  = 0.06624 Nm-1 at 330 K,52 although standard MD water
models yield values that are somewhat lower.53-54 Similar to earlier droplet simulations
54-58

the current work uses a non-polarizable force field. It has been noted

59-60

12, 15, 31,

that such an

approach may not adequately describe the behavior of “soft” ions such as Cs + which possess a
high polarizability (~tenfold higher than that of Na+).61 To circumvent polarizability issues, the
simulations of this study were therefore limited to droplets containing NaCl and/or NBu4Cl. The
NBu4+ behavior is largely invariant when using polarizable or non-polarizable force fields.62 All
simulations were carried out in triplicate with different starting configurations and random seeds
for initial velocity assignments.
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2.3. Results and Discussion
2.3.1. NaCl Effects on Protein Mass Spectra
In an initial set of experiments we explored the effects of NaCl on the ESI-MS behavior
of native Cyt c. When electrosprayed in NaCl-free solution the protein displays a charge state
distribution that is dominated by [M + 7H]7+ and [M + 8H]8+ ions (Figure 2.3a).63-64 Increasing
the NaCl concentration from zero to 10 mM dramatically reduces the base peak intensity. Protein
signals become almost unobservable for 1 mM NaCl when displaying the data using constant yaxis scaling (Figure 2.3a-d). These observations illustrate the well-known perils of conducting
protein ESI-MS in the presence of non-volatile salts.

Figure 2.3e-h provides a closer look at the same Cyt c data, using a y-axis range that
scales with base peak intensity. The spectrum acquired in 10 mM NaCl (Figure 2.3h) is of
particular interest. When considered in isolation, these data would be difficult to interpret.
However, comparison with the spectra acquired at lower salt concentrations (Figure 2.3e-g)
leaves no doubt that the humps marked 8+ and 7+ in Figure 2.3h represent heavily adducted
protein signals with unresolved tails that extend to m/z ~3000. The range of m/z < 1500 in Figure
2.3h is dominated by NanClm(n-m)+ clusters.29 When integrating the protein ion intensity for the
spectra in Figure 2.3 it is seen that R(C) of native Cyt c is not very strongly affected by NaCl; no
intensity loss is evident up to a salt concentration of 1 mM. Even at 10 mM R(C) remains above
0.6 (Figure 2.4a).
Observations similar to those described above were made when studying NaCl effects
for native Ubq and Lyz (Figure 2.5). Those data show a precipitous drop in base peak intensity,
whereas the integrated ion intensity R(C) remains constant up to 1 mM NaCl. At a salt
concentration of 10 mM the R(C) values of Ubq and Lyz exhibit a decrease down to 0.4 and 0.25,
respectively (Figure 2.4a).
ESI-MS experiments on the three proteins were also conducted under denaturing
conditions. The resulting spectra are shifted to higher charge states

63-64

that show less salt

adduction (Figure 2.6). Previous work 41 suggests that adduction is reduced for unfolded proteins

55

because the chains are ejected from droplets that experienced a relatively low degree of NaCl
enrichment. Salt interferences in Figure 2.6 only become prevalent at 10 mM NaCl, at which
point the base peak intensity has dropped by one order of magnitude. The integrated ion intensity
of the three denatured proteins decreases down to R(C)  0.5 in 10 mM NaCl (Figure 2.4b).
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Figure 2.3. ESI mass spectra of cyt c acquired at pH 7 in the presence of various NaCl
concentrations. Panels a/e, b/f, c/g, and d/h display the same data, but with different y (intensity)
axis scaling. Panels a-d shares the same y-axis range, whereas panels e-h were scaled according
to base peak intensity.
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Figure 2.4. Salt dependence of the integrated ion intensity R(C) relative to NaCl-free samples.
Data are depicted for three proteins (a) Under native conditions, and (b) In a denaturing
environment.
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Figure 2.6. ESI mass spectra of Cyt c (a-d), Ubq (e-h) and rLyz (i-l) acquired under denaturing
solvent conditions (pH 2 in water/methanol) in the presence of different NaCl concentrations
(zero to 10 mM NaCl, as indicated in the individual panels).
In summary, NaCl induces a dramatic reduction in the S/N ratio of protein ESI mass
spectra by lowering the intensity of [M + zH]z+ ions. However, R(C) remains surprisingly
insensitive
presence of NaCl. The sum of all adducted protein signals stays relatively close
A to
tothe
D (cytoC)
to that of [M + zH]z+ ions observed for NaCl-free samples. Even the R(C) drop seen for 10 mM
E to H (ubq)
NaCl is quite moderate, considering that cursory analysis suggests the near-complete loss of
I to L2.3d).
(r lys)We conclude that NaCl degrades ESI mass spectra primarily via adductsignal (Figure
mediated peak splitting (Figure 2.1b) rather than ion suppression (Figure 2.1c).
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2.3.2. Comparison with Other Salts
Although Na+ represents the most commonly encountered interfering cation in ESI-MS,
additional insights into the mechanism of signal degradation can be obtained by examining the
properties of other additives.33,

36, 65

We chose to study Cyt c in the presence of CsCl and

NBu4Cl. The consistent use of chloride salts ensures that any of the observed effects are
attributable solely to differences in cation behavior.
Addition of CsCl to Cyt c at pH 7 reduces the base peak intensity and causes extensive adduct
formation (Figure 2.7a-c). At a concentration of 10 mM the spectrum is crowded by Cs(n+1)Cln+
clusters, but close examination still reveals residual protein signals (Figure 2.8). Experiments
conducted with NBu4Cl reveal a very different behavior, resulting in protein ions that are
virtually free of adducts. However, a dramatic signal deterioration is seen for this salt, where
protein signals become almost undetectable in 10 mM NBu4Cl (Figure 2.7d-f). Spectra at this
high salt concentration are dominated by a NBu4+ peak that dwarfs all other signals by a factor of
several thousand (Figure 2.9). Observations similar to those described here for pH 7 were also
made in Cyt c measurements under denaturing conditions (Figure 2.10).
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cluster signals are indicated.
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Figure 2.9. ESI mass spectrum of Cyt c acquired at pH 7 in the presence of 10 mM NBu4Cl.
Protein signals are almost completely suppressed; instead the spectrum is dominated by NBu 4+.
Note that the signal intensity has been magnified by a factor of 3000 for m/z > 600.
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Figure 2.10. ESI mass spectra of Cyt c acquired at pH 2 in water/methanol and in the presence of
different concentrations of CsCl (a-c) and NBu4Cl (d-f). Protein charge states as well as the
composition of selected salt cluster signals are indicated.

Figure 2.11 compares the integrated ion intensities of Cyt c in CsCl, and NBu4Cl under
native and denaturing conditions. The NaCl data discussed above are included in Figure 2.11 for
reference purposes. In the case of CsCl the integrated ion intensity remains roughly constant up
to a salt concentration of 1 mM. Elevating the CsCl concentration further to 10 mM induces a
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notable R(C) reduction, down to around 0.1 and 0.2 for native and unfolded Cyt c, respectively.
A much more significant drop in R(C) is seen for NBu4Cl. This salt begins to lower R(C) already
at a concentration of 1 mM. For 10 mM NBu4Cl the integrated ion intensity is reduced by two
orders of magnitude (Figure 2.11).
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Figure 2.11. Salt dependence of the integrated ion intensity R(C) for Cyt c under (a) Native
solvent conditions and (b) In denaturing solution in the presence of NaCl, CsCl, and NBu4Cl.

65

The data presented above reveal that the detrimental effects associated with the three
salts are quite different. As noted above, NaCl does not cause a dramatic R(C) decrease. Instead,
the degradation of the spectral S/N ratio is primarily due to adduct formation which leads to
extensive peak splitting. The effects of NaCl can therefore be approximated by the scenario
depicted in Figure 2.1b. The opposite applies to NBu4Cl, i.e., a pronounced reduction in R(C)
without adduct formation. The effects of NBu4Cl are thus consistent with the ion suppression
scenario of Figure 2.1c. CsCl shows a behavior in-between these two extremes; it promotes the
formation of adducts while at the same time reducing R(C). It is clear from Figure 2.11, however,
that ion suppression by CsCl is less pronounced than for NBu4Cl. In summary, the tendency to
form protein/salt adducts follows the sequence NaCl > CsCl > NBu4Cl. Conversely, the potential
of these species to cause protein ion suppression exhibits the reverse order, NBu4Cl > CsCl >
NaCl.

2.3.3. MD Simulations of Salt-Containing Droplets.
To better understand the observed salt effects, we turned to MD simulations.
Considerable recent progress has been made in the application of MD techniques to MS-related
phenomena,12,

15, 31, 54-58

although realistic simulations of the complete ESI process (from

micrometer-sized early droplets to bare protein ions) still remain out of reach. The simulations of
the current work will be limited to protein-free nanodroplets, comparable in size to “late”
droplets in the ESI plume.7,

32

It will be seen that even this simplified approach provides

important insights. We focus on aqueous systems for two reasons. (i) Native ESI-MS studies
generally use water-based solvents.2,

66-67

(ii) ESI of water/organic mixtures induces H2O

enrichment because the organic component usually has a higher evaporation rate.68-69 Thus, late
ESI droplets tend to be predominantly aqueous, regardless of the initial solvent composition. For
reasons outlined in the Methods section we will focus on the behavior of Na+ and NBu4+, i.e., the
types of ions that epitomize the two scenarios of adduction vs. ion suppression in Figure 2.1.
The theoretical number of maximum excess charges zR that can be accommodated on a droplet is
usually estimated by the Rayleigh equation7, 70 which states that
zR =

8
0  r3
e

(2.1)
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where e is the elementary charge, r is the radius, 0 is the vacuum permittivity, and  is the
surface tension. For the droplets considered here with an initial radius of 3 nm Equation 2.1
yields zR  20. The droplet charge at the onset of our simulations was chosen to be z = 12, well
below the Rayleigh limit. Two droplet types were examined, where this charge was implemented
via incorporation of either 12 Na+ or 12 NBu4+. In addition, all droplets contained 10 Na+ / Clpairs, keeping in mind that realistic simulations have to include some counter ions.31
MD snapshots for a Na+ charged droplet are depicted in Figure 2.12a. As reported
earlier,15, 31, 54-55 droplet shrinkage due to water evaporation is accompanied by the IEM ejection
of solvated Na+. Prior to being ejected, Na+ ions tend to reside at intermediate radial positions
rather than at the surface.12 NBu4+ containing droplets show a different behavior. NBu4+ ions
rapidly move to the surface, with protrusion of alkyl chains into the vacuum environment (Figure
2.12b). As the droplets shrink, NBu4+ ions detach from the surface. Both the low surface affinity
of Na+ and the high surface affinity of NBu4+ seen here are consistent with previous reports,12, 17,
33, 36, 59-60, 71

reflecting the fact that Na+ interacts very favorably with water, with a hydration free

energy hydG = -365 kJ mol-1. In contrast, NBu4+ hydration is unfavorable (hydG  0).45
Figure 2.12c displays changes in droplet radius throughout the 35 ns simulation
window. When plotting the relative droplet charge z/zR on the same time axis it is seen that IEM
events give rise to saw tooth patterns (Figure 2.12d) that are reminiscent of experimental Doppler
interferometry data.72 Notably, the relative droplet charge remains much lower for the NBu4+
systems (z/zR = 0.59  0.05) than for the Na+ charged droplets (z/zR = 0.74  0.05). These
averages and standard deviations are based on three independent runs for each set of conditions.
Readers are reminded that both types of droplets contain NaCl as background electrolyte. In
principle, therefore, NBu4+ droplets should also be able to undergo Na+ ejection. However, we
did not observe a single Na+ ejection event as long as there was any NBu4+ present. In other
words, the ejection of NBu4+ is much more facile than that of Na+. This difference is due to the
tendency of Na+ to stay inside the droplet where it is tightly solvated. In contrast, the
hydrophobic alkyl chains of NBu4+ drive this ion to the surface, thereby facilitating its ejection at
much lower z/zR values.
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(a)

(b)

(c)

(d)

Figure 2.12. MD simulation results for the evaporation of ESI droplets carrying an initial 12+
charge caused by excess Na+ or NBu4+. All droplets contained an additional 10 Na+/Cl- pairs as
background electrolyte. (a) Na+ charged droplet at t = 0, 2.5 ns, and 21.5 ns, top to bottom. (b)
NBu4+ charged droplet at the same time points as in panel (a). Element coloring: Na+ blue, Clgreen, C black, O red. (c) Droplet size as a function of time. Also indicated is the number of
water molecules in the droplet at the beginning and at the end of the simulation window. (d)
Droplet charge z relative to the Rayleigh charge zR. Solid circles indicate ion ejection events.
Another interesting observation is that solvent evaporation proceeds faster for the Na+
charged droplets than for the NBu4+ containing systems (Figure 2.12c). The former shrink from
an initial value close to 4000 H2O down to less than 100 H2O in 35 ns. In the presence of NBu4+
the number of water molecules remaining after the same time period is roughly ten times greater.
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The different evaporation rates likely reflect a destabilization of the hydrogen bonding network
within the electrostatically stressed (high z/zR) Na+ containing droplets. Another contributing
factor could be the presence of NBu4+ ions at the surface which keep the droplet partially
wrapped in an organic layer, thereby inhibiting water evaporation due to steric effects.

2.3.4. Mechanism of Protein Ion Suppression
On the basis of the data described above one can propose a mechanistic framework to account for
the interfering effects that are associated with different salts. Shrinking droplets that approach the
Rayleigh limit have two options for relieving electrostatic stress. The first possibility is the
emission of small progeny droplets via jet fission.6 Alternatively, the droplet may eject ions via
the IEM.13 The two pathways are in kinetic competition with each other, governed by the
corresponding activation barriers.13 Under typical conditions fission is the preferred option for
larger droplets, whereas for radii below ~10 nm the high surface electric field favors ion
ejection.7, 13 Importantly, it is the small progeny droplets that ultimately produce gaseous protein
ions.7,

12, 32

Hence, the analyte ion yield is directly related to the number of nanodroplets

generated in the ESI plume.7
Protein ESI in the Absence of Salt Contaminants: Under favorable conditions the
evolution of ESI droplets proceeds as outlined in Figure 2.13.7, 32 Early droplets with z/zR  0.5
undergo solvent evaporation until they approach z/zR  0.8 (indicated by hatch markings in
Figure 2.13a).6, 32 At this point jet fission produces a litter of progeny droplets (indicated in solid
red).6 The charge-depleted parents undergo further evaporation until another round of jet fission
produces additional progeny droplets. These evaporation/fission events repeat themselves
through several generations. The prevalence of H+ or NH4+ as excess charge carriers under
typical conditions12,
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favors the formation of clean [M + zH]z+ ions from the nanodroplets,

keeping in mind that NH4+ adducts will be lost as NH3 during ion sampling.7
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(a)

+
+
+

(b)

NBu4+

NBu4+
+

Figure 2.13. Schematic of droplet evolution within the ESI plume. Time increases from left to
right. Droplet shrinkage due to solvent evaporation is indicated by horizontal arrows, fission
events that produce progeny droplets (solid red) are represented by vertical arrows. The progeny
droplets will subsequently produce gaseous protein ions. Parent droplets close to the Rayleigh
limit carry a red hatch pattern. (a) Shrinkage/fission scenario for droplets charged with H+, NH4+,
or Na+.7, 32 (b) Scenario encountered in the presence of NBu4+, where shrinking droplets remain
far below zR due to the facile loss of NBu4+. Droplet fission only takes place after ejection of all
NBu4+. Key features to note in panel (b): (i) the low number of progeny droplets implies a low
protein ion yield; and (ii) droplet evaporation is slowed down compared to panel (a).
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ESI in NaCl Solutions: Our data demonstrate that the main problem encountered in the
presence of NaCl is extensive adduction that spreads the total ion count over numerous [M + zH
+ n(Na - H) + m(Cl + H)]z+ species. Adducts are particularly prevalent under CRM conditions.41
Figure 2.4 reveals that R(C) is not strongly affected by the presence of NaCl. In addition, the
protein charge state distributions with and without NaCl remain almost unchanged (Figures 2.3,
2.5, 2.6). Taken together, this implies that (i) NaCl does not cause major interferences with the
droplet evaporation/fission events outlined in Figure 2.13, and (ii) NaCl does not strongly
interfere with release of protein ions from nanodroplets. The cartoon representation of Figure
2.13a therefore applies to both salt-free and NaCl contaminated protein solutions.
Effects of NBu4+: A key feature observed in our simulations is the facile IEM ejection of
NBu4+ which keeps the corresponding droplets far below the Rayleigh limit (Figure 2.12d).
Emission of NBu4+ will take place already for droplets much larger than those in Figure 2.12.
NBu4+ emission thus prevents these “would-be parents” from reaching the threshold of z/zR  0.8
which is required for progeny droplet formation via jet fission.6, 32 Since progeny droplets are the
precursors of gaseous analyte ions,7 the reduced value of z/zR represents a key reason why the
protein ion yield is lowered by NBu4+. Analogous considerations likely apply to other ionic
additives with high surface affinity. Jet fission will take place only after all NBu4+ have drained
from the droplet, because it is only then that droplets can reach the critical range of z/zR  0.8
(Figure 2.13b). The absence of NBu4+ from the final nanodroplets is evident from the fact that
charge states formed in NBu4Cl are similar to those observed for salt-free solution (Figure 2.7,
2.10). The presence of residual NBu4+ at the point of protein release would manifest itself as a
shift to lower charge states,7, 12, 14 because the corresponding nanodroplets would be far below the
Rayleigh limit (Figure 2.12d). Overall, a key factor responsible for protein ion suppression by
NBu4+ appears to be a shift in the kinetic competition from jet fission towards charge carrier
ejection (Figure 2.13b).
An additional aspect to consider is that solvent evaporation in the presence of NBu4+ is
quite slow (Figure 2.12c). The prolonged droplet lifetime increases the likelihood of droplet
collisions with metal components of the ion sampling interface, thereby further lowering the
yield of gaseous protein ions. The cartoon in Figure 2.13b indicates both the lower progeny
droplet yield and the longer droplet lifetime in the presence of NBu4+.
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Interferences Caused by Cs+: The propensity of Cs+ to suppress the protein ion intensity
is lower than that of NBu4+ (Figure 2.11). This suggests that the ability of Cs+ to interfere with
the ESI process via charge loss from early droplets is less pronounced. Consistent with this
interpretation, the hydration free energy of Cs+ (hydG = -250 kJ mol-1) is intermediate between
those of Na+ and NBu4+ .45 From an experimental point of view the main problem encountered in
the presence of Cs+ is the formation of adducts (Figures 2.7, 2.10).

2.4. Conclusions
The starting point for the current investigation was the hypothesis that salt interferences
in protein ESI-MS can be dissected into two unrelated effects, i.e., adduct formation and ion
suppression (Figure 2.1). The findings discussed above strongly support the validity of this idea.
NaCl induces major adduction, while not strongly interfering with the total ion intensity.
Conversely, NBu4Cl leads to the near-complete breakdown of protein ion formation, while not
causing any adduction. Other additives may show hybrid scenarios, exemplified by CsCl in this
work. The key factor that governs the nature of the interfering effects appears to be the surface
affinity of the cation. Species with high surface affinity (hydG  0) tend to cause ion
suppression, whereas those with low surface affinity (hydG << 0) tend to cause adduction. It is
possible that the extent of adduction can be modulated somewhat by factors such as protein size
and amino acid composition.
Equation 2.1 plays a key role in mechanistic discussions of the ESI process.
Specifically, Rayleigh’s theory is commonly used for estimating the amount of charge that can be
accommodated on a stable droplet.7,

32

However, Equation 2.1 was derived on the basis of a

continuum model, without any atomistic details.70 Recent work11, 74 has already suggested that
shrinking droplets may lose charge due to IEM events far below the Rayleigh limit. The
feasibility of these premature ion ejection events depends on the nature of the charge carrier, as
well as the electric field at the droplet surface. Consistent with those proposals11, 74 the current
work demonstrates that ions with high surface affinity (such as NBu4+) get ejected from ESI
droplets at z/zR << 1. We propose that this phenomenon represents the root cause for the
occurrence of protein ion suppression in the presence of low MW ions that possess high surface
affinity. Specifically, we propose that the hemorrhaging of charge at z/zR << 1 prevents shrinking
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ESI droplets from undergoing jet fission. Reduced jet fission implies that a lower number of
progeny droplets will be formed which are the precursors of gaseous protein ions.7 In addition,
the reduced droplet evaporation rate in the presence of NBu4+ may lower the yield of gaseous
protein ions as well.
Finally, we return to the concept of charge competition that is frequently mentioned in
the context of ESI-MS signal suppression.17, 32-33, 36 The framework proposed here (Figure 2.13)
is consistent with a competition mechanism in the ESI plume, where kinetic partitioning favors
either the IEM emission of small ions or the production of progeny droplets. The emission of
small ions drains the parent droplet charge in an unproductive fashion, whereas the formation of
nanodroplets will ultimately lead to production of gaseous protein ions. The competing nature of
these two processes becomes clear when realizing that the total amount of excess charge on the
initial ESI droplets is limited; hence, any charge that is lost via ejection of small ions will not be
available for the production of protein ions. This competition framework is suitable for
understanding the effects of species such as NBu4+ that reduce the total protein ion signal (Figure
2.1c). On the other hand, the behavior of salts such as NaCl is primarily based on the rather
trivial spreading of the ion count over a wide m/z range via adduct formation (Figure 2.1b). It is
hoped that the ideas put forward here will improve the general understanding of salt interferences
in ESI-MS, paving the way towards strategies to better cope with contaminants in biological
samples.
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Chapter 3. Mechanism of Protein Supercharging by Sulfolane
and

m-NBA:

Molecular

Dynamics

Simulations

of

the

Electrospray Process
3.1. Introduction
The capability to transfer intact proteins and protein complexes from solution into the gas phase
by electrospray ionization (ESI)1 has revolutionized the area of mass spectrometry (MS).2-5
During the ESI process analyte solution is dispersed into charged droplets. These droplets
undergo evaporation and jet fission close to the Rayleigh limit,6-7 ultimately producing
nanodroplets from which gaseous protein ions are released.8-9 These ions are then analyzed
according to their mass-to-charge ratio. Additional information is obtainable by applying various
excitation and fragmentation techniques,10-14 as well as ion mobility spectrometry (IMS).15-18
Early ESI experiments mostly employed denaturing solvents. Recent years have witnessed the
rise of “native” ESI, which uses aqueous solutions at neutral pH. Protein ions generated by native
ESI can retain solution-like structures, provided that collisional activation is minimized.2, 5, 15, 19
A key factor that governs the behavior of gaseous proteins is their charge state z. Low z
values are usually associated with compact conformations, while proteins with elevated charge
states tend to adopt extended structures.15-16,
experiments,11,

21

20

High z values are beneficial for fragmentation

and they increase the performance characteristics of Fourier transform mass

analyzers.14, 22 The following discussion is restricted to the widely used positive ESI mode, where
analytes carry excess protons and/or metal cations.8
Not surprisingly, there is tremendous interest in methods for manipulating the charge
states of gaseous proteins. Native ESI usually results in low z values, whereas denaturing
conditions produce ions that are highly charged.23-25 This effect has been linked to the
mechanisms by which different conformers emerge from aqueous ESI nanodroplets.9 While
several aspects of the ESI process remain contentious,26-27 there is considerable support for the
view that compact structures are released upon solvent evaporation to dryness28-29 as described
by the charged residue mechanism (CRM).30 The CRM produces ions that have z values close to
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the Rayleigh charge of protein-sized water droplets.8-9, 31 For unfolded proteins a chain ejection
model (CEM)2,

9

has been proposed that envisions the extrusion of polymer chains from the

nanodroplet surface.32 The CEM attributes the high z values of unfolded proteins to H+ migration
from the droplet to the protruding chain.9 Shifts in charge states may also originate from protein
structural changes within the droplet.33-34 For example, exposure of a native ESI plume to heat35
or acidic vapors36 can induce unfolding, resulting in elevated z values. Proton transfer reactions16,
37-38

and electron capture39-40 allow modifying charge states after protein release from the droplet.
Supercharging agents (SCAs) offer an alternative way to modulate protein z values

during ESI.41 SCAs are added to the bulk solution in low concentration where they do not affect
protein structure or stability.42 Yet, ESI of these samples produces greatly elevated charge
states.41, 43 Supercharging can increase z values for native42, 44-49 and for denaturing solutions.50-53
SCAs have large dipole moments.42-43,

51

Their surface tension values are in-between those of

methanol and water.51 In addition to one or more polar groups, most SCAs possess an aliphatic
moiety.43,

51

The low volatility of SCAs (bp > 180 C)42-43,

51

causes differential evaporation.

Hence, ESI nanodroplets have a SCA content that is significantly elevated relative to the bulk
solution.27,

51

Two widely used SCAs that embody all these characteristics are sulfolane

(C4H8SO2) and m-NBA (m-nitrobenzyl alcohol, HO-CH2-C6H4-NO2, see Figure 3.1 insets).43, 4546, 48, 51-52

The mechanism of supercharging has yet to be elucidated.27,

51

Despite the common

features noted above, there is no clear correlation between the effectiveness of SCAs and their
physicochemical properties.51 Initial work focused on the surface tension  .41 The charge of a
droplet with radius r at the Rayleigh limit8 is zR = 8(0  r3)1/2/e, where 0 is the vacuum
permittivity and e = 1.602  10-19 C. If SCA enrichment were to increase surface tension, the
droplet should support more charge and produce protein ions with higher z.9, 41 Unfortunately,
this idea is inconsistent with experimental data.54 For example, m-NBA enrichment in aqueous
droplets lowers the surface tension (m-NBA < water), but m-NBA increases protein charging in
native ESI.43 Other proposals envision that SCA-enriched droplets trigger chemical42 or thermal55
denaturation. Unfolding within the droplet would then produce high charge states, analogous to
conditions where proteins are electrosprayed in denaturing bulk solutions.23-25 This unfolding
mechanism is at odds with reports that some supercharged proteins retain a compact fold.44, 56
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Other investigations considered direct SCA-protein interactions,47, 52 as well as the SCA Brønsted
acid/base chemistry.27 None of those earlier studies has yielded compelling evidence for any
particular mechanism.
Molecular dynamics (MD) simulations can provide detailed insights into the ESI
process. 7, 9, 32, 57-63 Several studies demonstrated the field emission of small charge carriers from
the droplet surface.7,

9, 32, 58, 63

These events are consistent with the ion evaporation model

(IEM).64-65 MD work from our laboratory resulted in the an atomistic view of CRM protein
release from aqueous nanodroplets.57 The IEM ejection of small ions (such as Na+) plays an
ancillary role during the CRM

57

by keeping the shrinking water droplets close to zR.28-29

Surprisingly, there appear to be no previous MD studies on protein supercharging.
Here we use a combination of experiments and MD techniques to elucidate the
supercharging mechanism for two archetypical SCAs, sulfolane and m-NBA. Our simulations
focus on late generation nanodroplets within the ESI plume from which protein ions are released
into the gas phase.8 Holo-myoglobin (hMb) was chosen as model system, reflecting the use of
this heme-protein complex in numerous earlier supercharging experiments.27, 42-43, 46-47 Also, hMb
represents a minimalist example of a biologically relevant complex, keeping in mind the steadily
increasing use of SCAs for investigations on noncovalent assemblies.42-43, 48-49, 56 We specifically
focus on the role of SCAs in neutral aqueous solution, where proteins adopt their biologically
active conformations as they enter the ESI process.2, 5, 15, 19 Our data reveal that supercharging
proceeds via a previously unrecognized mechanism, where solvent segregation induces charge
trapping in the droplet and on the protein.

3.2. Materials and Methods
3.2.1. Electrospray Ionization Mass Spectrometry and Ion Mobility
Spectrometry
Equine hMb, sulfolane, m-NBA and ammonium acetate were purchased from Sigma (St.
Louis, MO). Protein samples were centrifuged to remove small amounts of insoluble debris,
followed by dialysis against 10 mM aqueous ammonium acetate. All solutions had a protein
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concentration of 10 μM and contained 10 mM ammonium acetate. For supercharging
experiments the samples were supplemented with 1% (v/v) sulfolane or m-NBA.
Mass spectra were acquired on a Synapt HDMS instrument (Waters, Milford, MA). The
Z-spray ESI source was operated at 2.8 kV. The desolvation and source temperatures were
200 °C and 80 C, respectively, and the cone was at 20 V. Average charge states were calculated
as zav = (zi Ii)/Ii, where Ii is the signal intensity of charge state i. IMS data were recorded using
the instrument’s travelling-wave cell. Potential gradients were tuned to be as gentle as possible to
minimize collisional activation. This includes lowering the cone to 5 V.66 Drift times were
converted to collision cross sections (). Instrument settings and  calibration procedure have
been summarized elsewhere.66

3.2.2. MD Simulations
All-atom MD simulations were conducted using the CHARMM36 force field

67

in

Gromacs 5.0 with GPU acceleration.68 Our choice of CHARMM is based on its excellent
performance for proteins in solution69 as well as for droplet systems.57 All bonds were
constrained, using LINCS70 for protein and SCAs, and SETTLE71 for water, thereby allowing for
a 2 fs integration time step. The hMb X-ray coordinates 1WLA72 served as starting structure.
Side chains and termini were set to their default pH 7 protonation states; this includes
deprotonation of both heme propionates. TIP4P/2005 water73 was chosen because it reproduces
the experimental surface tension better than other models.74 The topology and structure files for
sulfolane were taken from the GROMACS Molecule & Liquid Database.75 Parameters for mNBA were obtained using the ParamChem Server76 and the ZINC database.77 Initial ESI droplets
were generated by surrounding the protein with pre-equilibrated water. For SCA simulations 315
sulfolane or m-NBA were inserted at random positions, while eliminating any water molecules
that would result in steric clashes. In-house Perl software was used to carve the systems into
spherical droplets. The initial radius was r0 = 3.5 nm, corresponding to 5400 water molecules for
purely aqueous droplets, with the protein at its center. 26 random water molecules were replaced
with Na+. Together with the hMb 2- net charge the resulting net droplet charge was 24+,
corresponding to zR for a 3.5 nm aqueous droplet at 370 K.8 This charge regime is well within
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the range of experimentally measured values.6 A few short runs were also conducted on larger
droplets (5.5 nm radius).
Simulations were run by placing the droplets in a vacuum environment, effectively
without cutoffs for van der Waals or electrostatic interactions.57 The droplets were initially
subjected to steepest descent energy minimization. Subsequent production runs followed a
recently developed trajectory stitching approach.57 This method breaks up simulations into 250
ps segment during which the temperature was controlled by a Nosé-Hoover78 thermostat with a
coupling constant of 0.5 ps. After each segment the system was run through an in-house Fortran
program to remove any evaporated moieties (H2O, sulfolane, m-NBA, or Na+) that had moved
more than 7 nm from the center of mass. New velocities were then assigned from a
Maxwell-Boltzmann distribution prior to beginning of the next simulation window. This
trajectory stitching dramatically reduces wall clock time by gradually decreasing the number of
atoms in the simulation.57 Unless noted otherwise, the simulations were initially run at 370 K for
75 ns. Subsequently the temperature was elevated to 450 K for facilitating the evaporation of any
remaining solvent molecules. This temperature profile reflects progressive heating of protein ions
as they traverse the ion optics of the mass spectrometer.79 The temperatures used are in line with
experimental studies.80-81 The overall simulation window was 350 ns. All ESI simulations were
repeated five times with different initial atom positions and velocities.
Early tests revealed that the slow SCA evaporation precluded formation of desolvated
hMb within reasonable wall clock time. Starting at t = 150 ns, SCA molecules were therefore
subjected to “forced evaporation”. Under this scheme the SCA molecule farthest from the droplet
center was eliminated after each 250 ps run segment, corresponding to an SCA evaporation rate
of 4 ns-1. This strategy is reminiscent of biased82 or steered83 MD techniques used by others.
Forced evaporation reduces the wall clock time from months to roughly one week for each
droplet run. It could be argued that this forced evaporation scheme biases the temporal evolution
of the system towards a CRM scenario. However, the approach chosen here seems well justified,
considering that previous studies strongly argue against IEM or CEM-type behavior under native
ESI conditions.
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3.3. Results and Discussion
3.3.1. Supercharging of Holo-Myoglobin
Before discussing MD simulations, it is beneficial to examine the effects of SCAs
experimentally. The hMb mass spectrum acquired in neutral aqueous solution (without SCA) is
dominated by 9+ ions of the intact heme-protein complex (Figure 3.1a). Addition of 1%
sulfolane shifts the spectrum to higher charge states, with hMb17+ as the most intense ion. In
addition, the spectrum shows minor apo-myoglobin (aMb) signals (Figure 3.1b). Similar
supercharging effects are seen in the presence of 1% m-NBA, albeit with an elevated aMb
abundance (Figure 3.1c).
The structures of the gaseous hMb were probed by IMS (Figure 3.1d-h). Regardless of
solvent conditions, hMb9+ displays a collision cross section around 1740 Å2. This value coincides
with literature data, matching the calculated  of the crystal structure to within 2%.84 Elevated
charge states show larger  values, e.g., 3260 Å2 for hMb17+. Clearly, these highly charged ions
are extensively unfolded.42 Some of the  distributions in Figure 3.1 are multimodal, reflecting
the presence of co-existing conformers.15-18 The data in Figure 3.1 are consistent with earlier
reports,24, 27, 42-43, 46-47 illustrating the dramatic effects of SCAs on protein charge states.42-43, 48-49,
56
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Figure 3.1. ESI mass spectra of hMb in aqueous solution at pH 7. (a) Control without SCA. (b)
Supercharged, 1% sulfolane, and (c) Supercharged, 1% m-NBA. (d) – (h) IMS data for selected
charge states. Coloring: Red, purely aqueous; green, 1% sulfolane; orange, 1% m-NBA. The
heme peak in b, c was scaled by 1/3. Insets in b, c show the structures of sulfolane and m-NBA.
The signal at m/z 754 in Figure 1c corresponds to a singly charged contaminant ion.

3.3.2. Choice of Charge Carrier for Simulations
Electrosprayed proteins usually appear as [M + zH]z+ ions, i.e., they are charged by
excess protons (exemplified in Figure 3.1). The inclusion of H+ in standard MD force fields is
problematic.85 Realistic proton simulations call for QM/MM86, ab initio

60, 87

, or DFT/MD

84

methods
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that are out of reach for the size and time regime considered here. Luckily, there is a

way to sidestep this issue.57 Proteins electrosprayed in the presence of Na+ salts are charged by a
combination of protonation and sodiation, all the way to fully sodiated [M + zNa]z+8. Figure 3.2
demonstrates that this also applies to supercharged hMb. Similar to our earlier ESI simulations, 57
the present study thus uses Na+ as charge carrier, thereby simulating the formation of [M +
zNa]z+ ions. The inclusion of Na+ in MD force fields is straightforward.67 In neutral solution (and
in the initial droplets used here) hMb has a net charge of 2-. Thus, the charge state of hMb ions
carrying n Na+ in our simulations is z = (n – 2).

3.3.3. Charge Carrier Behavior in Different Solvents
As a final step before conducting ESI simulations we examine the behavior of water, sulfolane,
and m-NBA droplets under quasi-equilibrium conditions. Pure solvents (not mixtures) were used
to generate protein-containing droplets with radius r0  5.5 nm. The temperature was kept low to
ensure minimum evaporation (see Figure 3.3 for details). 20 Na+ were included as excess charge
carriers. For these tests we chose a starting configuration where all Na+ were initially placed in
contact with carboxylates and/or carbonyl groups on the protein surface.
The three droplet types exhibit very different behavior. In water each of the Na+
immediately separates from the protein and diffuses throughout the droplet (Figure 3.3a, b). In
sulfolane all Na+ remain associated with hMb (Figure 3.3c, d). Similarly, in m-NBA most of the
Na+ remain attached; only a few charge carriers venture slightly away from the protein (Figure
3.3 e, f).
The unconventional starting configuration used for the simulations of Figure 3.3 (with
all Na+ located at the protein surface for t = 0) helps illustrate an important point. Water is an
excellent solvent for Na+; its favorable hydration88 readily outcompetes Na+ interactions with the
protein. Na+ solvation by sulfolane and m-NBA is much less favorable, as reported for other
solvents that carry aliphatic moieties.89 In conclusion, small charge carriers such as Na+ exhibit
high affinity for water, lower affinity for the protein surface, and very low affinity for SCA
environments. It will be seen that these trends cause partitioning effects that are responsible for
ESI supercharging.
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Figure 3.2. (a) ESI mass spectrum obtained after infusion of holo-myogobin (hMb) in aqueous
solution containing 0.1 mM sodium
and 1%
m-NBA.
of the hMb undergoes heme
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loss, generating apo-myoglobin (aMb). Selected charge states are denoted using “h” and “a” for
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Figure 3.3. Quasi-equilibrium MD data for ESI droplets containing hMb (radius ~5.5 nm) and 20
Na+. Simulation snapshots on the left were taken after 2 ns. Plots show the distance of individual
Na+ from the closest protein heavy atom. (a, b) Water at 330 K; (c, d) Sulfolane at 370 K; (e, f)
m-NBA at 370 K. At the onset of the simulations all Na+ were placed in direct contact with the
protein. The net droplet charge corresponds to 0.42 zR (for water with  = 0.066 N m-1 at 330 K).

87

3.3.4. ESI Simulations
We modeled the release of proteins from nanodroplets consisting of water, water/sulfolane, and
water/m-NBA. The extended time frame of these runs necessitated the use of slightly smaller
droplets than in Figure 3.3 (r0  3.5 nm instead of 5.5 nm). Na+ and SCA molecules were inserted
in random locations, thereby ensuring unbiased starting configurations.
Purely aqueous droplets underwent rapid shrinkage due to water evaporation,
accompanied by ejection of solvated Na+. Any remaining Na+ associate with the protein (Figure
3.4a).57 MD data for water/sulfolane are exemplified in Figure 3.4b. Rapid water evaporation
results in sulfolane enrichment. Figure 3.4b/panel 2 reveals partial solvent segregation, where an
aqueous droplet core harbors the protein, while the outer shell primarily consists of sulfolane.
The sulfolane shell is dynamic enough to permit water evaporation, as well as the occasional
ejection of small clusters comprising one Na+ and a few water and sulfolane molecules (Figure
3.4b/panel 2). After ~40 ns most of the water has vanished, leaving behind the protein
surrounded by sulfolane (Figure 3.4b/panel 3). Complete sulfolane evaporation eventually
releases the protein into the gas phase (Figure 3.4b/panel 4). A very similar progression was seen
for water/m-NBA droplets (Figure 3.4c).
The three ESI scenarios in Figure 3.4 share several features. Droplet shrinkage is
accompanied by the field emission of Na+, in line with IEM events previously described for other
systems.9,

28-29, 64-65

The droplets produce gaseous proteins via solvent evaporation to dryness.

This morphological characteristic implies that ESI is a CRM process for the conditions studied
here,30, 57 regardless whether SCAs are present or not.
Protein charge states predicted by simulations with and without SCAs are summarized
in Figure 3.6. Water droplets produce z values around 9+. This is identical to the result of our
earlier simulations,57 despite the use of larger droplets in the present work. This consistency is
reassuring, as it confirms that the MD results are not affected by droplet size. Strikingly,
simulations of both water/sulfolane and water/m-NBA droplets produce charge states around
15+, i.e., significantly higher than for the purely aqueous systems. The simulated z values show
remarkable agreement with the experimental average charge states for all three solvent systems
(Figure 3.6).
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Experimental mass spectra acquired in the presence of SCAs cover a range of charge
states, whereas the water/SCA simulations produce z values that are quite well defined (see
Figure 3.6 caption). Charge heterogeneity in the experimental data likely reflects the fact that
individual ESI droplets contain different SCA concentrations, with higher concentrations
favoring formation of higher z values.42 Capturing this heterogeneity in our simulations is
difficult, as it would require knowledge of the exact ESI plume composition. Nonetheless, the
agreement between experimental and simulated z values in Figure 3.6 implies that our MD
approach successfully captures the key aspects of SCA behavior during protein ESI.
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Figure 3.4. MD snapshots illustrating the temporal evolution of hMb-containing nanodroplets.
(a) Water, (b) Water/sulfolane, and (c) Water/m-NBA. Time points are indicated along the top.
Blue arrows indicate various stages of Na+ IEM ejection. Coloring: Protein, pink; heme, black;
Na+, blue; water oxygen, red; sulfolane, dark green; m-NBA, orange. All Na+ in the final frames
are bound to hMb, connecting side chains are not shown to prevent clutter (see also fig. 3.5).
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Figure 3.5. Details of hMb interactions with selected Na+ ions after release from a water/m-NBA
droplet (t = 225 ns of Figure 3.4 c). Side chain contacts are indicated using regular labels, main
chain contacts are highlighted in bold.
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Figure 3.6. ESI charge states of hMb predicted by MD simulations compared to experimental
average charge states. MD results are the average of five independent runs, resulting in z values
8/9/9/9/10 (water), 14/14/15/15/15 (water/sulfolane), and 14/14/14/15/15 (water/m-NBA).
Experimental values are averaged over all peaks in the spectra from three measurements. Error
bars represent standard deviations.
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3.3.5. Anatomy of the ESI Process
After confirming that the MD results are consistent with experiments, we now dissect the
simulation trajectories to scrutinize the ESI events with and without SCAs. Most Na+ ejection
events take place within the first ~25 ns. More Na+ are retained in water/SCA than in purely
aqueous droplets (Figure 3.7a, e, i). Any retained Na+ will eventually contribute to the protein
charge. Understanding why aqueous droplets shed Na+ with higher efficiency thus holds the key
to deciphering the supercharging mechanism. We will discuss this central point in more detail
below.
Na+ attachment provides the protein with its net charge. Early on, Na+ ions show noisy
trajectories, arising from diffusive movement in the space between the protein and the droplet
surface. Within ~50 ns the profiles settle down at 0.22 nm, reflecting Na+ binding to carboxylate
and carbonyl oxygens on the protein (Figure 3.7c, g, k, see Figure 3.5 for interaction details).
There is a striking correlation between Na+ attachment (Figure 3.7c, g, k) and water evaporation
(Figure 3.7b, f, j): Na+ ions can roam the droplet interior only as long as there is water. Once the
water vanishes all remaining Na+ attach to the protein. The pure SCA environments encountered
for t > 50 ns cannot prevent Na+ attachment to the protein (see Figures 3.7g, k, t = 50 - 150 ns,
where all remaining Na+ are bound to hMb while most SCA molecules are still present). This
behavior arises from the Na+ affinity trends discussed earlier (Figure 3.3): Na+ prefers to be
solvated in water. In the absence of water, Na+ binding to the protein is preferred. Being
dissolved in an SCA environment is least favored.
Radial distributions report on the internal droplet structure (Figure 3.7, bottom row, t =
3-5 ns). In all three cases the protein resides close to the droplet center. It is surrounded by water
containing the Na+ ions. Note that the Na+ and water distributions closely coincide. Water-SCA
segregation causes sulfolane and m-NBA to accumulate in the outermost droplet layers (Figures
3.7h, l). This segregation is consistent with nanoscale de-mixing of other binary systems such as
water/methanol.9,
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Formation of an aqueous droplet core maximizes enthalpically favorable

water-water hydrogen bonding as well as water-protein contacts.91
The number of solvent molecules in the droplet is tallied in Figure 3.7b, f, j. Most of the
water has evaporated after ~50 ns, while only a handful of SCA molecules have left at this point.
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This enrichment reflects the low volatility of SCAs, in line with experiments.27, 51 As noted in the
Materials and Methods section, starting at t = 150 ns a “forced evaporation” scheme was applied
for speeding up the temporal evolution of SCA-containing droplets (arrows in Figures 3.7f, j).
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Figure 3.7. MD data, illustrating the evaporation of hMb-containing ESI droplets: (a-d) Water,
(e-h) Water/sulfolane, (i-l) Water/m-NBA. Top row: Na+ ejection from the droplet. Second row:
Solvent evaporation (vertical arrows in f, j indicate the onset of forced evaporation). Third row:
Average distance of Na+ in the droplet from the closest protein heavy atom. Bottom row: Radial
distributions, averaged over 3 - 5 ns and five MD runs. These P(r) data were generated by
tallying heavy atoms for each component with 4r2 normalization. Protein P(r) data are scaled by
 0.33.
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3.3.6. Electrospray Ionization Supercharging via Charge Trapping
For understanding the supercharging mechanism, it is necessary to recall three basic facts. (1)
Charge accumulation on the protein competes with IEM ejection of small ions (such as Na+)
from the droplet.28-29,

57

(2) Strong electrostatic interactions (e.g., R-COO- Na+) prevent the

protein from ejecting charge once the solvent has left.92 Thus, any charge carriers that did not
leave the droplet during solvent evaporation will contribute to the z value of the protein.28-29, 57
(3) Charge carriers can undergo IEM ejection only after coming close to the droplet surface.64
Hence, any factors that restrict charge carrier access to the droplet surface will reduce the IEM
ejection rate, thereby boosting the protein charge.
In purely aqueous systems, favorable solvation allows charge carriers to roam the entire
liquid space within the droplet, including positions close to the droplet surface (Figures 3.3a,
3.7d). The IEM ejection of charge carriers from aqueous droplets is therefore a facile process,
provided that the system net charge is sufficiently high.64-65 This facile charge loss causes protein
ions generated from water droplets via the CRM to have low z values.8-9, 31
Water/SCA droplets undergo solvent segregation. SCA molecules are enriched in the
outermost layers, while protein and water reside close to the center. Charge carrier partitioning
proceeds according to solvation preferences, i.e., small ions reside in the aqueous core (Figures
3.7h, l). The resulting charge carrier depletion at the droplet surface disfavors IEM ejection,64 a
view that is supported by experiments on m-NBA droplets.6 As the final water molecules escape
(leaving the SCA behind), all remaining charge carriers bind to the protein. Being a poor solvent
for small ions, the SCA is incapable of dissolving charge carriers away from the protein (Figure
3.3b, c), such that IEM ejection is shut down. Charge carriers remain associated with the protein,
causing it to emerge as highly charged CRM product once the SCA has evaporated.
In summary, protein supercharging is based on charge trapping within ESI nanodroplets.
This trapping results from two effects that are related to one another. (i) Early during nanodroplet
evaporation, SCA accumulation in the outermost layers restricts charge carrier access to the
droplet surface. (ii) After all the water has evaporated, charge carriers are bound to the protein
deep within the droplet. Unfavorable solvation characteristics prevent these charge carriers from
venturing into the surrounding SCA. Both (i) and (ii) interfere with the capability of the
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nanodroplets to shed charge via the IEM. As a result, more charge is imparted to the protein than
in the absence of SCAs.

3.3.7. Surface Charge of ESI Droplets
The trapping mechanism outlined above involves the binding of numerous charge carriers to the
protein, surrounded by an SCA shell, after all water has left. One might argue that such a charge
carrier accumulation should be electrostatically disfavored. This apparent conundrum is resolved
when solvation effects are taken into account.
We previously noted that water droplets containing excess Na+ undergo dipole
ordering.9 As a result, the droplets carry their entire net charge on the surface (as widely assumed
in the ESI literature8) while excess charge carriers (e.g., Na+) are located in the interior where
solvation is more favorable.88 This surface charge is a consequence of Gauss’ Law,93 which
states that a conducting sphere with radius r0 will carry its entire charge at r = r0. In MD units68
the electrostatic potential under such “ideal” condition is V(r) = z/r for r > r0, and V(r) = z/r0 =
const for r  r0.93 The V(r) profile predicted by Gauss’ Law is shown in Figure 3.8 (dotted lines
in each panel).
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Figure 3.8. Electrostatic potential V(r) of nanodroplets containing hMb and 20 Na+, generated
from the trajectories of Figure 3.3. (a) Water, (b) Pure sulfolane, (c) Pure m-NBA. Each panel
contains three data sets. 1. Gauss’ Law for an ideal conductor (black dotted lines). 2. Whole
droplet with hMb, 20 Na+, and solvent (solid lines). 3. hMb / 20 Na+ without solvent
contributions (dash-dotted lines). Each curve represents the average of 140 scans between 2 ns
and 3 ns.

It is has never been confirmed that the surface charge projection seen for water/Na+
droplets9 also applies in the presence of proteins and/or other solvents. We examined this aspect
by mapping V(r) for the three droplets depicted in Figure 3.3. a virtual test particle was scanned
from the droplet midpoint in radial direction. For each position r the electrostatic potential was
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calculated as V(r) = (qi/di) where the sum includes all atoms i, qi is the atom charge i defined in
the force field,67 and di is the distance between the test particle and atom i.
Droplet profiles were first generated by only scanning protein and Na+, omitting the
solvent. V(r) profiles generated under these conditions show dramatic deviations from Gauss’
Law (dash-dotted lines, Figure 3.8a-c). The mismatch is most pronounced for sulfolane and mNBA, reflecting Na+ accumulation close to the center (cf. Figure 3.3). In contrast, V(r) scans of
the whole droplets (protein, Na+, and solvent) agree closely with the ideal profiles (solid lines,
Figure 3.8a-c).
The data of Figure 3.8 confirm the expectation9 that ESI droplets containing a dipolar
solvent will project their net charge to the surface. The droplet interior is free of static fields
because V(r)  const for r  r0. As a result, large-scale electrostatic repulsion among charges
within the droplet is absent. This effect greatly reduces the energetic penalty associated with
charge carrier accumulation on the protein close to the center. Also, bound charge carriers will
not trigger electrostatic protein unfolding while the polypeptide chain is surrounded by a solvent
shell, because the charge is projected away from the protein. Instead, the net charge destabilizes
the whole droplet by forcing surface solvent molecules into orientations that satisfy Gauss’ Law93
at the expense of intermolecular contacts.9 The net charge of SCA droplets under these
conditions may exceed zR, in line with experiments on various non-aqueous systems.6

3.3.8. Supercharging and Protein Unfolding
Highly charged hMb ions generated in the presence of SCAs are unfolded (Figure 3.1f-h).
Similar observations prompted Williams et al. to propose that chemical42 or thermal55 unfolding
within ESI droplets is the primary origin of supercharging. Bulk solution studies confirmed that
high SCA percentages can reduce protein stability.34, 42 However, it is unclear if this effect can
trigger unfolding on the very short time scale of the final ESI steps,34 keeping in mind that
protein/SCA contact is limited by segregation (Figure 3.7h, l). These questions necessitate a
closer look at the relationship between supercharging and unfolding.
Figure 3.9 tracks the hMb radius of gyration (Rg) over 350 ns. For purely aqueous ESI
the protein retains a native-like compactness with Rg  1.5 nm throughout the entire time window
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(Figure 3.9a). For water/sulfolane and water/m-NBA compact conformations are retained only
for ca. 180 ns (Figure 3.9b, c). The final protein z values are determined after the last Na+
ejection event (blue vertical lines at ~70 ns, Figure 3.9). The Rg profiles therefore imply that hMb
supercharging is complete prior to unfolding. Significant conformational changes start to occur
later, during evaporation of the final solvent molecules (Figure 3.9b, c).
In summary, our data imply that unfolding within ESI droplets is not the origin of
supercharging by sulfolane or m-NBA. Electrostatically driven unfolding15-16, 20 takes place after
protein charging is complete. Major structural changes start during the final stages of
desolvation, and they likely continue for the bare proteins beyond the 350 ns window of Figure
3.9. Unfolding under these conditions is facilitated by electrostatic repulsion once the stabilizing
effects caused by solvent-mediated charge projection have disappeared (cf. Figure 3.8).
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Figure 3.9. Radius of gyration (Rg) as a function of time for ESI droplets consisting of water (a),
Water/sulfolane (b) Water/m-NBA (c) Averaged over five MD runs. Blue vertical lines denote
ejection of the last Na+ from the droplet. Also indicated are the time points where 80% of water
(a), sulfolane (b), and m-NBA (c) have evaporated. Representative structures populated at the
end of the simulation window (t = 350 ns) are shown along the right.
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3.4. Conclusions
The ESI charge states predicted by our MD simulations are in remarkable agreement with
experimental data (Figure 3.6). This high level of consistency suggests that the MD trajectories
describe the physics of the ESI process quite well, despite the limitations of classical force fields.
We focused on the fate of native hMb in charged nanodroplets consisting of water,
water/sulfolane, and water/m-NBA. In all cases the protein is released via solvent evaporation to
dryness, as envisioned by the CRM.30 ESI charge states generated in water are close to the
Rayleigh charge of protein-sized aqueous droplets.31, 57 In contrast, the elevated z values formed
in the presence of SCAs are inconsistent with the predicted zR() trend. This behavior implies that
supercharging is not a simple surface tension effect.43,
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Our results also indicate that neither

unfolding within ESI droplets,42, 55 nor the Brønsted acid/base properties of SCAs27 represent key
components of the supercharging mechanism.
Figure 3.10 summarizes the ESI process for water and water/SCA droplets. Without
SCAs, highly charged aqueous droplets generated by native ESI undergo rapid evaporation. The
aqueous environment favors relatively unrestricted movement of charge carriers, allowing them
to approach the droplet surface where IEM ejection takes place with high efficiency (Figure 3.10
a, b). The few remaining charge carriers bind to the protein as the final water layers evaporate
(Figure 3.10c). The low z values render proteins electrosprayed in water quite resistant to gas
phase unfolding, favoring the retention of solution-like conformations (Figure 3.10d).2, 5, 15, 19
Supercharging is caused by a charge trapping mechanism. Mixed water/SCA
nanodroplets undergo solvent segregation, resulting in an aqueous core that contains the protein
and an outer shell of SCA molecules. Charge carriers partition into the aqueous core where
solvation is more favorable than in the outer SCA layers. As a consequence, the IEM ejection of
charge carriers from the droplet surface proceeds at a lower rate (Figure 3.10e). Poor solvation
afforded by the SCA causes binding of all remaining charge carriers to the protein once the water
has evaporated. IEM ejection is no longer feasible after this point because charge carrier affinity
to the protein exceeds their affinity for the SCA environment; the charge carriers are trapped
(Figure 3.10f). SCA evaporation releases the protein into the gas phase without any additional
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charge loss (Figure 3.10g). As a result of their high z values, supercharged protein ions are prone
to electrostatically driven unfolding in the gas phase (Figure 3.10h).
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Figure 3.10. ESI in water without (a-d) and with supercharging (e-h). (a, b) Water droplet
undergoing solvent evaporation. Charge carriers (Na+ or H+, blue) can move to the surface and
undergo IEM ejection. (c) Native-like nascent gas phase protein. (d) Low charge favors retention
of compact structures. (e) Water/SCA droplet after solvent segregation. Na+ or H+ accumulate in
the aqueous core, reducing IEM ejection. (f) Na+ or H+ are trapped on the protein after water
evaporation. (g) Supercharged nascent gas phase protein. (h) High charge states favor unfolding.
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The supercharging mechanism outlined in Figure 3.10e-h suggest that an “ideal” SCA will be
dipolar and moderately miscible with water, while its evaporation rate will be much lower than
that of water. In addition, interactions of the SCA with the protein surface and with excess charge
carriers have to be less favorable than in the case of water. These features are consistent with
typical SCA characteristics previously noted in the literature.43, 51
The supercharging mechanism outlined in Figure 3.10 applies to proteins that are
electrosprayed from non-denaturing bulk solution in positive ions mode. Supercharging also
takes place for proteins that enter the ESI process as unfolded conformers, e.g. in the presence of
acids.50-53 Meaningful MD simulations under those conditions will require the use of mobile
proton methods, as the process likely involves protein release via the CEM 9, It will also be of
interest to examine the effects of SCAs in negative ion mode,47 and for analytes such as nucleic
acids.

94-95

Work in this direction is currently ongoing in our laboratory, and the results of those

endeavors will be reported elsewhere.
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Chapter 4. Crown Ethers Modulate the Location of Charge
Carriers in Electrospray Droplets: Implications for the
Mechanism of Protein Charging and Supercharging
4.1. Introduction
Electrospray ionization (ESI)1 transforms solution phase proteins into multiply charged gaseous
ions for analysis by mass spectrometry (MS). Of particular interest are “native” ESI-MS
experiments2-4 that aim to preserve solution structures and interactions in the gas phase. These
studies employ non-denaturing aqueous solutions and gentle ion sampling conditions. Native
ESI-MS reports on protein binding stoichiometries.2-5 Complementary information is obtainable
from dissociation experiments2, 6-7 and ion mobility spectrometry.8-10
In positive ESI the protein solution is dispersed into droplets that carry excess H+, NH4+,
or Na+.11-12 Evaporation and fission events close to the Rayleigh limit produce progressively
smaller droplets.11,

13

The mechanisms of analyte ion release from these nanodroplets were

shrouded in controversy for many years.1, 11-12, 14-17 Recent molecular dynamics (MD) simulations
helped address some of the questions in this area.18-24 For example, it is now widely accepted that
globular proteins are released via droplet evaporation to dryness during native ESI,20-24 as
envisioned by the charged residue model (CRM).11, 25 Charge carriers bind to the protein during
the final stages of evaporation, generating ions such as [M + zH]z+ or [M + zNa]z+ .11
The dissociation behavior26-32 and conformations of gaseous proteins33-35 are governed
by their charge state z. As a result, there is considerable interest in ways to manipulate these
charge states.33-34, 36-39 Native ESI generates low z values close to the Rayleigh charge of proteinsized water droplets,11,

25

in accordance with the CRM.20-24 Much higher charge states are

generated from proteins that are unfolded in bulk solution.40-41 According to the chain ejection
model (CEM) these highly charged ions form during protein expulsion from the droplet
surface.42-44
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A common strategy for modulating protein charge states is the use of supercharging
agents (SCAs).45-46 SCAs are added to the sample at low concentrations that do not significantly
affect the protein structure in bulk solution.44, 47 Yet, SCAs significantly enhance charging during
ESI. Typical SCAs (such as sulfolane, C4H8SO2) possess a nonpolar hydrocarbon moiety and one
or more polar groups.32, 45, 47 Their low volatility makes them evaporate more slowly than water,
such that late ESI nanodroplets are SCA-enriched.32,

45, 47-48

Supercharging takes place for

native30, 38, 45, 47, 49-53 and for denaturing solutions.32, 44, 54 Here, we focus on the role of SCAs in
native ESI, i.e., the conversion of folded solution phase proteins to highly charged gaseous
ions.30, 38, 45, 47, 49-52, 55
The mechanism of native ESI supercharging remains controversial.45-46,

48, 50, 54, 56

According to one proposal supercharging is caused by thermal or chemical unfolding in SCAenriched droplets.47 Within this model, SCAs cause proteins to switch from the CRM to the
CEM.

44

Although this “unfolding model” offers an intuitive explanation for supercharging, its

validity is under dispute.30,

45, 55, 57-59

The elevated CCSs observed for some supercharged

proteins44, 47, 58 do not prove that unfolding takes place within the droplet; alternatively, unfolding
could be caused by Coulombic repulsion after release into the gas phase.58,
supercharged proteins retain a native-like compactness,30,

60

60

A number of

making it unlikely that unfolding

constitutes the root cause of supercharging. Also, weakly bound complexes can be supercharged
without undergoing dissociation,30,

45, 55

prompting, Robinson et al.59 to conclude that

“supercharging does not appear to perturb the structure in that unfolding is not detected”.
Our group recently addressed this issue by applying MD simulations in which Na+
served as excess charge carrier for probing the supercharging mechanism, focusing on the SCAs
sulfolane and m-nitrobenzyl alcohol (m-NBA).58 The MD-generated [M + zNa]z+ ions closely
matched the z values of experimentally observed sodiated and protonated protein ions, both with
and without SCAs. In the simulations proteins were released via droplet evaporation to dryness.
Droplet shrinkage was accompanied by charge carrier ejection. The remaining charge carriers
underwent binding to the protein during the final stage of evaporation. The simulations indicated
(i) SCA enrichment at the droplet surface, followed by (ii) formation of an SCA layer around the
protein after complete water evaporation. Both factors inhibited charge carrier ejection from the
droplet because SCAs are ionophobic58 (e.g., the NaCl solubility in sulfolane is four orders of
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magnitude lower than in water61). We thus proposed58 that supercharging is caused by charge
trapping, not by unfolding. This “charge trapping model”58 and the aforementioned unfolding
model44, 47 represent two very different mechanistic views of protein supercharging in native ESI.
The current work examines the supercharging mechanism from a new perspective.
Crown ethers can bind small cations, thereby enhancing the solubility of these charge carriers in
nonaqueous solvents.62-63 We will test the following hypothesis: The charge trapping model58
envisions that supercharging is caused by the low solubility of charge carriers in the SCAenriched droplet layers. Under such conditions, the capability of crown ethers to act as phase
transfer catalysts62-63 should facilitate the shuttling of charge carriers to the droplet surface,
thereby favoring charge ejection. We predict that these conditions will lower the extent of protein
charging in the presence of SCAs. 18-crown-6 (18C6) is of particular interest due to its ability to
accommodate ESI-relevant species (Na+, NH4+ and H3O+) in solution and in the gas phase.62, 64-67
Previous studies explored 18C6 binding to Lys+ and N+-termini of gaseous peptides or
proteins,68-72 but the consequences of crown ethers for the ESI process remain largely
unexplored.39 The MD simulations of this work, as well as experiments on proteins and
dendrimers, support the proposed hypothesis. We report for the first time that 18C6 acts as a
powerful supercharging antidote. These findings support the view that native ESI supercharging
is caused by charge trapping.

4.2. Materials and Methods
4.2.1. Proteins and Reagents
Horse holo-myoglobin (17568 Da) bovine ubiquitin (8565 Da), 18C6 (264 Da) and
polyamidoamine dendrimer (generation 5, PAMAM succinamic acid dendrimer with 1,4diaminobutane core, theoretical mass 41669 Da) were from Sigma (St. Louis, MO). Neutral
solutions were prepared at a protein concentration of 5 μM, with 1 mM ammonium acetate or 1
mM NaCl. Dendrimers were electrosprayed in water containing 100 mM ammonium acetate. As
needed, the samples were supplemented with 1% (v/v) sulfolane and/or 1 mM 18C6.
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4.2.2. Mass Spectrometry
Spectra were acquired on a Synapt ESI mass spectrometer (Waters, Milford, MA).
Proteins were electrosprayed at 1.5 kV using gold-coated nanoESI emitters borosilicate glass
emitters at a flow rate of ~40 nL min-1.73 Standard experiments were conducted under gentle
conditions with cone voltage = 20 V, trap collision energy = 4 V, and source temperature = 80
C. If required, collisional heating was applied by raising the cone voltage to 120 V, or by raising
the trap collision energy (CE) to 40 V. Average charge states were calculated as zav = (zi Ii)/Ii,
where Ii is the integrated signal intensity of charge state i.

4.2.3. MD Simulations
ESI droplet simulations followed a strategy similar to that described earlier,24, 58 using
Gromacs 574 and the CHARMM36 force field.75 The TIP4P/2005 H2O model76 was used because
it closely mimics the experimental surface tension of water.77 18C6 parameters were obtained
from the ParamChem Server78 and the ZINC database.79 Initial protein coordinates were taken
from the crystal structure 1WLA, with default charges (NT+, Arg+, Lys+, His0, Asp-, Glu-, heme2-,
CT-), for an intrinsic hMb charge of 2-. The initial droplet radius was r = 4 nm. The droplet
compositions tested were (a) 8000 waters, (b) 7500 waters and 32 18C6, (c) 5300 waters and 460
sulfolane, (d) 4800 waters, 460 sulfolane, and 32 18C6. The initial water:sulfolane ratio was
chosen in accordance with our earlier supercharging simulations.58 32 18C6 molecules were
included because these conditions generated hMb adducted with (10  1) 18C6 prior to the onset
of forced evaporation in water/18C6 runs. This number is consistent with the experimental data
of Figure 4.2b (gentle source conditions), where the most intense signal corresponded to hMb
bound to 10 18C6. In all cases, 32 Na+ provided a net charge of 30+ which corresponds to the
Rayleigh limit of a 4 nm aqueous droplet.11 Initially the protein was centered, and all other
constituents had random positions within the droplet. After equilibration, production runs were
conducted at 370 K for 75 ns, followed by 200 ns at 450 K. Starting at t = 150 ns, sulfolane and
18C6 were subject to forced evaporation (see subsequent section).58 Runs were repeated five
times with different initial positions and velocities.
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Under experimental conditions ESI usually produces [M + zH]z+ ions.11 Modeling the
formation of such species would require QM or DFT methods for properly describing proton
transfer events. Unfortunately, the system size and time scale studied here exceed the capabilities
of such high level methods.80 As in previous work, our simulations thus focused on droplets
carrying Na+ as charge carriers, which produce [M + zNa]z+ ions instead of [M + zH]z+.11 In
contrast to protons, ions such as Na+ are well described by classical force fields.75 The final
simulated charge states reflect the sum of protein-bound Na+, minus the intrinsic 2- hMb charge.

4.2.4. Accelerated MD with Forced Evaporation
The ESI modeling strategy outlined in the main text readily produces free [M + zNa]z+ ions from
aqueous droplets.24 Unfortunately the slow evaporation of sulfolane and 18C6 cause an
unacceptable increase in wall clock time.58 This problem was overcome by subjecting sulfolane
and 18C6 to forced evaporation58 after 150 ns of regular MD. i.e., after the droplet had shrunk to
a fraction of its initial size due to complete water evaporation. Under this scheme, the sulfolane
or 18C6 with the largest distance from the droplet center was removed at a rate of 4 ns-1 (or 0.17
ns-1 for 18C6 after all other solvent molecules had left). This approach resembles biased MD
techniques that are widely used for various applications.81-83
18C6 forced evaporation causes a slight complication because some crown ethers
existed as [18C6 + Na]+ complexes. It has to be decided if forced evaporation of these 18C6
should include the bound Na+. Steered MD82 revealed that departing [18C6 + Na]+ lost their Na+
only if the Na+ was bound to a protein carboxylate (Figure 4.1). For reasons of simplicity, [18C6
+ Na]+ forced evaporation was therefore always conducted by removing the crown ether along
with its Na+, which represents the appropriate scenario for most of the [18C6 + Na]+ (those that
were not protein-bound). The simulated average protein z values were corrected for instances that
involved carboxylate-bound [18C6 + Na]+ (z = + 1.7 for water/18C6, and z = + 3.6 for
water/sulfolane/18C6). The magnitude of these corrections is relatively small, and all of the
arguments made in the main text remain valid regardless whether the correction is applied or not.
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Figure 4.1. Illustrative results of COM (center of mass) pulling simulations for hMb-containing
ESI droplets. The aim of these steered MD runs was to determine the proper forced evaporation
strategy for [18C6 + Na]+. In other words, we determined whether [18C6 + Na]+ that leave the
droplet depart with their Na+, or if the Na+ stays behind. Data were generated by adapting a
literature method.82 An external force (indicated by black arrows) was applied to pull on the
18C6 scaffold of [18C6 + Na]+, one crown ether at a time. This was achieved by placing the
18C6 COM in a harmonic potential with k = 1000 kJ mol-1 nm-2, and by moving the potential
minimum away from the droplet center at a velocity of 0.02 nm ps-1. Droplet displacement was
eliminated by harmonically restraining all protein backbone atoms with k = 1000 kJ mol-1 nm-2.
No external force was applied to Na+ or any other ion/molecule. The pulled 18C6 (orange/red)
with their Na+ (blue) are shown in spacefill representation. All other solvent molecules are shown
as sticks. The “initial” configurations in this figure represent MD-generated droplets at
intermediate stages of the ESI process. The “final” configurations represent snapshots taken ~90
ps later. (a) 18C6 pulling in the presence of water, culminating in departure of the entire [18C6 +
Na]+ moiety. (b) 18C6 pulling in the presence sulfolane (green), culminating in departure of the
entire [18C6 + Na]+ moiety. (c) 18C6 pulling out of sulfolane under conditions where the Na+ is
bound to a side chain carboxylate. This causes departure of an empty 18C6, while the Na+
remains bound to the side chain. (d) 18C6 pulling for a largely desolvated protein that only
retains a few crown ethers. The Na+ is bound to a side chain carboxylate. Pulling causes the
departure of an empty 18C6, while the Na+ remains bound to the side chain. In total, 50 COM
pulling simulations consistently revealed that departing [18C6 + Na]+ leave their Na+ behind only
if the metal is bound to a protein carboxylate (protein-COO-Na+18C6 → protein-COO-Na+
+ 18C6). In all other cases the entire [18C6 + Na]+ complex departed from the droplet.
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4.3. Results and Discussion
4.3.1. Effects of 18C6 on ESI Charge States
This work focused on holo-myoglobin (hMb), a heme-protein complex that served as model
system for many earlier mechanistic studies.38,

45, 47, 53, 58

Native ESI in aqueous ammonium

acetate solution generated hMb ions in the 8+ and 9+ charge states (Figure 4.2a), very similar to
earlier data recorded on different instruments and with different ESI sources.40, 47, 58 Addition of 1
mM 18C6 resulted in crown ether adduction,68 and a shift to slightly lower charge states (from
8+/9+ to 6+/7+, Figure 4.2b). Collisional activation caused loss of the 18C6 adducts, while the
charge state distribution remained virtually unchanged (Figure 4.2d).

4.3.2. 18C6 Suppresses Supercharging
Sulfolane is a typical SCA. As expected from earlier reports,30, 32, 38, 44-45, 47, 49-52, 54 high charge
states (around 15+, Figure 4.2e) were observed when electrospraying hMb from sulfolanecontaining aqueous ammonium acetate. The supercharged protein ions largely retained their
heme group,45 whereas denaturation in solution usually disrupts heme-protein interactions.40
Remarkably, the addition of 1 mM 18C6 to the sulfolane-containing solution suppressed
supercharging, i.e., the hMb charge state distribution shifted from around 15+ into the 6+ to 9+
range (Figure 4.2f). The experiments were repeated with collisional activation (cone 120 V).
Similar to the sulfolane-free solutions (Figure 4.2b, d), these harsher conditions removed 18C6
adducts without major changes of the charge state distribution (Figure 4.2f, h). It appears that the
capability of 18C6 to act as supercharging antidote has not been reported before.
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Figure 4.2. Mass spectra acquired after electrospraying holo-myoglobin without (panels on left)
and with 1 mM 18C6 (panels on right) in neutral aqueous solution containing 1 mM ammonium
acetate. (a, b) Data recorded without sulfolane under gentle conditions, i.e., cone 20 V. Extensive
adduct formation in (b) is due to noncovalent attachment of up to ~14 18C6. (c, d) Same as in (a)
and (b), but with in-source activation (cone 100 V). (e, f) Spectra acquired after addition of 1%
sulfolane under gentle conditions (cone 20 V). (g, h) Same as in (e) and (f), but with in-source
activation (cone 120 V). h8+, a14+, etc. denote hMb and aMb charge states. * indicates free
heme; # refers to an unidentified cluster.
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4.3.3. 18C6 Effects in NaCl-Containing Solutions
Native ESI-MS experiments on hMb were repeated in solutions containing NaCl instead of
ammonium acetate, giving rise to the formation of [M + (z-n)H + nNa]z+ ions, all the way to fully
sodiated [M + zNa]z+11. These conditions resemble those used for the subsequent MD
simulations, where Na+ served as charge carrier. In addition to gentle ESI conditions, we tested
the effects of source activation by raising the cone voltage. Alternatively, collisional activation
was applied by raising the trap CE (Figure 4.3). All experiments were also repeated with
ubiquitin, another common test protein (Figure 4.4).
The data obtained for the NaCl-containing samples resemble those of Figure 4.2 and can
be summarized as follows: Sulfolane causes supercharging. Addition of 1 mM 18C6 to the
sulfolane-containing solution shifts the spectra back to low charge states. This supercharging
suppression was observed even when lowering the 18C6 concentration from 1 mM to 0.1 mM or
0.01 mM (Figure 4.5). Collisional activation removes 18C6 adducts without major charge states
alterations. Thus, 18C6-induced shifts to lower charge states are not primarily caused by the loss
of 18C6-bound charge carriers from the gaseous protein. This conclusion is consistent with
previous work,71 where it was noted that collisional charge loss (such as protein-NH3+18C6 →
protein-NH2 + [18C6+H]+) is enthalpically unfavorable, in agreement with the data of Figure 4.1.
Therefore, the capability of 18C6 to act as supercharging antidote must have a different origin.
We resorted to MD simulations for uncovering the basis of this phenomenon.
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Figure 4.3. Mass spectra acquired after electrospraying holo-myoglobin without (panels on left)
and with 18C6 (panels on right) in neutral aqueous solution containing 1% sulfolane and 1 mM
NaCl. (a, b) Data recorded under gentle conditions. Protein ions in (b) show extensive sodium
and 18C6 adduction. (c, d) Same as in (a) and (b), but with in-source activation (cone 100 V). (e,
f) Same as in (a) and (b), but with quadrupole activation (trap collision energy 10 V). h15+,
a16+, etc. denote hMb and aMb charge states. * indicates free heme, scaled by 1/3 in panel (c).
The low m/z range in panels (b) and (f) is dominated by various NaCl/18C6 cluster ions.
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Figure 4.4. Mass spectra acquired after electrospraying ubiquitin without (panels on left) and
with 18C6 (panels on right) in neutral aqueous solution containing 1% sulfolane and 1 mM NaCl.
(a, b) Data recorded under gentle conditions. Protein ions in (b) show extensive sodium and 18C6
adduction. (c, d) Same as in (a) and (b), but with in-source activation (cone 100 V). Same as in
(a) and (b), but with quadrupole activation (trap collision energy 10 V). The low m/z range in
panels (b) and (f) is dominated by various NaCl/18C6 cluster ions.
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Figure 4.5. Mass spectra acquired after electrospraying holo-myoglobin in neutral aqueous
solution containing 1% sulfolane, 1 mM NaCl and (a) 0.01 mM 18C6, and (b) 0.1 mM 18C6.
Cone 20 V, trap CE 10 V. Even these reduced 18C6 concentrations still suppress supercharging.

4.3.4. Comparing MD and Experimental Results
The ESI droplets modeled here (initial radius 4 nm) were significantly larger than in earlier
studies,18-24 resembling the size regime encountered in experiments.11 Charge states predicted by
MD simulations on four types of hMb-containing droplets are compiled in Figure 4.6, along with
the corresponding experimental data. Gratifyingly, the MD data reproduced the experimental
trends. Water droplets produced charge states around 8+/9+. Slightly lower charge states were
seen for water/18C6. Supercharged proteins with z values around 14+/15+ were produced from
water/sulfolane droplets. The addition of 18C6 to the water/sulfolane droplets dramatically
reduced the extent of protein charging. The subsequent MD trajectory analyses reveal the
physical reasons underlying the sulfolane and 18C6 effects on protein ESI charge states.
The forced evaporation tool applied during the final stages of droplet shrinkage
necessitated small corrections for MD charge states generated in the presence of 18C6 (see
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Methods). Figure 4.6 includes results obtained with and without this correction. The MD data
reproduced the experimental trends, regardless whether the correction was applied or not.

average protein charge state

20
16

Experimental
MD (after correction)
MD (no correction)

12
8
4
0

6
e
6
ter
8C
lan
8C
wa
1
o
/
1
f
l
r
/
te
su
ne
wa
ola
ter/
f
l
a
u
w
s
ter/
wa
Figure 4.6. ESI charge states of hMb obtained experimentally and from MD simulations.
Experimental values are averages of three measurements acquired under the conditions of Figure
4.2 (cone 100 V, trap CE 4 V). MD data are based on five replicate runs for each condition. MD
data for 18C6-containing droplets are shown with and without forced evaporation correction.
Error bars represent standard deviations.

4.3.5. Common Features of MD Trajectories
Snapshots taken from representative MD runs for the four conditions are summarized in Figure
4.7. All trajectories shared several features: The evaporating droplets retained an approximately
spherical shape, with the protein in the interior. Multiply charged gaseous hMb was produced via
solvent evaporation to dryness, as envisioned by the CRM.20-24,

58

Droplet shrinkage was

accompanied by Na+ ejection from the droplet surface. None of these IEM events14, 18, 42 involved
completely desolvated Na+, instead the departing charge carriers were bound to 18C6 and/or
several water or sulfolane molecules. Examples of such IEM events are highlighted in Figure 4.7.
Ejected 18C6-bound charge carriers can be observed experimentally. Aqueous ammonium
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acetate/18C6 solution produced intense signals for [18C6 + NH4]+ and [18C6 + Na]+ (Figure
4.8), underscoring the role of Na+ as ubiquitous contaminant in analyte solutions,11 and giving
credence to the use of Na+ in our simulations.24, 58
water
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Figure 4.7. Snapshots taken from MD trajectories that culminate in the production of desolvated
hMb ions from ESI nanodroplets. Four solvent conditions were tested: (a) Water, (b)
Water/18C6, (c) Water/sulfolane, (d) Water/sulfolane/18C6. Time points are indicated along the
left hand side. Charge states of protein ions at the end of the simulation runs are shown (at t =
275 ns). IEM ejection events of solvated and/or 18C6-complexed Na+ are highlighted. Coloring:
Protein, pink; heme, black; Na+, blue; water oxygen, red; sulfolane, dark green; 18C6,
orange/red.
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Figure 4.8. (a) Mass spectrum obtained upon electrospraying 1 mM aqueous ammonium acetate
containing 1 mM 18C6. Close-up views of the [18C6 + Na]+, [18C6 + NH4]+, and [18C6 + H]+
signals are shown in panels (b) – (d). The intense [18C6 + Na]+ signal is consistent with the
presence of Na+ ions as ubiquitous contaminants in ESI-MS analyte solutions,11 supporting the
validity of our MD strategy that is based on nanodroplets charged with excess Na+. [18C6 + H]+
in panel (d) may be ejected from the droplet as protonated crown ether, or it could arise from loss
of ammonia from [18C6 + NH4]+7.1
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4.3.6. Principles that Govern the ESI Charge States of Proteins
Before proceeding, it is helpful to summarize the rules that govern the charge carrier behavior in
native ESI.24, 58 (i) Charge carriers can experience only two fates, ejection from the droplet or
binding to the protein. (ii) The ejection of bare charge carriers from desolvated proteins is not
feasible, at least not for the charge state range considered here.84 (iii) Any charge carriers that are
not ejected from the droplet will become part of the protein charge. (iv) Prerequisite for each
charge ejection from the droplet is that the charge carrier can (at least transiently) reside close to
the droplet surface; any factor that tends to exclude charge carriers from the surface will lower
the charge ejection efficiency. From (i) - (iv) it follows that any factor that hinders charge carrier
access to the droplet surface will increase the protein charge z. The repercussions of these
considerations will become clear in the next section.

4.3.7. MD Trajectories Reveal the Basis of Charging and Supercharging
In aqueous droplets water and Na+ shared the same radial distributions (Figure 4.9a), reflecting
the favorable solvation of Na+ in H2O.85 Under these conditions Na+ can roam the entire solventoccupied volume, including positions at the droplet surface from where charge ejection readily
takes place (Figure 4.9b). As the final water molecules evaporated, charge ejection came to a halt
(Figure 4.9b, c). The remaining Na+ underwent irreversible binding to hMb (Figure 4.7a, t  92
ns) at protein carboxylates (Figure 4.10).
For water/18C6 droplets (Figure 4.9b) all 18C6 were located close to the droplet
surface, consistent with their amphiphilic nature.62-63,

86-88

Na+ exhibited a bimodal radial

distribution, comprising water-solvated Na+ in the droplet interior and [18C6 + Na]+ at the
droplet surface (Figure 4.9d). The positioning of [18C6 + Na]+ at the liquid/vapor interface
facilitated ejection of these complexes from the droplet. Thus, the high surface affinity of [18C6
+ Na]+ was responsible for the slightly lower protein charge states in water/18C6 compared to
pure water (Figure 4.6). The behavior seen here for [18C6 + Na]+ mirrors the facile IEM ejection
of other cationic solutes that carry nonpolar groups.12 Charge ejection ceased just prior to
evaporation of the last water molecules (Figure 4.9e,f). At this point, residual Na+ and [18C6 +
Na]+ underwent ion pairing with protein carboxylates, while non-sodiated 18C6 bound to Lys+
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(Figure 4.10).68-72 These MD-predicted 18C6 adducts were experimentally observable under
gentle ESI conditions (Figure 4.2b). The number of MD-adducted 18C6 (10  1) was consistent
with the experimental data of Figure 4.2b, where the most intense signal corresponded to hMb6+
attached to 10 crown ethers. 18C6 removal by MD forced evaporation (Figures 4.7b, 4.9e) or by

Radial Distribution P(r)

collisional heating (Figure 4.2d) produced fully desolvated hMb.
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Figure 4.9. MD data for four types of hMb-containing ESI droplets, as noted along the top. Top
row: Spatial distribution of solutes, averaged over t = 25 to t = 32 ns in all repeat runs. For 18C6containing droplets two separate Na+ distributions are shown, reflecting the behavior of sodium
in [18C6 + Na]+ vs. all other sodium ions (denoted as Na+free). Middle and bottom rows: Timedependent changes in droplet composition for four typical trajectories, reflecting the occurrence
of solvent evaporation and charge ejection. Dashed vertical lines indicate the point where 200
water molecules remain in the droplet; after this point only panel (k) shows Na+ ejection (as
[18C6 + Na]+). Dotted blue lines indicate Na+ data after correction for [18C6 + Na]+ forced
evaporation (see Methods). The coloring of droplet components matches that of Figure 4.7.
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Figure 4.10. Protein interactions with Na+, 18C6, and [18C6 + Na]+, exemplified for a t = 205 ns
MD frame taken from a water/sulfolane/18C6 run. Coloring is as in Figure 4.7. Large blue
spheres represent Na+; small blue spheres represent N atoms of Lys+; hydrogens have been
omitted.

Water/sulfolane droplets (Figure 4.7c) showed sulfolane enrichment in the outermost
layers. This nanoscale segregation is consistent with phenomena reported for other binary
mixtures, such as methanol/water or ethanol/water, where the nonaqueous component undergoes
surface enrichment despite being “fully miscible” in bulk solution.86-89 A key driving force for
the sulfolane/water segregation seen here is the maximization of enthalpically favorable waterwater contacts in the droplet core.90 (Analogous arguments explain why 18C6 is driven to the
surface of the water/18C6 droplets discussed in the preceding paragraph.86-90) For the ESI
water/sulfolane droplets of Figure 4.7c these segregation phenomena produced a sulfolaneenriched surface layer that surrounded the protein-containing aqueous core (Figure 4.9g). The
ionophobic nature of sulfolane58, 61 (along with the high water affinity of Na+)85 largely confined
the charge carriers to the droplet interior. The resulting Na+ depletion at the droplet surface
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reduced the charge ejection probability. Because of this reduced IEM efficiency, a larger number
of Na+ remained trapped within the droplet compared to the water or water/18C6 droplets
(Figures 4.9h vs. 4.9b, 4.9e). Complete H2O loss from the water/sulfolane droplets subsequently
generated sulfolane-encapsulated hMb, concomitant with irreversible binding of all remaining
Na+ to protein carboxylates (Figure 4.7c, t = 92 ns). Further charge loss would require the
occurrence of highly unfavorable events, i.e., dissociation of protein-COO-Na+ ion pairs,
followed by Na+ diffusion through the ionophobic sulfolane environment. Hence, the protein
attained its final “supercharged” z value after all water had left the droplet, but long before
evaporation of the sulfolane shell had gone to completion.
These data for water/sulfolane reflect the charge trapping model outlined in the
Introduction.58 This mechanism causes supercharging via two interrelated factors, i.e., (i)
formation of a SCA layer at the droplet surface that tends to confine charges to the aqueous
interior, thereby impeding charge ejection. (ii) After complete water loss, the protein becomes
surrounded by an SCA shell and the remaining charge carriers are forced to associate with
protein carboxylates. Charge partitioning during droplet shrinkage is governed by the low affinity
of charge carriers for the SCA, their greater affinity for protein carboxylates, and their high
affinity for water.58,

85

For the three droplet types discussed so far (water, water/18C6, water

sulfolane), only Na+ solvation by water prevented irreversible charge carrier binding to the
protein. Charge ejection came to a halt once the number of H2O dropped below ~200 (vertical
lines in Figure 4.9b, e, h), forcing freely diffusible Na+aq to transition into carboxylate-bound
environments.
As noted, a key element of the charge trapping model is that SCAs exhibit a low charge
carrier affinity. This aspect is consistent with earlier work that focused on protein charging by
H+, where it was noted that SCAs generally exhibit a low H+ affinity in solution (i.e., a weak
Brønsted basicity).48, 91 These parallels support the view that the charge trapping model is not
limited to droplets containing Na+, but that it also applies to H+ and other ESI-relevant charge
carriers.
In water/sulfolane/18C6 droplets the charge carriers exhibited a bimodal distribution,
with H2O-solvated Na+ in the interior and abundant sulfolane-solvated [18C6 + Na]+ in the
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outermost droplet layers (Figure 4.9j). The latter reflect the capability of crown ethers to
solubilize cations in unfavorable solvents.62-63 [18C6 + Na]+ enrichment at the droplet surface
facilitated the ejection of these charged complexes. Numerous [18C6 + Na]+ remained at the
surface of the droplet even after complete water evaporation, thereby ensuring continued charge
ejection and suppression of charge carrier binding to the protein (Figure 4.7d at t = 92 ns, Figure
4.9k, l).
In summary, the MD data reveal that 18C6 nullifies the charge-enhancing effects of the
SCA by eliminating charge trapping. Our results confirm the hypothesis stated in the
Introduction, i.e., the proposal that 18C6 binds charge carriers (Na+, NH4+, H3O+)62,

64-67

and

shuttles them through the SCA trapping layer.

4.3.8. Relationship between Supercharging and Unfolding
Our MD runs showed that hMb in water/sulfolane retained a compact structure until the droplet
had almost completely dried out (Figure 4.7c), long after the final z value had been attained via
Na+ binding. Coulombically driven unfolding of the supercharged protein started to take place
during the final solvent evaporation steps (Figure 4.11). Hence, for the conditions examined here,
unfolding is caused by supercharging and not vice versa. In other words, our data argue against
the idea that native ESI supercharging is caused by protein unfolding within the droplet, with
subsequent protein extrusion from the droplet surface.44, 47 Instead, our findings support the view
that supercharging is caused by charge trapping. While supercharged hMb undergoes unfolding
in the gas phase,47,
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other supercharged proteins are more resilient and retain native-like

properties. 30, 45, 55, 60 The experimental observation of such compact supercharged proteins30, 45, 55,
60

would be difficult to reconcile with the unfolding model,44, 47 while our charge trapping model

readily explains how such species can form.
Notwithstanding the aforementioned conclusions, we do not rule out that unfolding may
contribute to supercharging under some conditions, likely in combination with the SCA-mediated
charge trapping outlined above. The latter scenario is supported by data on disulfide intact and
reduced proteins.44 The possible occurrence of protein unfolding within the droplet will depend
on various factors, including the droplet lifetime,92 confinement effects,93 and interactions with
gas/liquid interfaces.94
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Figure 4.11. Protein compactness during ESI, reported as radius of gyration (Rg) vs. MD
simulation time, averaged over all runs. (a) Behavior of hMb in water, water/18C6, and
water/sulfolane/18C6 droplets, all of which culminate in low charge states. In all three cases the
protein retains a tightly folded conformation. (b) Rg of hMb in water/sulfolane droplets, which
produce high charge states (supercharging). Vertical dashed lines in panel (b) indicate the
behavior of water, sulfolane, and Na+ in the evaporating droplets. Coulombically driven
unfolding starts to take place during the final stages of droplet evaporation. The protein reaches
its final ESI charge state z long before unfolding commences (the last Na+ binding event is
indicated in blue), implying that supercharging is not caused by unfolding. Instead,
supercharging is the cause of unfolding.

4.3.9. Dendrimer Supercharging
Dendrimers are hyperbranched globular macromolecules that are incapable of large-scale
unfolding.95-96 These analytes are well suited for further scrutinizing the competing
supercharging models. The charge trapping model predicts that dendrimers will undergo
supercharging, while according to the unfolding model dendrimers should be immune to SCAs.44,
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For meaningful test experiments it is important to use dendrimers with ”protein-like”

properties, i.e., with both acidic and basic sites, and with a MW similar to that of typical proteins.
Earlier work

46

examined the behavior of DAB-16 (1687 Da) and DAB-64 dendrimers

(7168 Da). The former did not undergo supercharging. For the latter, the presence of SCA in
water caused a broadened charge state distribution that suggested supercharging for a subpopulation of the analytes. The implications of those data46 for proteins are inconclusive The
absence of carboxylates in DAB dendrimers prevents analyte charging via R-COOneutralization, unlike for proteins where carboxylates represent the main charge carrier binding
sites.24 In addition, the small size of DAB-16 raises questions as to whether this species exhibits
true CRM behavior.1
Here we tested the behavior of G5 PAMAM succinamic acid dendrimer. Its theoretical
MW (41669 Da) is comparable to proteins that have previously been subjected to native ESI
supercharging.30, 45, 55, 59-60 This dendrimer possesses both basic sites (tertiary amines) and acidic
moieties (succinamic acid groups). A slight complication is the fact that PAMAM dendrimers
generally exhibit mass heterogeneity arising from defects in their branched structures,
particularly for large species that are comparable in size to proteins.96 ESI mass spectra recorded
in aqueous solution showed several broad maxima that can be attributed to the charge state range
of 7+ to 12+ (Figure 4.12a). Upon addition of sulfolane the spectra underwent a dramatic shift
towards lower m/z, corresponding to charge states around 15+ and higher (Figure 4.12b). Similar
data were obtained when repeating the experiments in NaCl-containing solution (Figure 4.13).
These spectra demonstrate the occurrence of sulfolane-induced supercharging for the PAMAM
dendrimer, confirming the prediction of the charge trapping model.
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Figure 4.12. ESI mass spectra of G5 PAMAM dendrimer in aqueous solution containing
ammonium acetate (a) Without sulfolane, (b) With sulfolane. Mass heterogeneity obscures
individual charge states. Red lines indicate expected peak positions for the calculated theoretical
mass.
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Figure 4.13. ESI mass spectra of G5 PAMAM dendrimer in aqueous solution containing
ammonium acetate (a) Without sulfolane, (b) With sulfolane. These data are analogous to those
of Figure 4.12, but here the experiments were conducted in the presence of 1 mM NaCl to
promote the formation of sodiated ions. Mass heterogeneity precludes the identification of
individual charge states. Red lines indicate peak positions for the calculated theoretical mass of
the analyte. Supercharging of the dendrimer in the presence of sulfolane is clearly apparent.
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4.4. Conclusions
The current work demonstrates that MD simulations represent a powerful tool for probing the
behavior of ESI droplets containing multiple interacting components. We applied crown ethers as
a mechanistic probe of the ESI process. The ability of 18C6 to act as phase transfer catalyst 62-63
alters the location of charge carriers inside ESI droplets, with dramatic consequences for protein
charge states. Crown ethers may also influence protein structures in solution97-98 and in the gas
phase,70 but our data do not support the view that such conformational factors are responsible for
the charge state shifts reported here. The mechanistic insights obtained in the current work can be
summarized in cartoon form (Figure 4.14), where blue “+” symbols indicate charge carriers.
While the current work focused on Na+, Figures 4.2, 4.3, 4.4 suggest that similar considerations
also apply to other ESI-relevant charge carriers such as H3O+ and NH4+ .11, 91
Evaporating ESI nanodroplets experience internal Coulomb repulsion which tends to
trigger charge ejection via the IEM.17 The efficiency of these events is modulated by the
capability of charge carriers to migrate to the droplet surface (because only surface charges can
undergo IEM ejection12,

14

). In aqueous solution (Figure 4.14a) the favorable solvation

characteristics afforded by water allow charge carriers to adopt positions throughout the droplet,
including locations close to the surface from where they can be ejected. The relatively few
remaining charge carriers in the vanishing droplet bind to the protein, producing low CRM
charge states.11, 24-25
The addition of SCA leads to supercharging via charge trapping (Figure 4.14b) 58. The
SCA initially forms an ionophobic surface layer. As a result, charge carriers preferentially reside
in the droplet interior such that their IEM efficiency is reduced; thus, a larger number of charge
carriers remain in the droplet compared to the purely aqueous droplets. Once all the water has
evaporated the SCA encapsulates the protein. Unfavorable interactions with the SCA force the
remaining charge carriers to associate with the protein. All these (many) charge carriers remain
bound until the SCA layer has evaporated – producing a desolvated supercharged protein ion.
Depending on their structural resilience, supercharged proteins may undergo electrostatically
driven unfolding (as in the case of hMb47,

58

demonstrated for several other proteins30,

45, 55, 59-60

), or they can retain compact conformations (as
). Our MD simulations and dendrimer
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supercharging data do not support the view that unfolding within the ESI droplet is the root cause
of supercharging.44, 47
Figure 4.14c illustrates how 18C6 acts as supercharging antidote. 18C6 solubilizes
charge carriers in the SCA, allowing the charge carriers to reside at the droplet surface such that
IEM ejection proceeds with high efficiency. Compared to the supercharging conditions of Figure
4.14b the droplets lose more charge, such that the dried-out protein at the end of the process has a
lower z.
Experimental supercharging spectra exhibit wide charge state distributions (Figure 4.2e,
g), whereas our simulations produced fairly well defined z values (Figure 4.6). The
experimentally observed charge state range is attributed to the heterogeneous nature of
evaporation/fission events in the ESI plume, which will yield nanodroplets with different SCA
concentrations.11 Nanodroplets containing more SCA will produce higher z values.47, 58 Modeling
this heterogeneity is difficult, as it would require knowledge of the exact ESI plume composition.
Regardless of these nuances, it is remarkable how well the current MD data capture the
experimental trends, i.e., a dramatic shift to higher charge states in the presence of sulfolane and
the suppression of supercharging by 18C6 (Figure 4.6).
Our use of 18C6 as a mechanistic ESI probe expands on previous studies, where this
remarkable molecule was applied to examine protein structures in solution68 and in the gas phase.
69-70

In future work we hope to apply strategies similar to those used here for uncovering the

mechanistic basis of supercharging under denaturing conditions, where the charge states formed
are even higher than under the native ESI conditions examined here.32, 44, 54
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Figure 4.14. Cartoon summary of MD and experimental results. (a) Native ESI in aqueous
solution, producing low charge states. A similar scenario is encountered for water/18C6 droplets
(not shown). (b) Supercharging via the charge trapping. A highly charged protein is formed
because charge ejection from the droplet is hindered. The supercharged protein may undergo gas
phase unfolding. (c) 18C6 acts as supercharging antidote; it prevents charge trapping by
promoting the ejection of charge carriers from the droplet surface. “X+” represents charge
carriers such as Na+, H3O+ or NH4+. “IEM” indicates charge carrier ejection (field emission).
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Chapter 5. Chain Ejection Model for Electrospray Ionization
of Unfolded Proteins: Evidence from Atomistic Simulations
and Ion Mobility Spectrometry
5.1. Introduction
Electrospray ionization (ESI) has revolutionized mass spectrometry (MS) by allowing the facile
transfer of proteins and other analytes from solution into the gas phase.1 During ESI charged
droplets emanate from a high voltage capillary. Solvent evaporation and jet fission decrease the
droplet size to the nanometer range, while maintaining a charge close to the Rayleigh limit. 2-7
The mechanisms whereby analyte ions emerge from ESI nanodroplets remain controversial.4, 8-18
Recent progress in this area has been fueled by molecular dynamics (MD) simulations. MD
studies revealed that small ions such as Na+ undergo field emission from the droplet surface,15, 1921

consistent with the ion evaporation model (IEM).8,

22

Simulations on peptides,23 globular

proteins,24 and nucleic acid duplexes25 indicated that these larger species are liberated by droplet
evaporation to dryness, as envisioned by the charged residue model (CRM).3-4
“Native” protein ESI experiments aim to preserve solution-like structures and
interactions in the gas phase by employing non-denaturing aqueous solutions and gentle ion
sampling conditions.26-29 Structural retention under these conditions is promoted by the low CRM
charge states of protein ions, which are close to the Rayleigh charge of protein-sized water
droplets.3-4
Electrosprayed protein ions can be further interrogated by ion mobility spectrometry
(IMS)30-35 and by various activation methods.36-38 Collision-induced dissociation (CID) of
multisubunit complexes usually causes ejection of one highly charged chain.39 This behavior has
been attributed to gradual unfolding of one subunit, H+ migration onto the unraveling chain, and
subsequent separation of this chain from the complex (Figure 5.1a).38, 40-41 This CID model is
consistent with IMS data,32, 37 the mobile nature of H+ in gaseous proteins,42-45 and the fact that
H+ migration onto the unraveling chain will minimize electrostatic repulsion.46-47
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While the CRM is widely accepted for globular proteins in native ESI,3-4, 11, 24,

48

the

behavior of unfolded proteins is more controversial.12, 48-49 [M + zH]z+ ions formed from unfolded
proteins exhibit wide charge state distributions centered at much higher z values than in native
ESI. This effect is encountered after unfolding by acid,50-51 base,52 heat,53 disulfide cleavage,54
mutations,55 and cofactor removal.51 The high charge states of unfolded proteins can boost mass
analyzer performance56-57 and enhance top-down fragmentation.58-59
Various attempts have been made to explain the dramatic shift to higher charge states
seen for unfolded proteins. Early work proposed that ESI charge states reflect the titration
behavior in solution,60 but subsequent studies showed this not to be the case.52, 61-62 Other ideas
focused on the accessibility of titratable sites,50, 54, 63 but even in native proteins most titratable
sites are accessible at the surface.64 It has also been proposed that COO- groups may neutralize
positive sites in folded gaseous proteins.12 Although such zwitterionic contacts are well
documented,65 it is unclear if they can account for conformation-dependent charge state
changes.48 Other studies pointed out that the gas-phase basicity of biomolecular ions could result
in H+ transfer from the solvent vapor.12,

66

While all these ideas are interesting, they do not

directly address the mechanism whereby unfolded proteins emerge from ESI nanodroplets.
Unfolded proteins in solution adopt disordered conformations, similar to certain
synthetic polymers such as polyethylene glycol (PEG).67 MD simulations of PEG-containing
aqueous ESI droplets by Consta et al. revealed that PEG binds Na+ from the solvent, followed by
polymer extrusion from the droplet surface.68 Our laboratory proposed that the ESI process for
unfolded proteins follows similar avenues.15 According to this “chain ejection model” (CEM,
Figure 5.1b), the protein is driven to the droplet surface by electrostatic and hydrophobic factors.
The protein then undergoes gradual ejection via “tadpole-like” structures where the droplet
carries an extended protein tail. This CEM scenario15 bears close parallels to the CID process of
multi-subunit systems (Figure 5.1a). Specifically, a central aspect of the protein CEM is the
migration of mobile H+ between the droplet and the protruding polypeptide tail. This H+ transfer
causes the unfolded protein to depart as a highly charged ion, analogous to H+ transfer during
CID which causes the departing subunit to be highly charged.15 H+ migration is absent for
sodiated PEG,68 i.e., the CEM scenarios of unfolded proteins and PEG chains are not equivalent.
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Several studies have endorsed the CEM.15, 26, 69-70 However, it is unsettling that protein
CEM processes have never been verified by atomistic MD simulations. Instead, the idea relies on
simple coarse-grained models, Monte-Carlo methods,15 and salt adduction studies.71 Atomistic
ESI simulations on unfolded proteins face two challenges. (1) Mobile H+ are difficult to treat
computationally. MD methods are available for H+ transfer in the gas phase,46-47 but H+ migration
in water (and between water and protein, Figure 5.1b) requires ab initio tools. The computational
cost of these tools makes them unsuitable for ESI droplets.72-74 (2) ESI droplets have to
accommodate the analyte at the onset of the simulation. This is not a problem for native proteins,
where a few thousand water molecules are sufficient for building a droplet that completely
engulfs the analyte.24-25 In contrast, the increased dimensions of unfolded proteins67 require
larger droplets, driving up computational cost which scales as N2 with the number of atoms.75
The current work scrutinizes the viability of the CEM by conducting atomistic MD
simulations on ESI droplets containing unfolded proteins. Myoglobin has been used in numerous
earlier ESI mechanistic investigations,24,

30, 50-51, 63, 69, 71

and therefore it was chosen as model

protein for our work as well. Difficulties associated with the treatment of mobile H+ were
circumvented by focusing on carefully selected pH environments. Graphics processing unit
(GPU)-accelerated algorithms76 allowed us to overcome challenges related to droplet size. MD
simulations were complemented by ESI-MS/IMS experiments. Our results support the view that
the ESI process of unfolded proteins in aqueous solution proceeds via the CEM.
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Figure 5.1. Cartoon depiction of two analogous gas phase processes. (a) CID of a noncovalent
protein complex. Subunits are depicted as spheres, excess H+ are represented by “+” signs. One
subunit (red) undergoes unfolding, and the protruding tail accumulates charge due to H+
migration from the residual complex. The subunit leaves as a highly charged unfolded ion. (b)
Proposed chain ejection model (CEM) for the release of an unfolded protein from an ESI droplet.
As the protein gets gradually ejected, the protruding tail undergoes charge equilibration with the
droplet via H+ migration. The protein leaves as a highly charged unfolded ion. Modified from
ref.15
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5.2. Materials and Methods
5.2.1. Protein, Reagents and Mass Spectrometry
Apo-myoglobin (aMb, Sigma, St. Louis, MO) was prepared by butanone extraction. The
protein was dialyzed against 10 mM neutral aqueous ammonium acetate, followed by
acidification with formic acid to pH 4 or pH 2. ESI-MS and IMS data were acquired on a Synapt
G2 instrument (Waters, Milford, MA). Aqueous aMb (5 μM) was infused at 5 µL min-1 using a
standard Z-spray ion source at +2.8 kV. The source and desolvation temperatures were kept low
(25 C and 40 C) and the cone was set to 5 V to minimize the in-source activation. IMS
calibration using a set of reference proteins yielded effective He collision cross sections ().77

5.2.2. MD Simulations
MD simulations were carried out using Gromacs 2016 with GPU acceleration,76 the
Charmm36 force field,78 and TIP4P/2005 water79 in trajectory stitching mode.24 A temperature of
370 K was chosen to mimic the presence of heating elements in typical ESI sources. Unfolded
aMb starting conformations were produced by heating aMb (1WLA without heme) from 320 K
to 450 K in vacuum using canonical charge states over 20 ns. Spherical water droplets with 5.5
nm radius (~22,500 water molecules) were built around the protein, and the aMb charge was set
to 22+, 27+, or 33+. All runs started with a droplet charge of 47+ which corresponds to the
Rayleigh charge zR of a 5.5 nm aqueous droplet,3-4, 24 calculated as zR = 8/e  (0  r3)1/2. To
attain this regime, charges contributed by aMb were supplemented by Na+ ions in random
positions. All runs were repeated three to five times with different initial aMb structures, Na+
positions, and starting velocities. The simulation time window was 75 ns. After release into the
gas phase the desolvated protein was allowed to run for an additional 500 ns at 320 K; this lower
temperature was chosen to reflect gentle ion sampling conditions.26-28,

80

He collision cross

sections were calculated using the trajectory method in Collidoscope.81 These  values were
determined by extracting MD structures from the 500 ns trajectories in 100 ns intervals.
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5.3. Results and Discussion
5.3.1. ESI-MS and IMS Experiments
ESI mass spectra of aMb acquired at pH 4 showed a bimodal charge state distribution
peaking at 9+ and 18+ (Figure 5.2a). The protein is known to be structurally heterogeneous in
solution at pH 4, comprising compact conformers and disordered species.51, 82 This heterogeneity
is reflected in the spectrum of Figure 5.2a, where compact conformers gave rise to lower charge
states (around 9+), while the more unfolded chains formed charge states around 18+.51
Acidification to pH 2 caused further unfolding,82 consistent with a shift to higher ESI charge
states (around 20+, Figure 5.2b).51 The highest detectable charge state was 27+.
IMS data for charge states 22+ to 27+ are shown in Figure 5.2c (the complete dataset is
shown in Figure 5.3). 22+ ions had collision cross sections of (3870  30) Å2, whereas higher
charge states showed larger  values, e.g., (4190  100) Å2 for 27+. This trend reflects the
internal Coulomb repulsion experienced by the gaseous ions.30-31 For the highly charged ions
considered in Figure 5.2c, collision cross sections measured at pH 4 and pH 2 were virtually
indistinguishable.
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Figure 5.2. Experimental ESI mass spectra for aMb recorded in aqueous solution at pH 4 (a) and
pH 2 (b). Selected charge states are indicated. Panel (c) shows IMS collision cross section ()
distributions for highly charged ions acquired at pH 4 (blue) and pH 2 (red).
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Figure 5.3.  distributions measured by IMS for the complete
set of aMb charge states at pH 4 (blue) and pH 2 (red).
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5.3.2. ESI Modeling Strategy
We already noted how difficult it is to model H+ migration in a droplet that carries a
polypeptide tail (as envisioned within the CEM, Figure 5.1b).15 Such H+ transfer can cause the
gas phase protein charge to be very different from that in solution.52,

61-62

However, the

magnitude of this disparity depends on the conditions. The solution charge is dictated by the pKa
values of titratable sites and by pH.64 Hence, a judicious choice of pH can result in a scenario
where the protein solution charge resembles the charge state of the resulting gaseous ions. Figure
5.4 shows that at pH ~4 the aMb solution charge is around 22+ (pH 4.25) to 27+ (pH 3.75). Gas
phase ions with charge states 22+ to 27+ can be produced by electrospraying aMb at pH 4
(Figure 5.2a). CEM-related H+ migration between droplet and protein will be minimal under
these conditions because solution charge  gas phase charge. In this specific case it is reasonable
to model the ESI process without mobile H+, thereby greatly simplifying the computational
approach.
Prior to applying the strategy outlined above, one has to consider that the droplet pH
will likely deviate from that of the bulk solution. Solvent evaporation tends to increase the H+
concentration. On the other hand, formic acid in the in the aMb solutions used here has buffering
capacity around pH 4 (pKa = 3.75). Therefore, the assumptions (1) solution pH  droplet pH and
(2) [protein charge in solution]  [protein charge after ESI] provide a reasonable foundation for
modeling the ESI behavior of unfolded aMb in the 22+ to 27+ charge states at pH 4.
Another aspect that has to be addressed is the intramolecular H+ distribution. Most
charge states can be implemented via a multitude of protonation patterns.12 To test whether the
aMb behavior is sensitive to this aspect we performed simulations on various protonation
patterns (Figure 5.5). Three 22+ patterns were tested, referred to as 22+[A] (all sites protonated,
except His), 22+[B] (N-terminus and all Arg/His/Lys protonated, all Asp and some Glu
deprotonated), 22+[C] (all sites protonated, except for some Lys). 27+ simulations were
conducted where all sites were protonated, except for some Lys. Simulations on fully protonated
aMb (33+) were included as well, although this value is beyond the range observed in our
experiments.
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To ensure that unfolded aMb chains were fully contained within the initial ESI droplet
we employed a droplet radius of 5.5 nm. To the best of our knowledge, these are the largest
protein-containing ESI droplets modeled to date. GPU-acceleration76 helped overcome the
computational cost associated with this system size. TIP4P/2005 water79 was chosen because it
reproduces the water surface tension, thus ensuring that the simulations yielded realistic data.24
The droplets were initially charged to the Rayleigh limit2-4 by supplementing the aMb charge
with Na+ ions, keeping in mind that Na+ represents a typical ESI charge carrier.3 Likely, other
ions such as NH4+ or H3O+ would yield qualitatively similar results to those discussed below for
Na+.
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Figure 5.4. Calculated aMb net charge in solution vs. pH (black). Also shown are the
contributions of titratable sites (basic = blue; acidic = red), weighted by their abundance in the
protein sequence. The number of sites and their pKa values64 are: 1 N-terminus+ (7.4); 2 Arg+
(12.0); 19 Lys+ (10.8); 11 His+ (6.5); 8 Asp (4.0), 13 Glu (4.4), 1 C-terminus (3.9). Hatch marks
highlight the range around pH 4, where the solution charge is between 22+ (pH 4.25) and 27+
(pH 3.75). CEM production of gaseous ions in these charge states from pH ~4 droplets will
involve minimal H+ migration because gas phase charge  solution charge

150

22+[A]

GLSDGEWQQVLNVWGKVEADIAGHGQEVLIRLFTGHPETLEKFDKFKHLKTEAEMKASEDLKKHGT
VVLTALGGILKKKGHHEAELKPLAQSHATKHKIPIKYLEFISDAIIHVLHSKHPGDFGADAQGAMTKAL
ELFRNDIAAKYKELGFQG

22+[B]
GLSDGEWQQVLNVWGKVEADIAGHGQEVLIRLFTGHPETLEKFDKFKHLKTEAEMKASEDLKKHGT
VVLTALGGILKKKGHHEAELKPLAQSHATKHKIPIKYLEFISDAIIHVLHSKHPGDFGADAQGAMTKAL

ELFRNDIAAKYKELGFQG

22+[C]
GLSDGEWQQVLNVWGKVEADIAGHGQEVLIRLFTGHPETLEKFDKFKHLKTEAEMKASEDLKKHGT

VVLTALGGILKKKGHHEAELKPLAQSHATKHKIPIKYLEFISDAIIHVLHSKHPGDFGADAQGAMTKAL
ELFRNDIAAKYKELGFQG

27+
GLSDGEWQQVLNVWGKVEADIAGHGQEVLIRLFTGHPETLEKFDKFKHLKTEAEMKASEDLKKHGT
VVLTALGGILKKKGHHEAELKPLAQSHATKHKIPIKYLEFISDAIIHVLHSKHPGDFGADAQGAMTKAL

ELFRNDIAAKYKELGFQG

33+
GLSDGEWQQVLNVWGKVEADIAGHGQEVLIRLFTGHPETLEKFDKFKHLKTEAEMKASEDLKKHGT

VVLTALGGILKKKGHHEAELKPLAQSHATKHKIPIKYLEFISDAIIHVLHSKHPGDFGADAQGAMTKAL
ELFRNDIAAKYKELGFQG

Figure 5.5. aMb charge patterns for MD simulations. Positive sites are indicated in blue, while
negative charges are indicated in red. The proton distribution in 22+[A] reflects the view that Arg
and Lys are key protonation sites in the gas phase,49 as well as the most basic residues in
solution.64 22+[B] allows for negatively charged sites in [M + zH]z+ ions, i.e., zwitterionic and/or
salt bridge motifs.12, 65 This pattern also reflects the partial deprotonation of Asp and Glu in
solution at pH 4 (Figure 5.4). 22+[C] was chosen in accordance with the view that protons in the
gas phase primarily reside on Arg/His/Lys46, 66, 83 Some Lys were left unprotonated because Lys
has a lower gas phase basicity than His.84
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5.3.3. MD Simulations Confirm CEM Behavior
Aqueous ESI droplets containing unfolded aMb were subjected to MD simulations. Typical data
for protonation patterns 22+[B] and 27+ are shown in Figure 5.6. Within a few ns the protein
migrated from the droplet interior close to the surface (Figure 5.6a, 5 ns; Figure 5.6b, 2.5 ns).
This was followed by partial aMb eruption as a hydrated bulge (Figure 5.6a, 7 ns). At this
particular point Na+ and aMb22+ had partitioned into opposite regions of the droplet, highlighting
the electrostatic forces within the system (see also Figure 5.7). Protein expulsion subsequently
produced an electrostatically stretched tail that protruded into the vapor phase (Figure 5.6a, 10
ns; Figure 5.6b, 12.5 ns). Further expulsion then caused aMb separation from the droplet.
Nascent gaseous proteins retained some water which evaporated within 75 ns. Data very similar
to those of Figure 5.6 were also seen for the other protonation patterns (22+[A], 22+[C], 33+,
Figure 5.8), confirming that the behavior reported here is robust and reproducible. Figure 5.6
embodies the central result of this work: for the first time atomistic MD simulations confirm the
formation of gaseous ions from unfolded proteins via the CEM.
The CEM trajectories showed slight variations. In some instances, aMb ejected with a
small droplet attached to one terminus. These small droplets then evaporated without separating
from the chain (Figure 5.9). Another variation involved ejection in a hairpin conformation. The
hairpins either opened up as they departed from the droplet (22+[A], Figure 5.10a), or they
retained looped conformations (22+[B], Figure 5.10b). In one instance aMb ejected without
extensive stretching (22+[B], Figure 5.10c). All other (16 out of 17) runs showed the hallmark of
the CEM, i.e., aMb ejection via droplets that carried an electrostatically stretched protein tail,
consistent with the mechanism of Figure 5.1b.15 None of the unfolded aMb chains showed CRM
behavior, i.e., protein release via droplet evaporation to dryness.

CS-22-1-HIS-POS

(a)
aMb charge
pattern 22+[B]

CS-27-1
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10.0 ns

12.5 ns

10.5 ns

17.0 ns

Figure 5.6. Typical snapshots from CEM simulation runs on Rayleigh-charged aqueous droplets
containing unfolded aMb. The protein net charge was (a) 22+ (pattern 22+[B]) and (b) 27+. Na+
is blue, the protein backbone is magenta, positive/negative charges on the protein are highlighted
as cyan/red spheres, respectively. Water oxygen is shown in red. The zoom level decreases from
top to bottom. “IEM” in (a) highlights the field emission of a Na+ ion.
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0.25 ns

5.0 ns

7.0 ns

7.5 ns

Figure 5.7. Snapshots taken from a CEM simulation run on aMb in protonation pattern 22+[B]
(same data set as in Figure 5.6). Water was omitted to more clearly reveal the behavior of the
protein (magenta) and Na+ ions (blue). Positive/negative charges on the protein are highlighted as
cyan/red spheres, respectively. Black lines indicate the approximate outline of the droplets.
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Figure 5.8. CEM ejection aMb from aqueous ESI droplets at the Rayleigh limit. The protonation
patterns used for these simulations were (a) 22+[A], (b) 22+[C], and (c) 33+. Na+ is indicated in
blue, positive/negative charges on the protein are highlighted as cyan/red spheres, respectively.
Water oxygen is shown in red.
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Figure 5.9. CEM ejection of aMb in charge states (a) 27+ and (b) 33+ from the ESI droplet. For
these two runs the nascent aMb ions retained a small progeny droplet at one terminus which
subsequently evaporated without detaching from the protein.
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10.00 ns

[

12.00 ns
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11.25 ns

Figure 5.10. Snapshots from simulation runs on three protonation patterns. In contrast to Figure
5.6 , these data illustrate less common scenarios, highlighting the variability of the ESI process.

5.3.4. Charge Loss at the Rayleigh Limit
Our simulations started with a droplet charge zD close to the Rayleigh limit zR.2-4 Droplet
shrinkage due to water evaporation (Figure 5.11a) had a tendency to increase the electrostatic
repulsion further, forcing the droplets to shed charge. Three competing charge loss processes
were encountered. The first was the IEM ejection of Na+ (Figure 5.6a). The second was CEM
ejection of the protein. Multiple Na+ ejections occurred early during each run, followed by long
plateaus where Na+ loss had come to a halt (Figure 5.11b). These plateaus represent the regime
where formation of a protruding protein tail had decreased the electrostatic repulsion within the
droplet to such an extent that Na+ ejection became kinetically unfavorable.
The third charge loss process was the formation of Na+-containing progeny droplets via
jet fission, a phenomenon well known from imaging studies on larger ESI droplets.5-6 Fission
events reminiscent of those experimental data,5-6 involving water filaments, took place in several
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MD runs and generated progeny droplets comprising ~50 water molecules and one or two Na+
(Figure 5.12). Similar to IEM ejection of Na+, jet fission was limited to time points prior to
formation of a protein tail. Plots of zD / zR confirmed that the droplets stayed close to the
Rayleigh limit during these early stages (Figure 5.11c). We limited the time frame of Figure
5.11c to the initial ~4 ns during which protein ejection had not started yet in most runs, keeping
in mind that the zR expression used here2-4 applies only to spherical systems.
All three of the aforementioned charge loss processes were kinetically viable, but
ultimately protein ejection was the main avenue by which the droplets relieved electrostatic
stress. In addition to its electrostatic driving force, the CEM behavior is favored by the fact that
unfolded proteins possess many solvent-exposed hydrophobic side chains. The tendency of
hydrophobic moieties to migrate to the liquid/vapor interface, rather than stay in the droplet
interior, is well established.15, 18 The case is completely different for folded proteins, where most
hydrophobic sites are buried, and where water interacts favorably with solvent-exposed
hydrophilic/charged residues.64 The latter conditions cause folded proteins to remain within the
ESI droplets until evaporation to dryness, resulting in CRM behavior.15 Solvent evaporation to
dryness causes CRM-produced protein ions to carry adducts arising from nonvolatile solutes,
including Na+ and other charge carriers.3, 15 In contrast, the CEM simulations of the current work
did not reveal a single instance of Na+ adduction to aMb. This behavior is in line with the
experimental finding that acid-unfolded proteins are much less prone to adduction than their
natively folded counterparts.71
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Figure 5.11. MD simulation data for typical CEM runs on aMb protonation patterns 22+[A]
(green), 22+[B] (black), 22+[C] (orange), 27+ (blue), and 33+ (red). (a) Number of water
molecules and (b) number of Na+ in the droplet vs. time. The end of each profile marks the point
where the protein chain separates from the droplet. (c) Droplet charge zD relative to the Rayleigh
charge zR, focusing on the initial regime where protein ejection had not started yet.
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Figure 5.12. Formation of small progeny droplets via jet fission in two ESI simulation runs.
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5.3.5. Protein Conformations after CEM Ejection
For each ESI simulation the behavior of desolvated aMb after ejection from the droplet was
explored in 500 ns MD runs. Representative structures from these vacuum simulations were
extracted, and their  values were compared with experimental IMS data (Figure 5.13).
Averaging the results of all aMb 22+ simulations yielded  = (3790  300) Å2, in good
agreement with the experimental result of (3870  30) Å2. Simulated 27+ ions had  = (4190 
100) Å2, close to the measured value of (4050  30) Å2. The MD structures that most closely
matched the experiments are shown along the right-hand side of Figure 5.13. These
electrostatically stretched proteins had a stick-like appearance, with local -helices, and some
coil formation at the termini. Electrostatic repulsion caused 27+ aMb to be slightly longer
(overall length ~ 350 Å) than the 22+ ions (~ 310 Å).
Overall, the results of MD runs on protonation patterns 22+[A], 22+[C], and 27+ agreed
well with the experimental data (Figure 5.13). The zwitterionic pattern 22+[B] deserves a closer
look. Two 22+[B] runs produced relatively compact structures that were incompatible with
experiments (Figure 5.13b, left). Non-local salt bridges in these runs limited the extent of
electrostatic stretching. A third 22+[B] run did yield a stretched structure that matched the
measured  value (Figure 5.13b). Salt bridges in this third run only involved sites in close
sequence proximity. Our data thus do not exclude the existence of local zwitterionic motifs in
unfolded gaseous proteins, but non-local salt bridges are unlikely. We note that previous
evidence for zwitterionic motifs in the gas phase was obtained primarily for tightly folded
proteins,12, 65 rather than unfolded species.
The gas phase conformations generated in our 500 ns vacuum simulations were
governed by the morphology of the protein during ejection. Proteins that left the droplet as
stretched chains retained extended conformations (Figures 5.3, 5.4a); proteins that ejected in
more compact structures (Figure 5.10b, c) gave rise to less extended ions (Figure 5.13b, left).
The near-absence of conformational changes in the 500 ns runs suggests that this conformational
memory persists for time periods much longer than the simulation window explored here
(overlays in Figure 5.13). The agreement between experimental data and MD-derived  values

161

in Figure 5.13 thus supports the fidelity of our MD data, and it bolsters the view that the
observed ions are CEM products.

(a) 22+[A]

(b) 22+[B]

(c) 22+[C]

(d) 27+

*

*

*
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3000

3500

4000

Collision Cross Section

4500

(Å²)

Figure 5.13. Experimental IMS data measured at pH 4 (blue) and pH 2 (red) for charge states
22+ (a-c) and 27+ (d). Vertical black lines represent average  values from individual MD runs,
standard deviations are indicated as horizontal bars. The four panels represent data for different
protonation patterns, as indicated. Shown on the right are MD structures of those trajectories that
best matched the experimental data (pink asterisks, overlays of five structures between 100 ns
and 500 ns, all at the same zoom level, N-termini pointing to the left). Also included in (b) are
MD structures from two runs that yielded more compact structures than those observed
experimentally. Positive/negative charges on aMb are shown as cyan/red spheres, respectively.
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5.4. Conclusions
This work marks the first time that the production of gaseous ions from unfolded proteins via the
CEM has been verified in MD simulations using an atomistic force field for protein and solvent.
The MD data are supported by IMS experiments, bolstering the view that unfolded proteins are
ejected from ESI droplets as electrostatically stretched chains (Figure 5.1b).15 This CEM
behavior can be contrasted to the CRM, which is operational in native ESI where protein are
folded.24
Computational challenges precluded the inclusion of H+ migration between droplet and
protein (Figure 5.1b) in our simulations. Depending on the titration behavior of the protein, H+
migration may increase or decrease the protein net charge during ejection. Here we focused on
aMb around pH 4, where z  solution charge, such that H+ migration could be neglected. How
likely is it that more advanced modeling strategies involving mobile H+ would overthrow the
viability of the CEM? Our IMS experiments demonstrated that the gas phase conformations of
aMb 22+ to 27+ produced at pH 4 were indistinguishable from those generated at pH 2. This is
despite the fact CEM-related H+ migration at pH 4 is negligible (z  solution charge), whereas
pH 2 will be associated with significant H+ transfer (z < solution charge). Hence, H+ migration
does not seem to affect the properties of these ions. In addition, our MD simulations consistently
produced CEM behavior for various protonation patterns and charge states, all the way to
aMb33+. It thus appears that CEM behavior is a robust property of acid-unfolded proteins. It is
unlikely that this conclusion would change when applying computational strategies that allow for
H+ migration.
Notwithstanding the aforementioned comments, it is hoped that future studies on the
ESI behavior of unfolded proteins will employ more sophisticated models that include H+
migration. Such strategies will be required for quantitatively explaining the wide range of ESI
charge states seen for unfolded proteins (Figure 5.2). We hypothesize15 that this charge
heterogeneity can be attributed to protein ejection from differently sized droplets, in conjunction
with the fact that denatured proteins comprise various conformers that may accumulate different
numbers of H+ during ejection.12, 51 It is possible that the CEM is not the only mechanism that is
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operative during ESI of denatured protein. Only the highly charged ions in the spectra were
attributed to the CEM, while less abundant ions in low charge states (such as 9+/10+, Figure
5.2b) may represent CRM products. We hope that the current work will stimulate additional
studies aimed at deciphering all these intricacies associated with the ESI process, as well as the
possible involvement of the CEM in “supercharging” experiments.69
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Chapter 6: Conclusions and Future Work
6.1 Conclusions
Despite the many advances in ESI-MS in various research areas, many fundamental aspects of
ESI remain intractable. The photographs of the droplet jet fission and progeny droplet formation
by Gomez and Tang1 have inspired quite a number of researchers to develop techniques that give
an atomistic view of the ESI process. In order to achieve a reliable and robust ESI analysis, it is
essential to understand the underlying mechanisms, in the words of Richard Cole, we don’t want
to be ‘blind men’.2 MD simulations are one of the tools that can provide a detailed information
regarding the ESI process.3-6 There is a general consensus that small ions are ejected from the
droplet via the IEM, while globular analytes follow the CRM.7-9 In this thesis, we have applied
MD simulations as a complementary method along with experimental investigations. Our work
has broken new ground in terms of applying MD simulations to IEM, CRM and CEM events,
and we have significantly contributed to understanding the mechanism of protein supercharging.
The main goal behind the work in Chapter 2 was to investigate the role played by
cations during protein charging in the positive ion mode. Analytes that have basic groups can be
charged by cation binding which enhances their ionization and detection. Generally, the presence
of non-volatile salts or buffers can be beneficial as most biological samples require the existence
of cations such as Na+ and K+ to preserve native structure and non-covalent complexes.
However, these non-volatile salts can be incompatible with the ESI-MS source. In literature,
these salts can cause interferences and degrade the protein ion signal. The mechanistic
understanding of salt interferences is yet to be explained. Instead of depending on experimental
work only, we employed all-atom molecular dynamics simulation to gain a more detailed image
of the behavior of nanodroplets in the presence of cations such as Na+ and NBu4+. Our findings
showed that salts such as NaCl will cause a major adduction, while not strongly affecting the
protein ion signal. Conversely, NBu4Cl completely degrades the protein ion formation. The main
factor behind their differential response is their free energy of hydration or their surface activity.
The surface accessibility of cation was described by the charge competition model, where species
like NBu4+ can be lost via facile ejection from the surface of the parent droplet. Species like Na+
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cannot be described by the charge competition model; rather it is a simple spread of ion count
over a wide m/z range via adduction.
Supercharging is a relatively new method that represents an addition to the field of
tandem MS. The efficiency of fragmentation in techniques such as electron capture dissociation
(ECD) and CID depends on the extent of charging.

To properly apply these dissociation

techniques, it will be beneficial to understand the mechanism behind protein supercharging. By
using experiments alone, it is impossible to obtain detailed insights into the temporal evolution of
the protein/droplet system during supercharging. The mechanism of supercharging has been
always controversial. In Chapter 3 we used a combination of MD simulations and ESI-MS/IMS
to examine the supercharging mechanism of sulfolane and m-NBA. Our data showed that native
supercharging takes place due to charge trapping; where supercharging agent (SCA) segregation
lead to an aqueous core that contains the protein and Na+/H+ as a charge carrier with an outer
shell of SCA. This layering will allow Na+/H+ to eject from the droplet via IEM with water. Once
water completely evaporates, the outer shell decreases the chances of IEM and the remaining
charges will irreversibly bind to the protein. The protein will be released via CRM and may
undergo gas phase unfolding due to charge repulsion. In Chapter 4, we tested this proposal by
using 18C6. As discussed above, based on our charge trapping hypothesis the solvation
characteristics of SCA determine the fate of charge carriers. 18C6 selectively binds Na+, thereby
enhancing the solubility of charge carriers in the SCA layer and reversing the supercharging
effects. Both MD simulations and experiments show agreement which reflects the utility of MD
simulations in interrogating the behavior of ESI-droplets during supercharging.
In Chapter 5, we studied the ESI mechanism for unfolded proteins. Several years ago,
our laboratory proposed that the CEM can explain the release of proteins under non-native
conditions. There has been a long gap between those earlier proposals and the actual MD
simulations of the current work due to difficulties associated with H+ migration and droplet size.
In the CEM, unfolded proteins migrates to the surface of the droplet due to electrostatic and
hydrophobic factors and get ejected via formation of intermediates where the droplets carry
extended protein tails. Our MD simulations along with ESI-MS/IMS have provided a clear
evidence that unfolded proteins are released via the CEM. To our knowledge, this is the first
study that shows the release of unfolded proteins from the droplet in an atomistic fashion.
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6.2 Future Directions
6.2.1 Studying the Effects of Anions on Protein Ion Signals in Negative Ion
Polarity
Chapter 2 explored the behavior of cations under positive polarity conditions. Even though
positive ion mode is the widely used for protein analysis, negative ion mode is important for
studying DNA and RNA duplexes.10 It will be exciting to explore the effects of anions such as
acetate, formate, chloride, and phosphate in proteins, protein complexes, and DNA in negative
ESI. Using MD simulations and ESI-MS/IMS can give more insights into the behavior of all the
previously mentioned anions especially acetate anion. As ammonium acetate is commonly used
as a “buffer” in direct infusion studies, many experiments have shown that the buffering capacity
of ammonium acetate is not as effective as other buffers, besides some protein-ligand interactions
are unstable in ammonium acetate.11-12

6.2.2 Investigating the Effects of Salts on Protein Supercharging
Chapters 3 and 4 shed light on the mechanism of supercharging. Exploring the effects of salts on
supercharging is important as metal ions such as (K+, Li+) are ligands for some proteins or
protein complexes. MD simulations for those cations in SCAs-containing droplets along with
observing the changes in charge state distributions in ESI-MS can be used to interrogate the
effects of cation size. This can be informative in designing experiments employing
supercharging.

6.2.3 Additional Supercharging Agents
We focused on the most commonly used SCAs sulfolane and m-NBA but studies for additional
SCAs can facilitate a better understanding of protein supercharging. 13-14

171

6.2.4 Examining the Effects of Supercharging Agents in Negative Ion Mode
There is a lot of discussion about whether SCAs increase the charge in the negative ion polarity.
Some reports suggest that m-NBA can efficiently increase charging in the negative ion mode15
while sulfolane fails to boost charges in the negative polarity.16 An expansion of the work
presented will be to investigate different SCAs in negative ion mode using ESI-MS/IMS along
with the MD protocols of Chapters 3 and 4. In negative ion mode, proteins are charged by proton
stripping so MD simulations using mobile proton algorithms have to be applied that can provide
more details about supercharging in the negative ion mode by investigating how H+ is
transferred.17

6.2.5 Uncovering the Mechanism of Supercharging Under Denaturing
Conditions
Unfolded proteins have unique features as they show high charge state distributions. Addition of
SCAs shift the ions to even lower m/z.18-19 Using our MD techniques of Chapter 3 which involve
‘forced evaporation’ of SCAs along with placing the unfolded protein in a big droplet and
judicious choice of pH as in Chapter 5 may be helpful in deciphering the behavior of unfolded
proteins during supercharging.

6.2.6 Can the Chain Ejection Model (CEM) be applied to Intrinsically
Disordered Proteins (IDPs)?
Generally, functional protein should have a compact conformation. IDPs are unique class of
proteins, characterized by loose structures at physiological pH. Despite lacking any stable
structures, they are vital to many cellular processes. This class of proteins is also known to be
associated with human diseases like cancer and Parkinson’s.20-21 Employing our modeling
strategy and ESI-MS/IMS in Chapter 5 will be able to uncover how these proteins are released
from the droplet to improve their characterization using ESI-MS.

172

6.3 References
1.

Gomez, A., Tang K, Physics of Fluids 1994, 6, 404-414.

2.

B., C. R., Journal of Mass Spectrometry 2000, 35, 763-772.

3.

Konermann, L.; Ahadi, E.; Rodriguez, A. D.; Vahidi, S., Analytical Chemistry 2013, 85,

2-9.
4.

Kim, D.; Wagner, N.; Wooding, K.; Clemmer, D. E.; Russell, D. H., Journal of the

American Chemical Society 2017, 139, 2981-2988.
5.

Consta, S.; Oh, M. I.; Malevanets, A., Chemical Physics Letters 2016, 663, 1-12.

6.

Consta, S.; Malevanets, A., Physical Review Letters 2012, 109 , 148301.

7.

Kebarle, P.; Tang, L., Analytical Chemistry 1993, 65, 972A-986A.

8.

Cech, N. B.; Enke, C. G., Mass Spectrometry Reviews 2001, 20, 362-387.

9.

Meyer, T.; Gabelica, V.; Grubmüller, H.; Orozco, M., Wiley Interdisciplinary Reviews:

Computational Molecular Science 2013, 3, 408-425.
10.

Porrini, M.; Rosu, F.; Rabin, C.; Darré, L.; Gómez, H.; Orozco, M.; Gabelica, V., ACS

Central Science 2017, 3, 454-461.
11.

Konermann, L., Journal of The American Society for Mass Spectrometry 2017, 28, 1827-

1835.
12.

Gavriilidou, A. F. M.; Gülbakan, B.; Zenobi, R., Analytical Chemistry 2015, 87, 10378-

10384.
13.

Zenaidee, M. A.; Donald, W. A., Analyst 2015, 140, 1894-1905.

14.

Wang, H.; Yong, G.; Brown, S. L.; Lee, H. E.; Zenaidee, M. A.; Supuran, C. T.; Donald,

W. A., Analytica Chimica Acta 2018, 1003, 1-9.
15.

Ogorzalek Loo, R. R.; Lakshmanan, R.; Loo, J. A., Journal of The American Society for

Mass Spectrometry 2014, 25, 1675-1693.
16.

Douglass, K. A.; Venter, A. R., Journal of The American Society for Mass Spectrometry

2012, 23, 489-497.
17.

Konermann, L., The Journal of Physical Chemistry B 2017, 121, 8102-8112.

18.

Donor, M. T.; Ewing, S. A.; Zenaidee, M. A.; Donald, W. A.; Prell, J. S., Analytical

Chemistry 2017, 89, 5107-5114.
19.

Teo, C. A.; Donald, W. A., Analytical Chemistry 2014, 86, 4455-4462.

173

20.

Beveridge, R.; Phillips, A. S.; Denbigh, L.; Saleem, H. M.; MacPhee, C. E.; Barran, P. E.,

Proteomics 2015, 15, 2872-2883.
21.

Natalello, A.; Santambrogio, C.; Grandori, R., Journal of The American Society for Mass

Spectrometry 2016, 28, 21-28.

174

Appendix I-Permissions

Title:

Author:

Exploring the Mechanism of
Salt-Induced Signal Suppression
in Protein Electrospray Mass
Spectrometry Using Experiments
and Molecular Dynamics
Simulations
Haidy Metwally, Robert G.
McAllister, Lars Konermann

LOGIN
If you're a copyright.com
user, you can login to
RightsLink using your
copyright.com credentials.
Already a RightsLink user or
want to learn more?

Publication: Analytical Chemistry
Publisher:

American Chemical Society

Date:

Feb 1, 2015

Copyright © 2015, American Chemical Society

PERMISSION/LICENSE IS GRANTED FOR YOUR ORDER AT NO CHARGE
This type of permission/license, instead of the standard Terms & Conditions, is sent to you because
no fee is being charged for your order. Please note the following:

▪
▪
▪
▪

▪

Permission is granted for your request in both print and electronic formats, and
translations.
If figures and/or tables were requested, they may be adapted or used in part.
Please print this page for your records and send a copy of it to your publisher/graduate
school.
Appropriate credit for the requested material should be given as follows: "Reprinted
(adapted) with permission from (COMPLETE REFERENCE CITATION). Copyright
(YEAR) American Chemical Society." Insert appropriate information in place of the
capitalized words.
One-time permission is granted only for the use specified in your request. No additional
uses are granted (such as derivative works or other editions). For any other uses, please
submit a new request.

Copyright © 2018 Copyright Clearance Center, Inc. All Rights Reserved. Privacy statement. Terms and Conditions.
Comments? We would like to hear from you. E-mail us at customercare@copyright.com

175

Title:

Author:

Mechanism of Protein
Supercharging by Sulfolane and
m-Nitrobenzyl Alcohol:
Molecular Dynamics Simulations
of the Electrospray Process
Haidy Metwally, Robert G.
McAllister, Vlad Popa, et al

LOGIN
If you're a copyright.com
user, you can login to
RightsLink using your
copyright.com credentials.
Already a RightsLink user or
want to learn more?

Publication: Analytical Chemistry
Publisher:

American Chemical Society

Date:

May 1, 2016

Copyright © 2016, American Chemical Society

PERMISSION/LICENSE IS GRANTED FOR YOUR ORDER AT NO CHARGE
This type of permission/license, instead of the standard Terms & Conditions, is sent to you because
no fee is being charged for your order. Please note the following:

▪
▪
▪
▪

▪

Permission is granted for your request in both print and electronic formats, and
translations.
If figures and/or tables were requested, they may be adapted or used in part.
Please print this page for your records and send a copy of it to your publisher/graduate
school.
Appropriate credit for the requested material should be given as follows: "Reprinted
(adapted) with permission from (COMPLETE REFERENCE CITATION). Copyright
(YEAR) American Chemical Society." Insert appropriate information in place of the
capitalized words.
One-time permission is granted only for the use specified in your request. No additional
uses are granted (such as derivative works or other editions). For any other uses, please
submit a new request.

Copyright © 2018 Copyright Clearance Center, Inc. All Rights Reserved. Privacy statement. Terms and Conditions.
Comments? We would like to hear from you. E-mail us at customercare@copyright.com

176

Title:

Author:

Crown Ether Effects on the
Location of Charge Carriers in
Electrospray Droplets:
Implications for the Mechanism
of Protein Charging and
Supercharging
Haidy Metwally, Lars Konermann

LOGIN
If you're a copyright.com
user, you can login to
RightsLink using your
copyright.com credentials.
Already a RightsLink user or
want to learn more?

Publication: Analytical Chemistry
Publisher:

American Chemical Society

Date:

Mar 1, 2018

Copyright © 2018, American Chemical Society

PERMISSION/LICENSE IS GRANTED FOR YOUR ORDER AT NO CHARGE
This type of permission/license, instead of the standard Terms & Conditions, is sent to you because
no fee is being charged for your order. Please note the following:

▪
▪
▪
▪

▪

Permission is granted for your request in both print and electronic formats, and
translations.
If figures and/or tables were requested, they may be adapted or used in part.
Please print this page for your records and send a copy of it to your publisher/graduate
school.
Appropriate credit for the requested material should be given as follows: "Reprinted
(adapted) with permission from (COMPLETE REFERENCE CITATION). Copyright
(YEAR) American Chemical Society." Insert appropriate information in place of the
capitalized words.
One-time permission is granted only for the use specified in your request. No additional
uses are granted (such as derivative works or other editions). For any other uses, please
submit a new request.

Copyright © 2018 Copyright Clearance Center, Inc. All Rights Reserved. Privacy statement. Terms and Conditions.
Comments? We would like to hear from you. E-mail us at customercare@copyright.com

177

Title:

Author:

Chain Ejection Model for
Electrospray Ionization of
Unfolded Proteins: Evidence
from Atomistic Simulations and
Ion Mobility Spectrometry
Haidy Metwally, Quentin Duez,
Lars Konermann

LOGIN
If you're a copyright.com
user, you can login to
RightsLink using your
copyright.com credentials.
Already a RightsLink user or
want to learn more?

Publication: Analytical Chemistry
Publisher:

American Chemical Society

Date:

Jul 1, 2018

Copyright © 2018, American Chemical Society

PERMISSION/LICENSE IS GRANTED FOR YOUR ORDER AT NO CHARGE
This type of permission/license, instead of the standard Terms & Conditions, is sent to you because
no fee is being charged for your order. Please note the following:

▪
▪
▪
▪

▪

Permission is granted for your request in both print and electronic formats, and
translations.
If figures and/or tables were requested, they may be adapted or used in part.
Please print this page for your records and send a copy of it to your publisher/graduate
school.
Appropriate credit for the requested material should be given as follows: "Reprinted
(adapted) with permission from (COMPLETE REFERENCE CITATION). Copyright
(YEAR) American Chemical Society." Insert appropriate information in place of the
capitalized words.
One-time permission is granted only for the use specified in your request. No additional
uses are granted (such as derivative works or other editions). For any other uses, please
submit a new request.

Copyright © 2018 Copyright Clearance Center, Inc. All Rights Reserved. Privacy statement. Terms and Conditions.
Comments? We would like to hear from you. E-mail us at customercare@copyright.com

178

Title:
Author:

Unraveling the Mechanism of
Electrospray Ionization
Lars Konermann, Elias Ahadi,
Antony D. Rodriguez, et al

Publication: Analytical Chemistry
Publisher:

American Chemical Society

Date:

Jan 1, 2013

LOGIN
If you're a copyright.com
user, you can login to
RightsLink using your
copyright.com credentials.
Already a RightsLink user or
want to learn more?

Copyright © 2013, American Chemical Society

PERMISSION/LICENSE IS GRANTED FOR YOUR ORDER AT NO CHARGE
This type of permission/license, instead of the standard Terms & Conditions, is sent to you because
no fee is being charged for your order. Please note the following:

▪
▪
▪
▪

▪

Permission is granted for your request in both print and electronic formats, and
translations.
If figures and/or tables were requested, they may be adapted or used in part.
Please print this page for your records and send a copy of it to your publisher/graduate
school.
Appropriate credit for the requested material should be given as follows: "Reprinted
(adapted) with permission from (COMPLETE REFERENCE CITATION). Copyright
(YEAR) American Chemical Society." Insert appropriate information in place of the
capitalized words.
One-time permission is granted only for the use specified in your request. No additional
uses are granted (such as derivative works or other editions). For any other uses, please
submit a new request.

If credit is given to another source for the material you requested, permission must be obtained
from that source.

Copyright © 2018 Copyright Clearance Center, Inc. All Rights Reserved. Privacy statement. Terms and Conditions.
Comments? We would like to hear from you. E-mail us at customercare@copyright.com

179

Curriculum Vitae
Haidy Metwally
Department of Chemistry
Western University

Education
-Western University- London-Ontario- Canada (September 2013- present)
• Ph.D. Candidate in Physical and Analytical Chemistry
Principal advisor: Professor/ Lars Konermann.
-Ain Shams University-Faculty of Pharmacy –Cairo-Egypt (2007-2012)
• M.Sc. Honors in Pharmaceutical Sciences-Pharmacognosy
Thesis: Phytochemical and Biological Studies of Some Artocarpus Species, Family
Moraceae- Cultivated in Egypt.
-Ain Shams University –Cairo-Egypt (2000-2005)
• B.Sc.Honors Specialization in Pharmaceutical Sciences.

Experience
-Western University-London-Ontario-Canada (September 2013- present)
•

Teaching and Research Assistant.

-National Organization of Drug Control and Research, Giza, Egypt, (2006-2012)
• Quality Control Specialist.

Honors and Awards
-Canadian Society for Mass Spectrometry (CSMS) travel award (2016)
•

The 29th Tandem Mass Spectrometry Workshop.

-Best Oral Presentation (2016)
•

Enabling Technology (ETP) Symposium in Ottawa.

180

Peer-Reviewed Publications
•

H. Metwally, Q. Duez, and L. Konermann “Chain Ejection Model for Electrospray
Ionization of Unfolded Proteins: Evidence from Atomistic Simulations and Ion
Mobility Spectrometry” Anal. Chem. 90, 10069 (2018).

•

Q. Duez, H. Metwally, and L. Konermann “Electrospray Ionization of Polypropylene
Glycol: Rayleigh-Charged Droplets, Competing Pathways, and Charge StateDependent Conformations” Anal. Chem. 90, 9912 (2018).

•

L. Konermann, H. Metwally, R.G. McAllister, and V. Popa, “How to Run Molecular
Dynamics Simulations on Electrospray Droplets and Gas Phase Proteins: Basic
Guidelines and Selected Applications” Methods 144, 104 (2018).

•

H. Metwally and L. Konermann “Crown Ethers Modulate the Location of Charge
Carriers in Electrospray Droplets: Implications for the Mechanism of Charging and
Supercharging” Anal. Chem. 90, 4126 (2018).

•

T. D. Schachel, H. Metwally, V. Popa, and L. Konermann “Collision-Induced
Dissociation of Electrosprayed NaCl Clusters: Using Molecular Dynamics Simulations
to Visualize Reaction Cascades in the Gas Phase” J. Am. Soc. Mass Spectrom. 27, 1846
(2016).

•

C.E. Bartman, H. Metwally, and L. Konermann “Effects of Multidentate Metal
Interactions on the Structure of Collisionally Activated Proteins: Insights from Ion
Mobility and Molecular Dynamics Simulations” Anal. Chem. 28, 6905 (2016).

•

H. Metwally, R.G. McAllister, V. Popa, and L. Konermann “Mechanism of Protein
Supercharging by Sulfolane and m-NBA: Molecular Dynamics Simulations of the
Electrospray Process” Anal. Chem. 88, 5345 (2016).

•

R.G. McAllister, H. Metwally, Y. Sun, and L. Konermann “Release of Native-Like
Gaseous Proteins from Electrospray Droplets via The Charged Residue model: Insights
from Molecular Dynamics Simulations” J. Am. Chem. Soc. 137, 12667 (2015).

•

H. Metwally, R.G. McAllister, and L. Konermann “Exploring the Mechanism of Salt
Induced Signal Suppression in Protein Electrospray Mass Spectrometry Using
Experiments and Molecular Dynamics Simulations” Anal. Chem. 87, 2434 (2015).

•

L. Konermann, R.G. McAllister, and H. Metwally “Molecular Dynamics Simulations
of The Electrospray Process: Formation of NaCl Clusters via the Charged residue
Mechanism” J. Phy. chem. B. 118, 12025 (2014).

181

Presentations and Posters
•

H. Metwally, and L. Konermann “Crown Ethers Modulate the Location of Charge
Carriers in Electrospray Droplets: Implications for the Mechanism of Protein Charging
and Supercharging” 66th ASMS Conference on Mass Spectrometry and Allied Topics San Diego- California-USA (2018).

•

H. Metwally, and L. Konermann “Crown Ethers Suppress Protein Supercharging in
Native ESI-MS: Evidence for a Charge Trapping Mechanism” 30thLake Louise
Workshop on Tandem Mass Spectrometry- Lake Louise-Alberta (2017).

•

H. Metwally, and L. Konermann “Molecular Dynamics Simulation of Electrospray
Process: Why Do Crown Ethers Suppress Protein Supercharging?” 9thInternational
Symposium on Enabling Technologies-Ottawa (2017).

•

H. Metwally, and L. Konermann “Mechanism of Protein Supercharging by Sulfolane
and m-NBA” 29thLake Louise Workshop on Tandem Mass Spectrometry- Lake LouiseAlberta (2016).

•

H. Metwally, and L. Konermann“ Mechanism of Protein Supercharging by Sulfolane
and m-NBA: Molecular Dynamics Simulations of the Electrospray Process” 33rd
Annual Trent Conference workshop on Mass Spectrometry- Toronto (2016).

•

H. Metwally and L. Konermann “Mechanism of Protein Supercharging by Sulfolane
and m-NBA: Molecular Dynamics Simulations of the Electrospray Process” 21st
International Mass Spectrometry Conference-Toronto (2016).

•

H. Metwally and L. Konermann “Exploring the Mechanism of Salt-Induced Signal
Suppression in Protein Electrospray Mass Spectrometry Using Experiments and
Molecular Dynamics Simulations” 98th Canadian Chemistry Conference and
Exhibition-Ottawa (2015).

•

H. Metwally, and L. Konermann “Mechanism of Salt-Induced Signal Suppression in
Protein ESI-MS” 31th Annual Trent Conference on Mass Spectrometry- Orillia (2014).

